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Outline 
Biomaterial and device engineering was in rapid development during the past 
decades and led to new perspectives for a large variety of applications in drug 
development, regenerative medicine and healthcare. In particular, microengineering 
tools and methods are now widely used to fabricate either two or three dimensions 
culture substrate or scaffolds to mimic the extracellular matrix for both in vitro and 
in vivo assays. Microengineering tools and methods are also used to fabricate 
microfluidic devices to more efficiently control the cell factors and physiological 
conditions in vitro.  
The purpose of this thesis work is to develop new tools and methods which can 
solve the current problems encountered in stem cells and cancer studies. 
Stem cells and pluripotent stem cells in particular are powerful for the 
development of new methods and new tools in tissue engineering and regenerative 
medicine. Yamanaka and John Gurdon were awarded the Nobel Prize in 2012 for the 
discovery that mature cells can be converted to embryonic-like stem cells (induced 
pluripotent stem cells or iPSCs), which can be differentiated into various specialized 
cell types. Their discovery holds very high potential for tissue engineering and 
transplantation therapy. So far, the studies on iPSCs are mostly based on 
conventional culture methods, i.e. the culture dish methods, which are not 
appropriate for most of envisaged applications. Therefore, there is a clear need for 
devices and methods for iPSC culture and handing under optimal physiological 
conditions and highly compatible to both in vitro and in vivo assays. In this work, we 
developed a culture patch method, which is based on the fabrication of crosslinked 
monolayer gelatin nanofibers, for iPSCs culture and differentiation. We show that 
both cardiomyocytes and neurons can be obtained on the culture patch under 
off-ground culture conditions and that the derived cardiac and neural patches can be 
used for removable electrophysiological measurements.   
Cancer cells and circulation tumor cells in particular are objectives of a huge 
number of investigations since many decades. In this work we focus on cancer 
diagnosis since the early diagnosis is significant to decrease mortality, which will 
also benefit for the further therapy. Capture of circulating tumor cells (CTCs), which 
have strong relation to metastasis, was chosen as the method for cancer diagnosis 
due to its ease of operation and non-invasion. In this thesis, we propose a new 
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microdevice to solve the main problems in the field of CTCs capture, including 
improving efficiency and viability, as well as minimizing contamination. Besides, 
building in vitro solid tumor model is significant for deep understanding the 
complexity and mechanism of tumor and anti-cancer drug studies. Multicellular 
tumor spheroid model has been proved to be an efficient model for evaluations of 
drug sensitivity and resistance compared to 2D monolayer cell culture. In this work, 
we develop a multi-well array with millimeter size for tumor spheroids formation 
and anti-cancer drug tests.  
Accordingly, this thesis is organized as follows: 
In chapter one, we first introduce the basic concepts of cell and cellular 
microenvironment. Then, we focus on two types of cells, i.e. induced pluripotent 
stem cells (iPSCs) and circulating tumor cells (CTCs), and the needs of advanced 
microdevice technologies for their in vitro manipulation. Next, we describe the state 
of the art developments of patterned substrates and scaffolds as well as microfluidics 
techniques. Finally, we outline the objectives of this thesis work. 
In chapter two, we present the technological development of this thesis work. 
Firstly, we describe the electrospinning technique for the fabrication of gelatin 
nanofiber scaffolds. Then, we introduce hydrogel formation techniques, with special 
focus on poly (ethylene glycol) (PEG) based hydrogel. Afterwards, we present 
several lithography techniques for surface patterning and microfluidic device 
fabrications. 
In chapter three, we present a study of culture and differentiation of induced 
pluripotent stem cells by using culture patch method. We first describe the 
fabrication of the culture patch which consists of a monolayer of crosslinked gelatin 
nanofibers formed on a honeycomb frame made of biocompatible polymer. Then, we 
present the results of cell proliferation on culture patch under off-ground culture 
condition. Next, we show how human pluripotent stem cells (hiPSCs) can be 
differentiated into cardiomyocytes and neurons on the culture patch under off-ground 
culture conditions and how this method is advantageous comparing to the 
conventional culture dish method.  
In chapter four, we present a study of isolation and culture of cancer cells. We 
first describe the development of a CTCs isolation technique by using conical shape 
holes and microfluidic device. The processing parameters such as flow rate and cell 
density are studied for different types of tumor cells. Cell culture is also performed 
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after isolation to show the post-isolation capability of the proposed device. 
Afterward, clinical trials are performed and mechanical analysis is used to 
theoretically demonstrate the advantages of the conical shape holes of the filter and 
the microfluidic design. Finally, we descried a multi-well device for tumor spheroids 
formation. The performances of the culture with three different types of materials are 
compared, showing the suitability of agarose formed device. Then, we show the drug 
effects on the tumor spheroids formation. 
In chapter five, a summary of the present thesis is given, together with a 
perspective of this work. 
In appendix, we present a method for depositing graphene dioxide (GO) on 
gelatin nanofiber patch. Raman spectra is applied to characterize the incorporation of 
GO on nanofibers. 
Outline 
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In this chapter, we first introduce the basic concepts of cell and cellular 
microenvironment. Then, we focus on two types of cells, i.e. induced pluripotent 
stem cells (iPSCs) and circulating tumor cells (CTCs), and the needs of advanced 
microdevice technologies for their in vitro manipulation. Next, we describe the state 
of the art developments of patterned substrates and scaffolds as well as microfluidics 
techniques. Finally, we outline the objectives of this thesis work. 
1.1 Cell and cellular microenvironment  
1.1.1 Cell 
The human body is made of eight interacting systems, including motor system, 
respiratory system, nervous system, circulating system, digestive system, endocrine 
system, urinary system and reproductive system. And each of them is functioning 
with specific and cooperative organs, such as heart and vessel in circulating system, 
ensuring the major activities of the body. The organs are formed by body tissues and 
each of them is composed of different types of cells, for instance, cardiomyocytes 
constitutes cardiac muscle tissue. Therefore, cells are the basic structural and 
functional units of the human body. Fig. 1.1 shows the levels of nervous system. 
 
Fig. 1.1 The human brain, like other body organs, is made of a huge number of cells 
of many types in a sophisticated but highly complex way [1]. 
As the smallest unit of life, cells are considered as "building blocks of life". The 
number of cells in human is more than 10 trillion [2]. The structure and the 
organization of cells are also sophisticated and highly complex, as shown as Fig. 1.2. 
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Each cell has a membrane, called plasma membrane and made mostly from a double 
layer of phospholipids. The membrane surrounds the cytoplasm of a cell, divides the 
interior of cell from its outside environment, regulates that move different molecules 
into and out of the cell, and maintains the electric potential of the cell. Inside the 
membrane, a salty cytoplasm takes up most of the cell volume and acts to organize 
and maintain the shape of cell. The eukaryotic cytoskeleton contains microfilaments, 
intermediate filaments and microtubules. There are numbers of proteins associated 
with them, and regulate the structure of cells by directing, bundling, and aligning 
filaments. Cell nucleus is the information center, containing most of genetic material 
of cell. The nucleus offers a place for genetic transcription which is segregated from 
the location of translation in the cytoplasm, allowing levels of gene regulation. The 
main function of the cell nucleus is to regulate gene expression and DNA replication 
during the cell cycle.  
  
Fig. 1.2 Scheme of the intracellular structure of a typical animal cell [3]. 
 
1.1.2 Cellular microenvironment 
The behavior and function of a cell are influenced by the immediate 
environment of the cell, named the cellular microenvironment. The structure and 
composition of the cellular microenvironment are also sophisticated and complex, 
which are coupled with cells as via biophysical, biochemical and other routes. 
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Considering an adhesion cell in a body, its cell microenvironment is composed of (i) 
extracellular matrix (ECM), (ii) homotypic or heterotypic cells surrounding the 
single cell, (iii) cytokines, hormones, and other bioactive agents around the cells due 
to autocrine, endocrine, and paracrine secretions, (iv) nano/microscale topography 
and physical properties of the adjuvant cells and the ECM, and (v) mechanical and 
dynamic forces caused by the movement of the organism or the movement of the 
physiological fluids such as blood. All these have a compound effect on the behavior 
of the cells, where the relative importance of each component is tissue and cell type 
dependent [4]. The controlling of the cellular microenvironment is a key aspect for 
understanding cell biology. And the cues derived from the surrounding 
microenvironment regulate cellular behaviors such as attachment, spreading, 
proliferation, migration and differentiation. 
 
a) Extracellular Matrix 
The extracellular Matrix (ECM) is the extracellular part of the body tissue 
providing the structural and biochemical support to the cell and regulating the cell 
behaviors such as cell adhesion, proliferation, migration and differentiation [5-8].  
Fig. 1.3 shows the composition of ECM. Generally, it is considered that the 
ECM consists of two classes of insoluble biomacromolecules. One predominant 
component is the insoluble macromolecules, protein fibers including collagen and 
elastin which are structural fibers providing tensile strength to the ECM, as well as 
other proteins such as fibronectin, laminin and vitronectin which are adhesive fibers 
defining ECM function by acting as adhesive ligands.  
 
Fig. 1.3 Schematic of the composition of ECM [9]. 
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Among them, collagen is the most abundant protein in ECM (accounts for 90% 
of bone matrix protein content), with more than 20 types of structures supporting the 
fibrin structure for cells [10-14]. Elastin, in contrast to collagens, give elasticity to 
tissues, is found in large quantities in tissues requiring elastic properties such as 
artery and bladder tissues [15]. Fibronectin and laminin are mainly in charge of 
adhesion to ECM, which are also widely used for substrate treatment before cell 
culture [16]. Another class of biomacromolecule is glycosaminoglycans, only 
playing roles in structure network and tissue resilience, but not deciding cell fate. In 
addition, proteoglycans have negative charge which can attract positive charged 
sodium ions (Na+), and help trap and store water molecules and keeps the ECM 
hydrated. Besides, growth factors are also an essential component in the matrix of 
ECM, such as fibroblast growth factor (FGF), epithelial growth factor (EGF) and 
vascular endothelial growth factor (VEGF). Typically growth factors as signaling 
molecules between cells are important for regulating a variety of cellular processes, 
including stimulating cellular growth, proliferation, healing, and differentiation [17]. 
Table 1.1 summarizes the ECM components and their role in ECM dynamics. 
Table 1.1 ECM components and their role [18]. 
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b) Cell-ECM interaction 
The interaction between cell and ECM is mainly controlled by specific 
cell-surface cellular adhesion molecules (CAM) known as integrin (shown in Fig. 
1.3), which is a family of cell surface receptors attaching cells to the ECM and 
mediating mechanical and chemical signals from it. These integrin signals control 
the activities of growth factors receptors, ion channels, cytoplasmic kinases, and the 
intracellular actin cytoskeleton organization, directing cells to live or die, to 
proliferate, or to exit the cell cycle and differentiate. There are two subunits of 
integrin, α and β, which are bound covalently together. During their inactive state, 
integrin are freely diffusive within the cell membrane until they encounter an 
available binding domain in the ECM [19]. Once ligand binding, there will be a 
conformational change within integrin leading to the cytoplasmic proteins 
recruitment. These larger and clustered structures of integrin, such as fibronectin and 
laminin, and cytoplasmic proteins are generally called cell adhesions. The 
attachment of fibronectin to the ECM domain recruits intracellular signaling 
pathways as well as association with the cellular cytoskeleton via a set of adaptor 
molecules such as actin [20]. Therefore, integrin-mediated cell adhesions provide 
dynamic, bidirectional links between the cytoskeleton and the ECM, promoting 
cytoskeleton rearrangement and also inducing changes in cell shape which in turn 
alter the ability of cell proliferation or differentiation [21].  
 
c) Cell-Cell interaction 
The cell–cell interaction refers to the direct interactions between cell surfaces, 
playing a critical role in the function and development of multicellular organisms. 
This interaction between cells allows cells to communicate with each other in 
response to the changes in their microenvironment. The capacity of sending and 
receiving signals is crucial for the cell survival. The loss of communication between 
cells can result in uncontrollable cell growth and cancer. The cell-cell interactions 
involve cell junctions which are multiprotein complexes. Cell junctions can be 
divided into three categories, based upon the functions they serve (Fig. 1.4): tight 
junctions, anchoring junctions, and communicating junctions (called gap junction in 
animal) [22]. Tight junctions are multi-protein complexes that hold cells of a same 
tissue together and prevent movement of water and water-soluble molecules between 
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cells. Gap junction, which is composed of transmembrane proteins called connexins, 
is the main site of cell-cell signaling or communication allowing small molecules to 
diffuse between neighboring cells. Cell-cell interactions for adhesion can be 
mediated by cadherin, which is a family of adhesion receptors, and essential for 
anchoring cells to their niche directing cell behaviors.  
 
Fig. 1.4 Three major types of cell junctions: (a) tight junction; (b) anchoring junction; 
(c) communicating junction [22]. 
 
d) Extracellular fluid 
The native extracellular microenvironments are extremely heterogeneous in 
three-dimension and they undergo dynamic and continuous remodeling with time. 
Therefore, biomechanical forces indisputably play a significant role within cellular 
microenvironment. Extracellular fluid (ECF) is one of these forces that can drive 
biochemical and biophysical changes with the cellular microenvironment. Typically, 
ECF represents all body fluid outside of the cells. ECF provides the cells of the body 
with nutrients and a means of waste removal. In mammals, the ECF can be divided 
into two main components: interstitial fluid and blood plasma. The interstitial fluid is 
found in the spaces between cells, which plays an important role in cellular behavior, 
signaling, lymphangiogenesis and angiogenesis. Blood and lymphatic vessels are 
continually exposed to mechanical forces. ECF plays a crucial role in various 
physiological and disease systems. In cancer, interstitial fluid flow may cause 
reorganization of the ECM and promote the invasion of tumor cells regulated by 
autologous chemotaxis. When tumor reach a critical size, new blood vessel is 
generated via secretion of VEGF, leading to an increase in interstitial fluid pressure 
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in tumors. Due to the high dynamic and complex condition of the cell-ECM 
interaction, a detailed understanding of the dynamic aspects of cellular 
microenvironment in terms of spatial and temporal variations of different chemical, 
mechanical, and biological stimuli is highly important in tissue or organ engineering 
[23]. 
 
1.1.3 Cell culture 
Cells can be isolated from a body tissue and cultured outside their natural 
environments in vitro. By controlling the conditions in culture, the complex cellular 
processes can be maintained or changed by design. The mammalian cell cultured in 
vitro was demonstrated for the first time in the early 20th century [24]. Afterwards, 
this technique was widely developed and applied in biological laboratories, 
pharmaceutical companies and hospitals for fundamental research, diagnosis, drug 
screening and therapeutic purposes. The development of a culture beyond the 
primary culture results in a “cell line.” The importance of a cell line lies in its ability 
to provide a renewable source of cell material for repeat studies. Currently, various 
cell lines, the corresponding culture medium and protocols are available 
commercially. A number of biological therapeutics such as antibodies, clotting 
factors, hormones, immune-adhesions, and vaccines have been produced by the cell 
culture related bio-production systems. 
Basically, cells can be cultured under certain temperature and gas mixture 
conditions which could mimic the in vivo environment of cells by an incubator (ex. 
37°C, 5% CO2 for mammalian cells). Culture medium is one of the critical factors 
for cell culture, which is in specific pH and normally contains the essential nutrients, 
glucose and growth factors. The growth factors are usually derived from animal 
blood, such as calf serum [25].  
Conventionally, cells are cultured in culture dishes, flasks, multi-well plates, etc., 
the surfaces in such culture platforms are commonly flat in two dimension and 
treated by surface coating or other methods to provide a better cell adhesion and 
proliferation. However, this in vitro environment for cells is still different from that 
in vivo. In vitro, the in vivo cell-cell interaction may lost and cells may have some 
kinds of genetic and phenotypic instability. To mimic the natural environment in vivo, 
various sophisticated methods and instruments have been developed to modulate cell 
behaviors by supplying appropriate conditions, and a mass of research has been 
Chapter 1 Introduction 
14 
developed to culture cells on more complex substrates with physical or chemical 
topographic cues. Before introducing the state of the art of these approaches, we 
briefly describe the stem cell technologies since their behaviors and functions are 
more critically depending on the cellular microenvironment.    
 
1.2 Stem cell and induced pluripotent stem cells  
1.2.1 Stem cell 
Stem cells are undifferentiated cells with capacities of differentiation into 
specialized cell types and division to produce more stem cells. Due to their 
outstanding properties they hold great potential as tools for the application in tissue 
engineering, regenerative medicine as well as in vitro modeling for disease study, 
drug screening and toxicity tests [26].  
Typically, a stem cell is required to possess two main properties: 
Self-renewal: defined as the capacity to go through numerous cycles of cell 
division while maintaining the undifferentiated state. 
Potency: defined as the ability to differentiate into specialized cell types, which 
requires stem cells to be either totipotent or pluripotent—to be able to generate any 
type of mature cells.  
Stem cells are rare in most tissues. Accordingly, in order to study their properties, 
stem cells have to be identified prospectively and purified carefully. However, the 
rigorous identification and purification of these somatic stem cells has only been 
achieved in a few occasions [27]. For instance, hematopoietic stem cells (HSCs) 
have been isolated from mice and humans [28, 29], and have been proved to be 
responsible for the generation and regeneration of the blood-forming and immune 
systems.  
Basically, by different differentiation potentials, stem cells can be classified into 
three types: totipotent, pluripotent, and multipotent stem cells, as shown in Table 1.2 
[30].Tissue-specific multipotent adult stem cells have been isolated from various 
adult tissues in many species. Besides, embryonic stem cells (ESCs) have been 
isolated from embryos, which have the ability to differentiate into all types of cells in 
an adult organism. In recent years induced pluripotent stem cells (iPSC) have drawn 
increasing attention to be the substitution of ESCs [31]. 
Chapter 1 Introduction 
15 
Table 1.2 Classification of stem cells according to their differentiation potentiality 
(totipotent, pluripotent, and multipotent)[30].  
 
 
1.2.2 Induced pluripotent stem cells 
The investigation of induced pluripotent stem cells, also known as iPS cells or 
iPSCs, which can be generated directly from somatic cells and differentiated into 
almost any kind of cell types, were pioneered by Shinya Yamanaka in 2006 at Kyoto 
University, who was awarded the 2012 Nobel Prize “for the discovery that mature 
cells can be reprogrammed to become pluripotent”[31, 32]. In their work, Yamanaka 
et al introduced four specific genes encoding transcription factors, also dubbed 
“reprogramming factors” or “Yamanaka factors”, including Oct4 (Pou5f1), Sox2, 
cMyc, and Klf4, into a given cell type to derive iPSCs.  
iPSCs are able to be differentiated into ectodermal, mesodermal and endodermal 
cells (Fig. 1.5), which are extremely similar to natural pluripotent stem cells, such as 
embryonic stem cells (ESCs) in many aspects, including the expression of certain 
stem cell genes and proteins, doubling time, chromatin methylation patterns, 
embryonic body formation, viable chimera formation, potency and differentiability, 
but the full extent of their relation to natural pluripotent stem cells is still being 
assessed [33]. However, ESCs derived from human embryo are strictly prohibited in 
many countries, so the number of ES cell lines that are approved for research usage 
is very limited. This ban constrains the possibility to solve some of the most urgent 
questions, especially those relating to the modeling and curing disease [34]. iPSCs 
may probably be supplements to ESCs on the regenerative medical application. 
iPSCs from patient provide a specific platform from which to get mechanistic 
information of various diseases, to carry out in vitro drug screening, to evaluate 
potential therapeutics and to explore gene repair coupled with cell-replacement 
therapy. Additionally, most ESCs represented generic cells isolated from presumably 
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normal embryos. And they are genetically foreign to any particular patient, then 
during transplantation process, immune rejection can occur because recipient's body 
does not recognize the transplanted cells or require that the recipient take lifelong 
therapy with toxic immunosuppressive medication, while the iPSCs generated by 
reprogramming could avoid the immune rejection risk [35]. Thus iPSCs are now 
studied more and more for prospective applications in disease modeling, cell therapy 
and regenerative medicine [36, 37]. 
 
Fig. 1.5 Human iPSCs derivation, differentiation and applications. [38] 
 
However, no general method is yet available for mass production of high quality 
hiPSCs with minimized risks of genetic instability and tumorigenicity. Previous 
studies have shown that both culture medium and culture substrate affect the cell fate 
decision of hiPSCs but only limited efforts have been devoted to the effects of 
culture stadium and it is not clear what are the best material stiffness and the best 
surface morphology of the stadium for clinic grade applications.  
The first concern of iPSCs culture is the proliferation, i.e., iPSCs have to be 
propagated over many generations without losing their pluripotency, their purity and 
quality. Under conventional culture conditions, hiPSCs are impure and show often 
important chromosomal abnormalities and high tumorigenic risk. By adding feeder 
cells [39] or using Matrigel coated substrate [40], the quality of hiPSCs could be 
largely improved but both are not relevant for clinic applications because of the 
presence of animal factors. Xeno-free conditions have been achieved using culture 
substrates coated with recombinant proteins such as laminin, vitronectin, E-cadherin 
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or synthetic polymers culture substrates [41]. These studies, together with additional 
assays using non flat substrates [41], highlight the importance of using appropriate 
extracellular matrix (ECM) proteins /molecules and textured surfaces which take 
into account some of the specificity of in vivo stadium but not allow regulating other 
aspects of cellular microenvironments, i.e., soluble factors and cell-cell interaction.   
The second concern of iPSC culture is the controlled differentiation. iPSCs have 
been re-differentiated into several somatic tissues, including active motor neurons 
[42-44], insulin-secreting islet-like clusters [45], hepatocyte cells[46, 47] and a 
number of cardiovascular cells (arterial endothelium, venous endothelium, lymphatic 
endothelium, and cardiomyocytes) [48, 49]. However, how to efficiently derive 
iPSCs into well-defined cellular lineages with high yields and high purity becomes 
the primary point. Since adult cells such as cardiac and neurons have different 
morphology and different physiochemical and biochemical responses which impose 
different organization and different mechanic stiffness. In many cases, the 
differentiated stem cells have better to be organized in form of tissues for easy 
applications which suggestion the importance of cell-cell interaction under less 
imposed conditions. In this thesis, we are mainly focusing on cardiomyocytes and 
motor neuron differentiation. 
 
1.3 Cancer and circulating tumor cells 
1.3.1 Cancer 
Cancer, also known as malignant tumor or malignant neoplasm, is a group of 
diseases involving abnormal cell growth with the potential to invade or spread to 
other parts of the body [50]. The progression from normal cells to cells that can form 
a detectable mass to outright cancer involves multiple steps known as malignant 
progression and it accounts for millions of deaths every year worldwide. In 2008, the 
death due to cancer was around 13% of all human deaths (7.6 million), and this 
number is projected to pass 13 million in 2030 [51, 52].  
All tumor cells show six hallmarks of cancer, including i) Cell growth and 
division without the proper signals to do so; ii) Continuous growth and division even 
when there are signals telling them to stop; iii) Avoidance of programmed cell death; 
iv) Limitless number of cell divisions; v) Promoting blood vessel construction; vi) 
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Invasion of tissue and formation of metastases [53]. 
Despite all efforts by scientists, cancer is still one of the leading causes of death. 
In 2012 about 14.1 million new cases of cancer occurred globally (not including skin 
cancer other than melanoma)[54]. However, among all the cancer related mortalities, 
metastasized cancer accounts for 90%. So complete understanding metastasis is 
significant for decreasing cancer resulted death and conquering cancer.  
 
1.3.2 Metastasis and circulating tumor cells  
Metastasis, or metastatic disease, is the spread of a cancer or other disease from 
one organ or part to another not directly connected with it. Cancer metastasis is a 
complex process, which is still not completed understood. But it has been proved 
that during metastasis, circulating tumor cells (CTCs) play a critical role.  
CTCs were discovered firstly by the Australian pathologist Thomas Ashworth in 
1869 in the blood of a patient with metastatic cancer, who noted that some cells 
present in the blood did not look like normal blood cells, while appeared similar to 
those in the patient's solid tumors. He postulated in the article in Australian Medical 
Journal that “cells identical with those of the cancer itself being seen in the blood 
may tend to throw some light upon the mode of origin of multiple tumors existing in 
the same person”. A whole comparison of the morphology of the circulating cells to 
cancer cells led Ashworth to conclude that “One thing is certain, that if they (CTCs) 
came from an existing cancer structure, they must have passed through the greater 
part of the circulatory system to have arrived at the internal saphena vein of the 
sound leg”[52, 55-57]. Over one hundred and forty years, cancer research has indeed 
confirmed that the critical role of CTCs in the metastasis of carcinomas [58].  
The dominate perception consists that metastasis includes three steps: epithelial 
to mesenchymal transition (EMT) and invasion, hematogeneous spread and 
extravasation, and then metastatic colonization, as shown as Fig. 1.6. 
 
a) Epithelial to mesenchymal transition (EMT)  
In 2005, Elizabeth Hay (Harvard University, Boston, MA), first described the 
EMT [59], a morphogenetic process in which cells lose their epithelial 
characteristics and gain mesenchymal properties during embryogenesis, wound 
healing, and carcinoma invasion and acquire a fibroblast-like morphology [60, 61]. 
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One critical event in EMT is the downregulation of E-cadherin with the phenotypic 
change of tumor cells, which will reduce the cell-cell adhesion and improve the 
motility of cancer cells in primary tumor [62]. The EMT process in cancer metastasis 
is highly complex and still mostly not understood but it is believed that it is a 
hallmark of metastasis and proposed to induce cancer stem cell (CSC) properties in 
non-CSCs [63, 64]. 
 
a) Hematogeneous spread and extravasation 
After EMT process, cancer cells exhibit a motile, invasive phenotype, which 
enable them to detach from the tumor body and enter into circulation, but it is 
believed that CTCs could not proliferate in circulation system [58, 65]. Then 
following with blood flow, CTCs could travel to other part of body until they are 
captured at capillary beds of specific organs [66, 67]. Then CTCs penetrate through 
endothelial cells layer and invade into the secondary organ. 
 
b) Metastatic colonization and secondary tumor formation  
Once CTCs successfully invade into secondary host organ, they will undergo the 
mesenchymal to epithelial transition (MET) [68, 69]. As opposed to EMT, the 
converse MET is associated with the downregulating of mesenchymal phenotypes 
and upregulation of epithelial phenotypes. Then the cancer cells start to proliferate 
and colonize in the new environment to form secondary tumor. 
 
Fig. 1.6 Process of cancer metastasis. Tumor cells shed into the vasculature from a 
primary tumor and circulate in the bloodstream. Then CTCs extravasate into a distant 
area and form new metastatic colony [70]. 
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1.3.3 Cancer diagnosis techniques 
The earlier diagnosis of primary tumor, which will warn the further metastasis, 
is believed to be the key weapon to win the war on cancer. Currently, there are three 
main techniques for cancer diagnosis (Fig. 1.7), including imaging, bio-spy and 
blood analysis [71]: 
  
Fig. 1.7 Cancer diagnosis techniques 
a) Imaging  
Oncologists use imaging methods to detect the visible signs of tumors. Normally 
it relies on a series of diagnostic imaging tests, including:  
i. X-Rays: by using X-Rays, the basic images of dense areas in the body 
(such as tumors) could be obtained. 
ii. CT Scans: by using electromagnetic imagery, the detail images of 
internal structures can be created. 
iii. Magnetic resonance imaging (MRI): it can produce images of highly 
active internal structures by magnets and radio waves. 
iv. Positron emission tomography (PET) scans: by PET scanning, the areas 
of the body which have abnormally high and potentially cancerous 
metabolic activity. 
However, some of the early tumors are too small to be detected by the 
techniques mentioned above, which will delay the illness and make wrong diagnosis. 
 
b) Bio-spy  
Bio-spy means that doctors have to take out some tissue samples from the 
patient body and send to a laboratory for evaluations by microscope or other 
machines. It can reveal that whether a growth is cancerous or benign and where the 
cancer originates and what type of cancer cells, which plays a significant role for the 
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treatment plan decision.  
There are several ways for the doctors to obtain the samples for bio-spy, such as: 
i. Fine-needle aspiration, which could extract cells through a thin, hollow 
needle; 
ii. Excisional bio-spy, which removes the whole tumor from the body and 
test the certain samples of the tumor. 
iii. Thoracoscopy or Mediastinoscopies: doctors insert a camera-equipped 
tube into the chest of patients for sampling.  
Although bio-spy normally results into a more accurate diagnosis, tissue damage 
could be happened during the sampling process, which may lead some cancer cells 
to run out from the original tumor and cause metastasis[72]. 
 
c) Blood analysis  
In recent years, researchers have spent a considerable amount of time to develop 
blood test methods for cancer diagnosis. Part of them focuses on detecting tumor 
specific biomolecules, such as specific-proteins which are present in certain cancer 
patients.  
Another part of blood analysis focused on cancer cells, especially circulating 
tumor cells (CTCs). CTCs are derived from primary tumor and penetrate into 
circulating systems, such as blood vessel, which are significant markers to real-time 
monitor the metastasis of cancer patients. Therefore, more and more attentions have 
been paid to explore cancer diagnosis methods based on CTCs. 
 
1.3.4 CTCs isolation 
The major challenge of CTCs isolation is the rarity of CTCs in blood (Fig. 1.8), 
even in patients with advanced metastatic cancer, CTCs are in the range of a few 
cells per milliliter blood [73]. Besides, there are also estimated a few million white 
blood cells (WBCs), a few billion red blood cells (RBCs) and some other kinds of 
cells surrounding one CTC in 1 ml of whole blood [74]. Thus, high efficiency and 
high purity of isolating of CTCs is the primary step for the further CTCs analysis.  
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Fig. 1.8 The rarity of CTCs in blood [75]. 
Recent years, there are numerous techniques developed for CTCs capture (Fig. 
1.9). Currently, two approaches are in competition, depending on whether or not the 
capture is affinity-based. The affinity-based capture relies on immunochemical 
interaction between magnetic beads [72, 76-80] or patterned structures [81-84] and 
tumor cells that express special surface markers such as EpCAM, an epithelial cell 
adhesion molecule over expressed by majority of tumor cells. These methods are 
efficient for capturing CTCs of epithelial phenotypes but not applicable to those with 
down-regulated or lost epithelial markers. It is known that when epithelial cells of 
solid tumors enter into a blood stream they may undergo epithelial to mesenchymal 
transition [85, 86]. In contrast, the non-affinity methods, including centrifuging 
deflection [87-91], dielectrophoretic separation [92-94] and size-based filtration [76, 
95-108] are able to isolate both epithelial and mesenchymal phenotypes, which are 
more appropriate for analyses of tumor heterogeneity, tumor drug resistance, etc. 
However, these approaches are technologically biased and it is often difficult to 
reach a trade-off between capture efficiency, purity and cell viability which are all 
important criteria for both fundamental and clinical studies. For example, the 
size-based filtration has been developed for more than several decades but the most 
of reported results were obtained by using track-etched polycarbonate filters [76, 
95-99]. The main problem of this approach is contamination: the track-etched 
cylindrical holes of the filter have generally high retention ratio of non-tumor cells if 
the size of the holes is sufficiently small to reach high tumor cell capture efficiency. 
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Furthermore, the randomly distributed holes are prone to significant coalescence of 
two or more holes allowing tumor cells to escape from the filter. More recent studies 
have shown that a variety of microfabrication techniques could be used to 
manufacture filters of different hole-types and densities [36-45], but none of them 
were able to meet the critical requirements for both clinical application and 
fundamental studies. 
 
1.3.5 Cancer cell culture 
With many recent advances, cancer cell culture research is more important than 
ever before. Due to the limitation of CTCs sources, most of current cultured cancer 
cells are either isolated from primary tumor or specific cancer cell lines. There are 
various methods to characterize and authenticate cell lines, to isolate and develop 
specific types of cancer cells, and to develop new cell line models. Functional assays 
are provided for the evaluation of clonogenicity, cell proliferation, apoptosis, 
adhesion, migration, invasion, senescence, angiogenesis, and cell cycle parameters. 
Other methods permit the modification of cells for transfection, drug resistance, 
immortalization, and transfer in vivo.  
As we know that before metastasis, a primary tumor was formed at the 
anatomical site where tumor progression started to yield a cancerous mass. Therefore, 
one strategy in drug discovery is to against the tumor progression. However, the 
most previously used cell based assays for cancer drug studies are based 
two-dimensional (2D) culture which does not take properly into account the three 
dimensional (3D) characteristics of tumor formation in vivo [109, 110]. And it is 
becoming more and more apparent that 2D monolayer cultures of tumor cells cannot 
completely represent the characteristics of three-dimensional solid tumors. 
Consequently, the multicellular tumor spheroid model, which is of intermediate 
complexity between in vivo tumors and monolayer cultures, was developed [111].  
Suspension culture is frequently used for multicellular spheroid formation but it 
is not easy to control the size consistency of the spheroids and to handle them for 
systematic studies [112, 113]. Suspension culture using spinning flask or rotating 
bioreactors can improve the size uniformity of the spheroids but undesired shear 
stress can be introduced during the spheroid formation. Culture with hanging drops 
can also improve the size uniformity and overcome the problem of mechanical 
disturbance. This technique is however time-consuming and not easy to perform 
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drug tests during spheroid progression. More recently 2D and 3D patterned 
substrates are used to support spheroid formation [114, 115]. In particular, various 
micro-well arrays are proposed for 3D cell aggregation, depending on 
microfabrication techniques [116, 117]. To facilitate the diffusion of nutrients, drugs 
and other factors into the spheroid area, it is also important to form the 3D assays 
with the materials of high permeability [118]. This approach allows controlling cell 
population in each spheroid as well as high-throughput screening. However, the 
available systems are mostly appropriate for small size spheroid formation, which 
cannot efficiently recapture the spheroid complexity of solid tumours.  
 
1.4 Improved culture substrates and bio-scaffolds  
Coming back to the general cases of cell culture, when cells are placed in a petri 
dish, a flask and a multi-well plate, where their in vivo physiological conditions are 
lost without surrounding organization of extracellular matrix proteins and blood 
capillary and they are forced to adapt a two-dimensional support where both 
underneath diffusion and cell-cell become less efficient. The problem arises when 
this change of scenario becomes critical, which is the case of pluripotent stem cells 
such as embryonic stem cells and iPSCs. So far, the most of studies on iPSCs, 
including their creation, their renewal and their differentiation have been based on 
the use of conventional culture techniques, which poses a problem of quality control 
and the risk of genetic instability, tumorigenicity, etc. [119-121].  
Before going into more details, we put forward the great potential of iPSC 
derived tissues for regenerative medicine [122]. To this regard, the three-dimensional 
structuration or bio-scaffold fabrication is needed. Therefore, we introduce in the 
following notions of the materials and methods that are used for the fabrication of 
culture substrate and tissue scaffolds. For the design of substrates and scaffolds, the 
most central and primary factor is biomaterial. 
 
1.4.1 Biomaterials 
Over the past few decades, biomaterials have transformed from simply 
interacting with the body to influencing biological processes for the goal of tissue 
regeneration [123]. Basically, there are three main groups of biocompatible materials 
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for tissue engineering, including inorganic materials such as metals and ceramics, 
natural polymers and synthetic polymers. Each of these three types of biomaterials 
has specific advantages and disadvantages for a certain application. So currently 
more and more composite scaffolds which are composed of different types of 
materials are studied. 
 
a) Inorganic materials 
The inorganic materials such as metals and ceramics have been widely used in 
the medical field, particularly in orthopedic tissue replacement, especially the 
ceramic scaffolds such as hydroxyapatite (HA) and tri-calcium phosphate (TCP), 
which have been widespread applied for bone regeneration. The special properties of 
ceramic scaffolds, such as high mechanic stiffness, low elasticity, a hard brittle 
surface, as well as the outstanding biocompatibility due to their similar chemical and 
structural property to the mineral phase of natural bone, make them exhibit excellent 
in bone regeneration field [123]. Additionally, it has been reported that the 
interaction of osteogenic cells with the ceramic scaffolds can enhance the 
proliferation and differentiation of osteoblasts, which will improve bone 
regeneration [124, 125]. Titanium and titanium alloy have also been largely applied 
for not only implants, such as artificial limbs, but also dental products like crowns, 
dentures, etc. are also getting much attention in dentistry [126, 127].  
However, due to the non-biodegradation and the limitation in processability, the 
application of metals and ceramics is still very limited in tissue engineering. So 
currently, polymer biomaterials have drawn increasing attention and are in rapid 
development, including natural polymers and synthetic polymers. 
 
b) Natural polymer materials 
The naturally derived polymers including polysaccharides, alginic acid, chitosan, 
gelatin and proteins of natural extracellular matrices such as collagen in particular 
and so on, are widely applied in tissue engineering [128-131]. Although generally 
natural polymer materials have poor mechanical strength, they are increasingly 
studied because of their biodegradation, less host response and the increased 
recognition for cells and tissues [18].   
As one of the key structural proteins found in the ECM of many tissues in 
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mammals, collagen has been shown to be a suitable material for many of clinical 
medicine applications in the past several years, such as injectable collagen for the 
augmentation of tissue defects, hemostasis, burn and wound dressings and nerve 
regeneration [132, 133]. However the main disadvantage of collagen is the potential 
antigenic and immunogenic response that can be provoked during its in vivo 
application [134]. Gelatin is the product of collagen after thermal denaturation or 
disintegration, which has been reported with a lower immunogenicity in vivo [135, 
136]. Due to the biodegradation, biocompatibility, as well as the lower cost in 
commercial use compared to collagen, gelatin has been increasingly utilized in many 
areas of tissue engineering, which is also one of the materials we chose in this work 
in Chapter 3. 
 
c) Synthetic polymer materials 
In the past several decades, many synthetic biocompatible polymers have been 
applied in the attempt to produce scaffolds, such as poly-l-lactic acid (PLLA), 
polyglycolic acid (PGA), poly(lactic acid) (PLA), poly-dl-lactic-co-glycolic acid 
(PLGA) and poly(ε-caprolactone) (PCL) [137]. PGA, PLA and their copolymer 
PLGA have been widely used as scaffolds for bone and cartilage repair [138, 139]. 
PCL-based materials are mostly used for skin, vascular as well as neural tissue 
engineering [140-142]. The main advantages of these synthetic polymer materials 
are the easy tailored architecture and controllable degradation property by flexible 
adjustment of the polymers and composition of different polymers[123, 143]. 
However, the main drawback of synthetic polymers compared to natural polymers is 
the risk of immunogenic rejection because of the lower bioactivity.  
Among the various synthetic polymers, poly(ethylene glycol) (PEG) based 
hydrogels drawn increasingly attentions because of their water content controllability, 
hydrophilicity, and biocompatibility, especially lithographically-fabricated PEG 
based hydrogels, such as poly(ethylene glycol) diacrylate (PEGDA) and 
poly(ethylene glycol) dimethacrylates (PEGDMA), which can be easily tailored with 
the designed and controllable regular structures based on microfabrication 
techniques [144-146]. We chose also PEGDA as one of the materials for the scaffold 
in Chapter 3.  
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1.4.2 Culture substrate  
A variety of substrates have been proposed to improve the culture performance 
of iPSCs. Matrigel [147] or recombinant proteins such as laminin [148] are 
commonly used to generate a gel layer on the flat surface of substrate to promote the 
adhesion of iPSCs. These methods are versatile but not allow mimicking the 
organization of the extracellular matrix proteins. To obtain a patterned substrate with 
appropriate surface stiffness which are more interesting for the control of stem fate 
of iPSCs [149], synthetic polymers such as PCL, PLGA, PLLA, etc. and natural 
biopolymers such as collagen, chitosan, alginate, hyaluronic acid, etc. have been 
used. In addition to the lithography defined substrate patterning which will be 
described in the next chapter, oxygen plasma etched substrates [150], porous 
materials [151, 152], electrospun nanofibers [153] have been successfully employed 
for iPSC culture but none of them fully take into account the specificity of the 
cellular microenvironment in term of three dimensional permeability and protein 
organization.  
In parallel, suspension culture of iPSCs has been studied using bio-reactors such 
as shaker, rotator, etc.[154]. These methods can efficiently increase the yields but the 
agitation of the solution can introduce undesired shear forces on the cells.  
Microfluidic devices with minimized shear forces have also been used for iPSC 
culture [155] but it showed no advantage on the cell fate control due to the fact that 
they are not flexible for iPSC handling and the exogenous contact with the support 
material is always large. Alternatively, suspension culture can be done using carriers 
such as microspheres. This type of off-ground culture could be applied to iPSCs 
culture [156, 157] but it is limited by the difficulty of cell harvesting and 
uncontrollable exogenous contact with the carrier materials. Therefore, there is a 
clear need for devices and methods for iPSC culture and handing under optimal 
physiological conditions and highly compatible to both in vitro and in vivo assays. 
 
1.4.3 Bio-scaffolds  
Tissue engineering, as one of the main purposes of cell culture, has emerged in 
the development of biological substitutes which can restore, maintain, or improve 
function of tissue or organs [158-162]. As an interdisciplinary field, tissue 
engineering involves the combining of cell, scaffold, and bioactive agents to 
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fabricate functional new tissue to replace damaged tissue [163, 164], as shown as Fig. 
1.9. In this approach, a well-designed scaffold is one of the critical tools to serve as 
an extracellular matrix (ECM) mimic substrate for the implanted cells adhesion and 
to guide actively the tissue regeneration process in vitro and in vivo.  
 
Fig. 1.9 Tissue engineering can be relied on (i) cells alone, (ii) cells with scaffolds, 
and (iii) scaffolds alone. In all cases, the micro-environmental factors are important 
for the quality of the tissue substitute [165]. 
 
For tissue engineering, scaffold design plays an important role in manipulating 
cells behavior and guidance of tissue formation [123, 166-169]. The best scaffold 
should be mimicking the ECM of the target tissue in its native state, intuitively. 
However, normally it is difficult to mimic exactly the complex composition and the 
multiple functions of the ECM in native tissues [170]. Therefore, the current concept 
of scaffold design in tissue engineering is to mimic the functions of native ECM as 
much as possible. Although the final requirements depend on the specific purpose of 
the scaffold, a number of key considerations and requirements are significant when 
designing or determining the suitability of a scaffold for a specific application in 
tissue engineering: 
• Biocompatibility 
The first and basic criterion is the scaffolds should be biocompatible for cell and 
tissue, which can allow cells adhesion, migration and proliferation on the surface and 
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prevent any immune rejection of the surrounding tissue after implantation [171, 
172].  
• Suitable mechanical properties 
The strength of scaffold should be comparable to the in vivo tissue at the specific 
implantation area. For instance, a scaffold requires more flexibility or rigidity 
depending on the application in cardiovascular and bone respectively [173, 174]. 
• Good permeability 
Based on a sufficient mechanical strength, the porosity of scaffold should be large 
enough to provide sufficient space for sufficient nutrient transport and waste 
products removal for cells [173, 175-177]. 
• Suitable surface 
The surface should permit cell adhesion, promote cell growth, and allow the 
retention of differentiated cell functions. Besides, it has been reported a lot that the 
topography introduction of scaffold surface can enhance tissue organization resulted 
into promoted tissue function [178-180]. 
• Manufacture possibility 
For clinical and commercial applications, the scaffold should have possibility of 
scale-up production from laboratory scale to larger batch production [181]. The 
development of scalable manufacturing processes to good manufacturing practice 
standard is critically essential for ensuring successful conversion of tissue 
engineering strategies to the clinic [182]. 
 
According to the criterions above, in the past decades, there have been many 
novel methods to shape biomaterials into complex architectures to achieve scaffolds 
with desired properties for specific tissue engineering applications.  
 
a) Solvent casting 
Solvent casting is a very simple, easy and inexpensive method, which consists 
of dissolving a polymer in a volatile solvent and casting it on a solution that will 
provide support to the polymer while the solvent is evaporating [183]. However the 
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main drawback is the induction of residual solvents which may retain some toxicity 
for the scaffold. Drying in vacuum may overcome this problem, but it will be very 
time consuming. Therefore some researchers developed particulate leaching method, 
which could be also combined with solvent casting.  
 
b) Particulate-leaching 
Particulate leaching is one of the most popular techniques which has been 
widely applied for scaffolding in tissue engineering [184]. Porogens such as salt, 
wax or sugars can be introduced to create pores or channels in the resulting scaffold. 
The process is easy to carry out: porogens with desired size are poured into a mold, 
then a polymer solution is cast into the porogen-filled mold, after evaporation, the 
porogens can be leach out to form the pores, which can be size-controlled by the size 
of porogens. Injection of high pressure CO2 can also create pores, without utilization 
of organic solvents and high temperature, which is called gas foaming method [185]. 
 
c) Phase separation 
The general principle of phase separation is to dissolve polymer in a solvent 
and to then extract the solvent by liquid-liquid phase seperation or solid-liquid 
demixing. These techniques have been largely used to fabricate porous membranes 
for filtration and separation [186]. But the main problem for this method is the not 
uniform distributed and not controllable pore size, which makes it limited used in 
tissue engineering.  
 
d) 3D printing 
3D printing can be used for rapid prototyping of scaffolds, by which the 
biomimetic architectures (size, shape, inter connectivity, branching, geometry and 
orientation) can be designed with the help of computer added design software. Fig. 
1.10 shows a 3D printer machine in our lab in ENS (a), a 3D-printed Eiffel tower (b), 
a 3D-printed PEGDA scaffold before (c) and after (d) integration of porous gelatin 
structure. However, the main drawbacks of rapid prototyping techniques are the 
limited material selection and low achieved resolution. 
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Fig. 1.10 (a) 3D printer (ProJet® 1200, 3D Systems) in ENS; (b) 3D-printed Eiffel 
tower; (c) 3D-printed PEGDA scaffold; (d) Porous gelatin PEGDA scaffold.  
 
e) Hydrogel formation methods 
Hydrogels are three dimensional crosslinked polymer networks with the ability 
to absorb large amounts of water, which have been demonstrated as outstanding 
scaffolds for 3D cell culture and played an ever increasing role in tissue engineering 
field in the last decade [187]. In biomedical engineering field, biocompatible 
hydrogels have been successfully applied to wound dressings, cartilage wound 
healing, bone regeneration and especially drug delivery systems development 
[188-191]. Hydrogel scaffolds have been increasingly studied for the application in 
tissue engineering for the connective tissue replacement, and have been proved to 
improve cell migration, enhance angiogenesis, and increase nutrient diffusion [192].  
More details of the hydrogel formation technique used in this work will be described 
in chapter 2. 
 
f) Electrospinning 
To realize effective tissue engineering, it is crucial to apply as many biomimetic 
scaffolds as possible [193]. With the increasing development of nanotechnology, 
nanofibers fabrication attracts more attentions, because nanofiber scaffolds can 
mimic native ECM structure at nanoscale [194-196]. There are several methods for 
the fabrication of nanofibers, including anisotropic crystal growth, molecular 
self-assembly, lithography, atomic deposition and template. Among all these 
techniques, electrospinning, which was observed first in 1897 by Rayleigh [197], 
holds high potential due to the easy operation, low cost and well-control of nanofiber 
morphology and chemical compositions. Fig. 1.11 shows the schematic of typical 
C                 d 
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electrospinning. More details of the electrospinning technique used in this work will 
be described in chapter 2.  
 
 
Fig. 1.11 Schematic of typical electrospinning [198].  
 
1.5 Microfluidic device technologies 
Microfluidic device techniques have been widely studied to improve biological 
and biomedical studies, due to their unique advantages of fast sample processing and 
precise fluid manipulation [199].  
1.5.1 Introduction of microfluidic device 
Microfluidic technology has passed a long way since the first application by 
Terry et al. in 1979, which was a miniature gas chromatographic analyzer [200], 
while the first cell culture in a microchannel was achieved by Doroszewski et al. in 
1977 [201]. In concept, microfluidic is to manipulate fluids precisely by microscale 
devices, which was firstly established by semiconductor industry and later expanded 
in the field of micro-electromechanical systems (MEMS). Commonly these devices 
were called “miniaturized total chemical analysis system” (μTAS) [202] or 
lab-on-a-chip, which show a number of advantages such as cost effectiveness, low 
consumption of reagents, high sensitivity, high resolution and so on [203]. 
For biological applications, there are several reasons to choose microfluidic as 
the tool [204]: a) the increased interests in biochemical analysis of single cells, such 
as for drug evaluations, external stimuli on cell behavior, etc.; b) possibility of 
integration of all kinds of analytical standard operations into microﬂuidic systems; c) 
several techniques for manipulating large quantity of cells simultaneously can be 
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applied to microﬂuidic systems; d) the size of cells ﬁts very well with that of 
commonly used microﬂuidic devices (10~100 µm); e) micromechanical devices are 
very well capable of manipulating single objects with cellular dimensions; f) small 
dimensions geometries with large electrical ﬁeld strengths can be obtained with 
small voltages; g) fast transfer of heat and mass in microﬂuidic systems.  
There are two main methods to produce fluid flow in microfluidic device: 
pressure driven flow and voltage driven electrokinetic flow (Fig. 1.12). And in 
different microscale channels, the behaviors of fluids are different, which are mainly 
related to several factors, such as laminar versus turbulent flow, surface and 
interfacial tension, capillary forces (Fig. 1.13) [199]:  
 
 
Fig. 1.12 Methods for driving a flow. (i) Pressure-driven flow using a vacuum at the 
outlet or a syringe pump at the inlet. (ii) Electrokinetic flow using a voltage applied 
across the microchannel[205]. 
 
(a) Laminar versus turbulent flow 
The Reynolds number (Re) is a dimensionless value that represents the ratio of 
inertial to viscous forces in a fluid. Re is proportional to the characteristic velocity of 
the fluid and the length scale of the system, while inversely proportional to the 
viscosity of fluid. Turbulent flow is normally with high-Re number (~2000) having 
flow profiles that increasingly mix stochastically. For highly predictable fluid 
dynamics, Re is normally in the laminar flow regime in microfluidic systems. 
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Molecular transport also changes dramatically at microscale because convective 
mixing does not occur, enabling predictable diffusion kinetics.  
 
(b) Surface and interfacial tension  
Compared to gravity, surface and interfacial tension plays more dominant role on 
the microscale, which is much more critical on the macroscale. Surface tension 
represents the tendency of a fluid in a surface to reduce the free energy by 
contracting at the surface–air interface. Interfacial tension is a similar phenomenon, 
but is generally applied to two immiscible fluids (ex. oil and water). There have been 
lots of studies using these phenomena to conduct protein and cell sorting, perform 
nanoreactions for protein crystallization, and passively drive fluids through 
microchannel. 
 
(c) Capillary forces  
Capillary effect refers to the movement of a fluid through a thin restriction, 
such as in narrow tube or porous material, which is a more dominant in microscale. 
In microfluidic, capillary force can even force fluids to spread in opposition to 
gravity. Thus, capillary effect has been used to control fluids in many applications, 
such as at-home pregnancy test and portable glucometers to monitor blood glucose 
levels.  
 
 
Fig. 1.13 Useful microfluidics concepts: laminar versus turbulent flow; surface and 
interfacial tension; capillary forces [199]. 
 
1.5.2 Biological applications of microfluidic 
Intrinsically, microfluidic techniques have so many benefits and hold high 
Chapter 1 Introduction 
35 
potential to influence variety of research fields. By combining different techniques 
from other areas, such as optical trapping for bio-particle manipulation and 
single-molecule detection, the rapid development of multifunctional microfluidic 
devices offers various opportunities for biological and biomedical studies [206], 
including tissue organization, culture and analysis (Fig. 1.14). In this section, several 
biological applications of microfluidic in recent years are highlighted. 
 
 
Fig. 1.14 Tissue organization, culture and analysis in microsystems [207]. 
 
a) Cell sorting  
Cell sorting and purification is an essential preparatory step in many biological 
and medical assays. Over the past two decades, there has been several microscale 
separation techniques developed, such as optical tweezers, fluorescence or magnetic 
activated cell sorting, centrifugation, filtration and electric field-based manipulations 
based on cell size, morphology, magnetic and dielectric properties [204].   
Fluorescence-activated cell sorting (FACS), also called flow cytometry has been 
widely used by biologists for cell sorting. A throughput of 104 cells/s is common 
with available FACS systems, however, the machines in present are normally large 
and high-cost, and the viability of cells after sorting is usually compromised. It has 
been reported to integrate miniaturized FACS sorters into microfluidic devices, 
which was restricted to handle one order of magnitude of cells per second because of 
the small microliter volumes they are able to manipulate, but with good cell viability 
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after sorting [208]. Magnetic based cell trapping which has low power requirement 
has also been used for isolating cells with magnetic susceptibility or with magnetic 
nanoparticles in microfluidics [209]. 
Due to the relative ease of microscale generation and structuring, electric 
field-based approaches are well suited to be miniaturized in microfluidic chips. And 
the cell sorting and manipulation by electric field shows high speed, flexibility and 
easy controllability. Especially dielectrophoresis based methods, have been 
successfully applied in microfluidics to manipulate and isolate various biological 
cells, such as bacteria, yeast and mammalian cells [204]. 
Size-based cell filtration is the most popular and easiest method in microfluidic 
systems, especially for rare cell isolation of blood samples. Yu-Chong Tai et al 
developed a parylene microfilter and integrated it into a PDMS microsystem for 
capturing circulating tumor cells (CTCs) in human blood, which reached ~90% 
CTCs recovery under pressure driven [100]. Microcavities in microfluidic have also 
been utilized to isolate lung carcinoma cells based size and deformability of cells 
[102]. The main limitations for these methods are the clogging and contaminations. 
Nagrath et al. [210] produced a micro-posts array in microfluidic system coated with 
specific antibody of CTCs (EpCAM), which can achieve high efficient separation of 
viable CTCs from peripheral whole blood samples, by the interaction of target CTCs 
with the antibody. However, this method is not applicable to those with 
down-regulated or lost epithelial markers and it is well known that when epithelial 
cells of solid tumors enter into a blood stream they may undergo epithelial to 
mesenchymal transition, which will make some of the tumor cells lose their surface 
marker [85, 211].There are also other techniques for CTCs capture in microfluidic, 
such as spiral centrifuge channels [88], Herringbone-chip [82] and so on, shown as 
Fig. 1.15. In this thesis, we design and fabricate a microfluidic device with 
integrated microfilter for CTCs capture to overcome all the drawbacks. 
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Fig. 1.15 Microfluidics-based CTCs capture and enrichment: A) Microcavity filter. 
B) CTC-chip. C) Herringbone-chip. D) Arc-shaped trap. E) Spiral microfluidic 
channel [212].  
 
b) Cell analysis 
Performing cellular analysis in microfluidic devices has many advantages, 
including less cell consumption, automated reagent supply, as well as controllable 
and  reproducible mixing of reagents to cells [204]. There are many approaches for 
analyzing cells in microfluidic chips. Patch clamp and optical probes can be used to 
monitor intracellular signaling. Patch clamp has been widely used for the 
measurement of action potential or ion channels of cells, such as cardiac and neuron 
cells. Cell morphology variation can be detected with electrical impedance 
spectroscopy. Thermometric calorimeters can be used for cell metabolism 
monitoring. Genetic analysis can also be performed in microfluidic devices. Pal et 
al.[213] designed an integrated genetic analysis microdevice which can perform two 
independent serial biochemical reactions: polymerase chain reaction (PCR) 
amplification of a sample followed by restriction endonuclease digestion (RD).  
Among many others, electrode-based techniques such as multi-electrode array 
(MEA) are the most common tools for real-time monitoring of cell 
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electrophysiological activities (shown as Fig. 1.16). Compared to patch clamp, 
electrophysiological measurement with MEA is non-invasive to cells because it does 
not require breaching of the cell membrane. With respect to in vivo arrays, the major 
advantage over patch clamping is the high spatial resolution. Besides, large-scale, 
parallel recordings with tens of implanted electrodes are possible, which make such 
extracellular recordings the method of choice to identify of neural circuits and to 
study their functions. In this thesis, MEA is used to record the electrical signals (field 
potential) of cardiomyocytes and motor neurons differentiated from human induced 
pluripotent stem cells (hiPSCs), as well as the reaction of cardiac sheet to cardiac 
drugs. In the following chapters, the impedance measurement as well as MEA will 
be introduced in detail. 
 
 
Fig. 1.16 The multi-electrode array (MEA) with embryonic cortical neurons after 14 
d in culture, noting the elaborate axonal network and the recorded representative 
neuron signals. Electrodes and wires appear as black dots and lines, respectively 
[214]. 
 
c) Cell culture and organ on chip 
Compared to the conventional culture using culture dishes, flasks or multi-well 
plates, microfluidic culture provides a controllable micro-environment to guide cell 
migration and differentiation, facilitating cell manipulation and analysis at 
single-cell level. Microfluidic culture can also be used to regulate the cell-substrate 
interactions and cell-cell coupling [206, 215]. Numerous studies have shown that the 
cell morphology can be modulated by changing the surface topography [216, 217]  
while a microfluidic controlled biomolecular gradient has been widely used to 
control the biological pattern formation and morphogenesis, including angiogenesis 
and axon path finding [218]. 
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Fig. 1.17 Organs-on-chips. (a) Microfluidic “alveoli-on-a-chip”. (b) Biologically 
inspired design of a human breathing lung-on-a-chip microdevice. (c) The human 
gut-on-a-chip. (d) Kidney-on-a-chip. (e) Microfluidic flow-stretch chip that mimics 
the cardiovascular systems [219]. 
 
However, 2D cell culture in microfluidic cannot mimic the aspects of the in vivo 
tissues. Thus in recent years, 3D microfluidic tissue engineering attracted increasing 
attentions because of the more in vivo mimic cell culture conditions compared to 2D 
culture. Vukasinovic et al.[220] designed a simple and scalable microfluidic 
perfusion system and cultured 700 µm thick neural-astrocytic (1:1) constructs at cell 
density approaching that of the brain (50,000 cells/mm3). They found that with 
forced convection interstitial perfusion, cell viability reached 90% over 2 days, 
whereas unperfused controls exhibited widespread cell death. One of the main 
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application fields of 3D microfluidic cell culture is tissue engineering in 
microfluidics. Many researchers tried to combine various techniques with the 
microfluidics to control not only cell behaviors but also tissue organization, soluble 
gradients and mechanical stimulation. These micro engineered in vitro models are 
called “organs-on-chips” [219]. Compared to other conventional techniques, 
microfluidic tissue engineering can achieve the dynamic control of nutrients and 
reagents supply much conveniently. Organs-on-chips provide a significant tool to the 
researchers to study the physiological and pathophysiological processes in living 
organs, to operate drug screening and to assess the efficiency of treatment. Various 
organ models on chips have been developed currently, such as lung, heart, brain, gut, 
liver, and even body-on-chip composed of several linked tissues (Fig. 1.17). 
The fundamental element of lung is the layer of epithelial and endothelial cells 
which allows the exchange of gas between air and blood. Douville et al.[221] 
developed a microfluidic “alveoli-on-chip” composed of a flexible PDMS membrane 
that provides a more physiologic recreation of the stresses, which is the first in vitro 
technique to systematically study the role of both solid and fluid mechanical forces 
in ventilator-induced lung injury (Fig. 1.17a). Huh et al.[222] described a 
biomimetic microsystem that reconstitutes the critical functional alveolar-capillary 
interface of the human lung (Fig. 1.17b). By using this system, they studied bacteria 
and inflammatory effect as well as nanotoxicology.  
Grosberg et al.[223] reported a ‘‘heart on a chip’’ that exploits muscular thin 
film technology to measure contractility, combined with a quantification of action 
potential propagation, and cytoskeletal architecture in multiple tissues, which 
allowing real-time data collection and analysis during pharmacological intervention.  
Brain is one of the most complex organs in vivo, in which blood-brain barrier 
(BBB) is a unique feature of human the key structure of the brain, not only protects 
brain homeostasis, but also prevents toxic substances to enter the brain. Griep et 
al.[224] reported a small model of BBB-on-chip by the well combination of fluidic 
shear stress and thin membrane, which was suited to study barrier function in detail 
and evaluate drug passage to finally gain more insight into the treatment of 
neurodegenerative diseases. 
Microvasculature is an essential component for organ-on-chip systems. Miller et 
al.[225] printed rigid 3D filament networks of carbohydrate glass and used it as a 
sacrificial template to achieve cylindrical networks (microvascular structures) with 
Chapter 1 Introduction 
41 
endothelial cells and perfused with blood under high-pressure pulsatile flow. 
One of the major goals of organs-on-chip technique is to replace animal models 
due to the high cost, time-consumption, and the requirement of large amount of 
compounds of animal tests. Additionally, the traditional animal testing approaches 
often fail to predict human toxicity and efficiency, and often question the ethics of 
sacrificing animals if they cannot predict clinical outcomes reliably [219]. Thus in 
recent years, human induced pluripotent stem cells (hiPSCs) generated from the 
somatic cells of human are becoming more promising cell sources for 
organs-on-chip study, which not only are identified as suitable alternatives to 
supplant the need for animal studies but also largely improve the accuracy of drug 
assessment due to the in situ cell source compared to animal cells or embryonic stem 
cells (ESC). And in theory, hiPSCs are able to be differentiated into any type of 
human cells. So far, hiPSCs have been successfully differentiated into various types 
of cells, such as multi subtypes of neurons, cardiomyocytes, hepatocytes, endothelial 
cells and so on. Thus the organs-on-chips based on hiPSCs have high potential to 
provide more and reliable organ models of human and be more precisely predictive 
human relevant models for toxicity and efficacy test.  
 
1.6 Research objectives  
The purpose of this thesis work is to develop cell devices and methods for 
advanced biological and biomedical studies. More specifically, we were interested in 
cell processing which rely critically on the progress of the microdevice engineering. 
We have chosen to study culture and differentiation of induced pluripotent stem cells 
by using as well as isolation and culture of circulating tumor cells, since both are 
critically depending on the progress of in vitro cell processing.  
For induced pluripotent stem cells, the primary importance is to prepare ECM 
mimic scaffolds for high quality processing, including stem cell proliferation and 
differentiation as well as stem cell derived tissue formation. These scaffolds have 
also to be appropriate for drug test and regeneration medicine. Therefore, we firstly 
developed a new type of substrate by considering the requests of versatility and 
flexibility for both in vitro and in vivo assays. Unlike conventional 2D culture and 
some so called 3D culture, we wish to design and fabricate a monolayer nanofiber 
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scaffold to provide a 3D permeability environment for cells like in vivo condition, 
which should be also convenient for handling for downstream analysis and 
implantation. The emerging hiPSCs were chosen as the cell source because of its 
pluripotency which provides diversity and genomic homogeneity which leading to 
more reliable models and the more accurate assessment for drugs as well as the 
non-immune rejection during further implantation. Due to the importance of cardiac 
and motor neuron cells in drug screening and disease therapy, we mostly wish to 
different hiPSCs into cardiac and motor neurons for generating cardiac patch and 
motor neuron patch. The promoting role of this scaffold for both differentiations will 
be discussed according to both various qualitative and quantitative characterizations. 
In particular, we wish to achieve electrical signals of cardiac and neuron patches by 
simply transferring onto multi-electrode array and then perform drug test by 
monitoring the changes of electrical signals. 
For circulating tumor cells, great effort has been devoted to the methodical 
development of the high efficiency isolation. Clearly, their culture and studies after 
isolation are also important not only for diagnosis but also mechanistic 
understanding of cancer metastasis as well as disease modeling, drug assay and 
development. This importance of post-CTC isolation processing would require more 
careful design of the isolation and culture devices. The current methods for CTCs 
capture have various drawbacks such as contamination, clogging, low efficiency and 
low viability of captured cells. Therefore, we firstly designed and fabricated conical 
hole membranes for high efficiency and high selectively filtration of CTCs. Then, we 
used microfluidic channels to introduce cross flow for further decreasing the 
contamination effect and improving the cell viability. Both theoretical and 
experimental investigations were performed to optimize the device design and the 
flow rate. Our results showed that CTCs could not only be efficiently isolated at high 
selectivity but also be cultivated at a reasonable proliferation rate, thereby providing 
a new perspective for many interesting studies. In parallel, we undertook a primary 
study of 3D tumor spheroids culture to mimic the in vivo tumor by simply using 
cancer cell line U87 instead of isolated CTCs. Here, we developed a multi-well assay 
form by agarose molding for millimeter size tumor spheroid generation and 
maintaining and we succeeded to show anti-cancer drug effects based on such a 
tumor spheroid assay form.   
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In this chapter, we present the technological development of this thesis work. 
Firstly, we describe the electrospinning technique for the fabrication of nanofiber 
scaffolds. Then, we introduce hydrogel formation techniques, with especial focus on 
poly(ethylene glycol) (PEG) based hydrogel. Afterwards, we present several 
lithography techniques lithography techniques for surface patterning and 
microfluidic device fabrications. 
 
2.1 Electrospinning  
Electrospinning is a straightforward but yet simple technique to produce 
nanofibers with uniform diameter and different materials [1, 2]. Generally, the setup 
for electrospinning includes three parts: a syringe, a high-voltage power supply and a 
conductive collector. A polymer solution is first prepared by completely dissolving 
of polymer in certain solvent. During electrospinning, a syringe is used to feed 
polymer solution with a constant flow rate controlled by syringe pump. The needle 
of syringe is connected with a positive electrode, while the negative electrode 
connects on the collector. During the fiber towards to the collector, the solvent is 
evaporated and dry fibrous mats are generated on the collector. Several processing 
parameters are important to the performance of nanofibers, such as the solution 
composition, the voltage, the distance between needle and collector, as well as the 
temperature and humidity of environment [3-5]. Fig. 2.1 shows a typical 
electrospinning setup used in this work. 
Various biodegradable natural or synthetic polymers can be easily used to 
fabricate submicron fibers. To improve the performance of nanofibers in tissue 
engineering, the fabricated nanofibers can be treated by surface modification using 
such as plasma and wet chemical etch, surface graft polymerization, and 
co-electrospinning of surface active agents and polymers [6-8]. Surfaces of 
nanofibers can also be chemically modified with attaching specific bioactive ligands 
to improve cell adhesion, proliferation, and differentiation by mimicking the ECM 
morphology and functions [6]. 
A large number of investigations have shown that the cellular behaviors, such as 
attachment, proliferation and differentiation, can be modulated by regulating the 
parameters of nanofiber such as chemical composition, fiber morphology, diameter 
Chapter 2 Technological developments 
64 
and alignment [9] (Fig. 2.2).  
 
 
Fig. 2.1 Electrospinning setup used in this work.  
 
 
Fig. 2.2 Properties of electrospun nanofibers (ex. chemical composition, fiber 
morphology and mechanical properties) can influence cellular behaviors (attachment, 
morphology and differentiation)[9].  
 
Among many others, the porosity of the fiber mat is an important parameter to 
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control cell migration, cell morphology, cell proliferation as well as phenotypic 
expression [10-12]. An appropriate porosity of scaffold allows the diffusion of 
nutrients to the cells and waste product out of cells. The mechanical property of 
nanofiber, which can be controlled by changing the compositions of materials, also 
plays a critical role in cell morphology. It has been shown, for example, that the 
stiffness of scaffold influences cellular behaviors in 3D porous structures [13].  
Furthermore, nanofibers can also be used for repairing damaged tissues, 
including sciatic nerve, heart, tendon, and blood vessel. Shin et al [14] fabricated 
poly(ε-caprolactone) (PCL) nanofiber scaffold and seeded with mesenchymal stem 
cells (MSCs), then implanted in the omenta of rats, and they found the nanofiber 
scaffold with cells maintained their original size and shape after 4 weeks. Nimet et al 
[15] applied PCL nanofiber mat into rat and found that the diameter of nanofiber 
significantly influenced the in vivo degradation. Manning et al [16] developed a 
heparin/fibrin-based delivery system (HBDS)/poly(lactic-co-glycolic acid) (PLGA) 
nanofiber scaffold with growth factor incorporated, and the in vivo studies in a large 
animal tendon model verified the potential of this scaffold for improving tendon 
healing (Fig. 2.3). The injuries recovery of both peripheral and central nervous 
systems can greatly benefit from the neural tissue engineering strategy with a 
scaffold or conduit to facilitate the regrowth of nerves [17]. The electrospun collagen 
nanofibers have been fabricated for skin wound healing, which showed an effective 
wound-healing accelerators in early-stage wound healing [18].  
 
 
Fig. 2.3 HBDS/PLGA nanofiber scaffold with adipose-derived mesenchymal stem 
cells (ASC) cultured for in vivo implanting at the site of the flexor tendon for tendon 
healing. the PLGA was labelled with FITC (green), the HBDS was labeled with 
Alexa Fluor 546 (red) and the ASC nuclei were labeled with Hoechst 33258 (blue) 
[16]. 
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Nevertheless, there are still important challenges to meet for real applications of 
electrospun nanofibers. Due to the relative poor mechanical properties, thin 
nanofiber scaffolds are general fragile and they have not enough strength for the 
further in vitro cell culture and in vivo implantation. This explains why the most of 
the developed nanofiber scaffolds so far were relatively thick with low porosity 
which inhibits cell penetration inside the fiber mats. In such a case, the permeability 
of the scaffold is also poor to prevent the efficient diffusion of nutrient. In this work, 
we propose a solution to this problem by electrospinning monolayer nanofiber on a 
stronger supporter (see chapter 3). 
 
2.2 Hydrogel formation methods 
Hydrogels could be classified into physical- or chemical-stimuli responsive 
hydrogels. The physical stimuli, includes temperature (such as agarose) and electric 
or magnetic fields, while chemical stimuli, includes pH, ionic factors (such as 
alginate) and chemical agents. Hydrogels can be either natural or synthetic [19]. 
Natural hydrogels are composed of either proteins, such as collagen and gelatin, or 
polysaccharides, such as alginate and agarose. The main advantages for these 
hydrogels are the low toxicity, good biocompatibility and biodegradability due to the 
similar chemical structure to the ECM. Synthetic polymers to form hydrogels are 
mainly based on chemical polymerization technique, which can control the structures 
and functions more precisely, such as PEG-based hydrogels made by photo-initiation 
polymerization [20, 21].  
PEG hydrogels are attractive as scaffolds, because not only they can provide 3D 
environment for tissue, but also the macroscopic physical and microscopic chemical 
structures of them can be easily tailored and modulated by precise lithography 
related techniques and chemical synthesis control, respectively. Besides, it is also 
very simple to modify them to be biodegradable by incorporation of degradable 
segments or copolymerization with other polymers or biomolecular. The synthesis of 
PEG-based hydrogels through photo-polymerization is the most common method to 
convert PEG prepolymer solution into crosslinked insoluble hydrogels, which allows 
the synthesis of hydrogel scaffolds with spatial and temporal control [22]. The most 
widely used polymers for photo-polymerization include poly (ethylene glycol) 
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diacrylates (PEGDA) and poly (ethylene glycol) dimethacrylate (PEGDMA). So far, 
PEGDA has been widely applied in cell encapsulating [23, 24], cartilage tissue 
regeneration [25], tissue resurfacing [26] and wound healing [27]. Koh et al [28] 
presented an easy and effective method for the encapsulation of cells inside 
PEG-based hydrogel microstructures fabricated using photolithography. Temenoff et 
al [29] found that changing the molecular weight of PEG in synthesis affected the 
final tensile and swelling properties of oligo (poly (ethylene glycol) fumarate) 
hydrogels while the presence of interface did not have a significant effect. Fig. 2.4 
shows PEGDA macroporous scaffold for osteochondral defect regeneration. Besides, 
these PEG-based hydrogels are inherently resistant to non-specific cell adhesion and 
protein adsorption, thus they have also been reported a lot for the application in 
anti-fouling coating and anti-cell adhesive cell spheroids formation [30, 31].  
 
 
Fig. 2.4 Macroporous scaffolds of poly(ethylene glycol) diacrylate (PEGDA) with 
high swelling properties for osteochondral defect [32]. 
 
2.3 Lithography techniques 
Micro- and nanofabrication is utilized to produce micro and nanostructures or 
features of the sizes in micrometer or nanometer range. It is essential for modern 
science and technology development. Historically, microfabrication techniques were 
firstly developed for the semiconductor productions to make devices on various 
substrates such as silicon wafer, glass, plastic or other types of material. However in 
present, the conception of miniaturization and integration has been widely applied to 
other areas, such as physics, chemistry, life science, material science, computer 
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science, ultra-precision engineering, and equipment design. In this thesis work, we 
are particular interested in their applications in biological research [33-35].  
Among different techniques of microfabrication, lithography is a common 
patterning method which can also be applied to fabricate micro-topography and 
microstructures for cell biological research. However, traditional photolithography 
methods alone can only generate photoresist patterns on a substrate. It is necessary to 
use pattern transfer techniques to transfer photoresist patterns onto other substrates 
and materials, such as wet and dry etching, selective deposition and lift-off. More 
recently, soft lithography has been widely used to produce topographic and chemical 
patterns on a substrate for cell biological studies. The most commonly used soft 
lithography techniques include microfluidic patterning, stencil-assisted patterning 
and micro-contact printing [36].  
 
2.3.1 UV photolithography 
Photolithography is a technique to transfer a predesigned pattern on a 
photomask onto a substrate pre-coated with photoresist involving shining UV light. 
A main advantage of photolithography is that it can used to fabricate multiple 
structures at once (i.e. in parallel), producing very complex patterns in relative short 
time. The schematic of traditional photolithography by using photoresist is shown as 
Fig. 2.5.  
 
Fig. 2.5 Schematic diagram of conventional photolithography methods  
(Positive and negative photoresists) 
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The basic process for UV lithography includes mask preparation, substrate 
cleaning, photoresist coating, baking, alignment, UV exposure and developing.  
Before coating the wafers, the cleaning process should be carried out as 
following: 
For Glass substrate: 
- Acetone + Ultrasonic 5 min 
- Isopropanol + Ultrasonic 5 min 
- Plasma O2 5 min 
- Bake on hotplate (200℃ for 5 min) 
For Si wafer substrate: 
- Piranha Clean (1:1 96% H2SO4 : 30% H2O2) : 10~20 min. 
- DI water rinse: 15 min (3 baths 5 min each one) 
- Sample dry: N2 gun or reactive ion etching (RIE) 
- Bake on hotplate (200℃ for 5 min) 
After the cleaning process, the photoresist can be spin coated. A certain 
thickness of liquid photoresist layer is spin-coated on a clean substrate, such as Si 
wafer and glass. The thickness of resist is controlled by the spinning speed. After 
coating, a soft bake with certain temperature is processed to remove the solvent in 
the resist and enhance the adhesion between resist and wafer. After cooling down to 
room temperature, the substrate is exposed to a UV light with the photomask closely 
contacting to the resist layer. And the distance between photomask and resist affect 
the final pattern resolution greatly. The more closely adhesion between resist and 
mask, the higher resolution will be obtained. During the UV exposure, some 
chemical reactions occur in the photoresist under the transparent part of mask. For 
the positive resist, the UV light let the bonds of long chain polymers of the resist 
broken and become short polymer chains, which will be easily solved and taken 
away in development process; while in contrast, for negative resists, UV light results 
in a crosslinking reaction of the resist polymers, which let the resist less soluble 
while the unexposed resist will be removed by the developer. Notably, for all the 
negative resist, a post-baking process is needed after UV exposure to further activate 
cross-linking.  
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a) Mask design and fabrication  
Basically, the masks for UV photolithography include two kinds: optical mask 
and transparency mask, shown as Fig. 2.6. The optical mask is made of a thin layer 
of chromium on glass or quartz and a high resolution of UV light can be obtained 
(~1 µm), while transparency mask made of a plastic transparency film with black ink 
patterns, which can be produced easily by a printer, can reach a relative low 
resolution (>20 µm). 
 
 
Fig. 2.6 Illustration of transparency mask and standard optical mask 
In this work, all the masks are designed by a photolithographic mask design 
software L-Edit (Tanner research, USA). Then photo masks with micro patterns can 
be produced by a focused laser beam generator with high precision X-Y stage. In our 
lab, we use micro pattern generator machine μPG 101 (Heidelberg Instruments) by 
direct laser writing to fabricate photo masks (Fig. 2.7). In brief, the designed pattern 
is inputted into the machine by μPG 101 software and written onto a commercial 
blank optical mask, which is a quartz plate coated with 1000 Å thick chrome and a 1 
μm layer of AZ1518 positive photoresist on top (Nanofilm, CIPEC Company). The 
designed pattern can be exposed on the substrate by a laser beam travelling over the 
surface of substrate. A minimum feature size can reach to 1 μm with an accuracy of 
0.1 μm. After the laser exposure, the exposed substrate was developed by immersion 
into AZ-726 MIF developer (Micro Chemicals) for around 30 s with gentle agitation, 
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following with DI water rinsing to remove the residual developer. Then the mask 
was treated with a wet etching process about 45s with gentle agitated Chrome-Etch 
3144 (Honeywell) to remove the exposed chrome layer, followed with thorough DI 
water rinsing. Finally, the remained AZ1518 resist can be removed with a short time 
acetone ultrasonic bath to obtain a photomask with the designed chrome pattern on 
top.  
 
 
Fig. 2.7 μPG 101 direct laser writer (Heidelberg Instruments) [37]. 
 
b) Photoresist 
Photoresist is a UV light sensitive material, which is composed of basic 
materials, UV sensitive initiator and solvent [38]. In this thesis, both positive 
photoresist (AZ series) and negative photoresist (SU-8 series) were used for either 
filter or microfluidic fabrications.  
AZ40XT photoresist (Fig. 2.8a) is a new developed AZ series resist, which a 
chemically amplified ultra-thick positive resist. The field of application of the AZ 
40XT starts at 15-30 µm, where litho-processes with conventional positive resists 
become very time-consuming due to increasing delays for rehydration of 
N2-outgassing, both not required for the AZ 40XT. Via single coating, 100 µm resist 
film thickness can be obtained. Even for very high resist film thicknesses, AZ 40 XT 
requires only short soft bake times, no delay for rehydration, very small exposure 
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doses due to its chemical amplification, and shows a high development rate. 
Therefore, processing of the AZ 40XT goes much faster as compared to conventional 
thick resists. Compared to most other positive resist, a post exposure bake is 
obligatory for AZ 40XT to finalize photoreaction and make it developable [39]. 
The SU-8 series photoresists (Fig. 2.8b) are the main negative photoresists, 
which consists of chemically amplified, epoxy based negative resists that are highly 
functional, optically transparent and photo imaginable to near UV (365nm) radiation. 
SU8 resist is a polymer with large distribution of viscosity that can be spun or spread 
over a thickness ranging from <1 micrometer up to > 300 micrometers. Cured films 
or microstructures are very resistant to solvents, acids and bases and have excellent 
thermal and mechanical stability. 
 
     
Fig. 2.8 Microtructures generated by photoresist. (a) 60 µm features in AZ 40XT 
with 40µm thickness; (b) 10µm features in SU-8 2000 with 50µm thickness [39, 40]. 
 
2.3.2 Soft lithography 
 
Fig. 2.9 Schematic of soft lithography. 
a b 
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Soft lithography is generally a series of techniques for replicating patterns or 
structures with "elastomeric stamps, molds, and conformable photomasks" [41]. The 
features of construct are from nanometer to micrometer scale [42]. The process of 
soft lithography consists of elastic stamp creating, to transfer the patterns onto glass, 
silicon or polymer surfaces, shown as Fig. 2.9. The most notable material for soft 
lithography is polydimethylsiloxane (PDMS), which is also the most widely used 
material and proved to be an efficient and economic method for nano- and micro 
fabrication [43-48]. Also other elastomers such as polyimides, polyurethanes, and 
cross-linked Novolac™ resins were used in soft lithography [49]. 
PDMS is a polymer belonging to polysiloxanes family, which can be 
characterized by silicon backbone and oxygen atoms [50]. PDMS has outstanding 
physical properties and chemical stability in wide range of environments. It also has 
optical transparence about ~300 nm and thermal stability to 150 °C. Especially the 
low surface energy (21.6×10-3 J m-2) of PDMS allows easy release from templates 
and surfaces [51]. The most widely used two commercial PDMS products for soft 
lithography are Sylgard 184 from Dow Corning and RTV 615 from GE Toshiba 
Silicones Co., Ltd. In my thesis, all PDMS is RTV 615, which contains two 
components: part A and part B (curing agent). The normal ratio of A and B is 10:1 
(w/w) and after mixing completely, cured PDMS can be obtained after two hours at 
80°C. Fig. 2.10 shows the schematic of PDMS crosslinking. 
 
Fig. 2.10 Schematic of PDMS crosslinking [52].  
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Basically, the PDMS stamp is replicated from a master, which is normally 
fabricated by photolithography, as well as electron beam and focused ion beam 
lithography. Although PDMS is safe, it’s still a sticky and messy polymer. So it’s 
necessary to wear disposable gloves during working with PDMS. The PDMS 
mixture of part A and B should be stirred for at least 3 minutes for even mixing.  
Then the premixed PDMS prepolymer solution is casted on the top of the mold. 
However this stirring process will cause many air bubbles inside PDMS solution and 
these bubbles have to be removed before curing. To degas the PDMS, we transfer the 
PDMS mixture into a vacuum chamber (Fig. 2.11). The vacuum will lead the 
bubbles to expand and rise to the surface of mixture. The degas time is normally 
depended on the amount of PDMS mixture. After degassing, we can remove it from 
the vacuum chamber and pouring the PDMS mixture onto from the edge of the 
master and as low as possible to prevent to create new air bubbles. The PDMS will 
flow to a uniform height over the mold eventually. Some air bubbles will form again 
on the surface of the master, especially the area near the turns of the channels. And 
after about 10 minutes, these small bubbles will float up to the surface, but which 
will usually burst during the curing process and will not affect the final performance 
of device. 
 
 
Fig. 2.11 Photograph of PDMS degassing vacuum chamber in ENS lab. 
 
Then the PDMS mixture and master can be placed in an 80℃ oven for curing to 
harden. The curing time should be normally at least 2 hours. After curing, the solid 
PDMS mold can be taken out from the oven and wait for several minutes for cooling 
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to room temperature, which makes it easier to be peeled off. Then, the solid PDMS 
with the desired patterns can be peeled away gently and cut carefully with a knife. 
However, sometimes especially for the small size patterns, a release agent 
deposition process generally based on silanization mechanism (Fig. 2.12) is 
necessary for the master to peel PDMS mold off more easily. In my thesis work, we 
used trichloromethylesilane (TMCS) for surface anti-sticking treatment. The master 
or mold was evaporated in TMCS vapor for 1~3 min.  
 
 
Fig. 2.12 Silanization mechanism of surface treatment with TMCS. 
 
2.4 Microfluidic device fabrication 
With advances in microfabrication, microfluidic devices can be easily 
manufactured which revolutionize both personalized healthcare medicine through 
point-of-care diagnostics or high-throughput drug discovery.  
Among all the polymers used for microfluidic devices fabrication, PDMS is the 
most popular material. PDMS microfluidic devices can be fabricated by soft 
lithography, which is also the main technique for rapid prototyping of microfluidic 
devices [53, 54]. The physical and chemical properties of PDMS are contributory to 
achieve patterns and structures with high-quality. Clean room facilities are necessary 
to fabricate features in the size range of 1 to 500 μm typically, which is relevant to 
microfluidic systems. 
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Fig. 2.13 Schematic of PDMS microfluidic chip fabrication. 
Fig. 2.13 shows the general process of microfluidic device fabrication. After 
peeling off from the master or mold, solidified PDMS layer with patterns can be cut 
into proper size, and the holes with certain sizes for the channels can be punched 
with biopsy punch. To ensure a good bonding effect and prevent small particles from 
clogging the channels, the glass slides should be cleaned carefully before bonding. 
Wearing gloves is necessary throughout the cleaning process to avoid skin oils to 
stick onto the surface of slide. The surface should be first rinsed with distilled water 
and then rinsed again with isopropanol. Afterwards a nitrogen gun is used to dry off 
the residual isopropanol. Then the PDMS and glass slide are treated with low 
temperature oxygen plasma (Fig. 2.14). Inside the plasma machine, the bonding 
surfaces of the slide and the PDMS device are subjected to high energy plasma 
which strips away electrons on the surface to transform the surfaces into hydrophilic. 
Once contact the two surfaces to each other, a strong bond will be generated. Finally 
half an hour baking in an 80°C oven can enhance and stabilize the bonding.  
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Fig. 2.14 Photo of plasma cleaner in ENS lab. 
 
2.5 Conclusion 
We presented the micro and nanofabrication techniques used in this work. We 
have chosen hydrogel formation and nanofiber electrospinning techniques for the 
fabrication of scaffolds because of the biomimetic properties of two candidates. 
Lithography based fabrication techniques have been chosen for the device 
fabrication, including conventional UV photolithography and soft lithography. We 
believe that these fabrication techniques are essentials and compatible to the most of 
biological studies. We will provide in the following chapters a few examples of their 
application in the studies of stem cells and cancer cells.    
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In this chapter, we present a study of culture and differentiation of induced 
pluripotent stem cells by using culture patch method. We first describe the 
fabrication of the culture patch which consists of a monolayer of crosslinked gelatin 
nanofibers formed on a honeycomb frame made of biocompatible polymer. Then, we 
present the results of cell proliferation on culture patch under off-ground culture 
condition. Next, we show how human pluripotent stem cells (hiPSCs) can be 
differentiated into cardiomyocytes and neurons on the culture patch under off-ground 
culture conditions and how this method is advantageous comparing to the 
conventional culture dish method.  
 
3.1 Introduction 
A major challenge of cell culture is to find suitable substrates with appropriate 
stiffness, surface morphology and adhesion molecules for down-regulation of 
cell-matrix tractions. This is particularly important for the cell fate regulation of stem 
cells which depends critically on the cellular microenvironment. Previously, different 
culture protocols have been proposed for iPSC culture but few of them were 
designed to mimic the in vivo organization of extracellular matrix (ECM) proteins 
and the in vivo hydrodynamic of nutrient and cellular factors. Besides, the stem cells 
have to be derived to the targeting cells at high purity, high efficiency and yield, high 
purity. Since these targeting cells are tissue specific, they have to be differentiated on 
different types of substrates and under different physiological conditions. It is 
therefore a real challenge to develop a general culture perform for culture and 
differentiation of iPSCs.  
By considering the high potential of iPSCs derived tissues for regenerative 
medicine [1], we put forward the importance of patch form as a general culture 
platform. It has recently been demonstrated that cells placed on a gel layer could 
give a therapy efficacy significantly better than that without a material support. After 
cell seeding and cultivation, the culture patch can be transformed to functioning cell 
patch which can be used not only for therapy but also for different types of 
cell-based assays such as toxicity test and drug screening. In addition, the cell 
patches of different types of cells derived from iPSCs may be integrated into a 
microfluidic device, thereby allowing easy control of more realistic physiological 
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conditions to mimic the in vivo body circuitries [2]. Thus the culture patch method 
should open a new perspective for different types of in vitro and in vivo assays in 
advanced biomedical research and drug development. 
As example, we designed a culture patch in form of crosslinked monolayer 
nanofibres supported by honeycomb frame. Biocompatible nanofibers are promising 
to mimic the in vivo organization of ECM proteins for a better understanding of 
cell-material interaction and prospective applications in regenerative medicine [3, 4]. 
Among many others, we have chosen to fabricate gelatin nanofibers by 
electrospinning [5]. Previously, gelatin nanofibrous substrates have been 
successfully used for cell culture and long term expansion of human pluripotent stem 
cells (hiPSCs) [6]. To further improve the culture performance, and by considering, 
in addition, the requests of versatility and flexibility for both in vivo and in vitro 
assays, we propose in this part a new type of substrate based on monolayer network 
of gelatin nanofibers bounded on patterned honeycomb frame of PEGDA for hiPSCs 
culture, which not only mimic the in vivo organization of the ECM but also take into 
account the hydrodynamic properties of the in vivo cellular microenvironments. 
Besides, this substrate allows off-ground culture with much enhanced permeability 
and much decreased exogenous contact of cells, due to the extremely high porosity 
of the patch and extremely low material inclusion. Since cardiac and neuron cells are 
the mostly important for drug screening and disease therapy, we are mainly 
interested in hiPSCs differentiation into cardiomyocytes and motor neurons in this 
work. And the differentiation difference between in off-ground environment and in 
conventional 2D culture environment is compared. 
 
3.2 Fabrication of culture patch  
This culture patch is made of crosslinked monolayer gelatin nanofibers, as 
shown as Fig. 3.1. The patch frame is a honeycomb shaped and highly porous 
membrane mounted on a ring of the same material for easy handling with sufficient 
mechanic stability. The crosslinked monolayer nanofibers can be produced by 
electrospinning while the honeycomb frame can be produced by soft-lithography, 
both relying batch processes for mass production. In the following, we will give the 
details of the fabrication process. 
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Fig. 3.1 Design of nanofiber patch composed of PEGDA honeycomb frame and 
monolayer gelatin nanofibers.  
 
3.2.1 PEGDA honeycomb network fabrication 
 
Fig. 3.2 Schematic of PEGDA honeycomb frame fabrication. (a) PDMS mold 
fabrication by lithography; (b) Aspiration-assisted PEGDA frame production; (c) 
PEGDA ring mounting and Au deposition. 
 
The fabrication procedure of PEGDA honeycomb network is shown in Fig. 3.2. 
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It includes three steps: 
 
a) PDMS mold fabrication 
Chromium mask of honeycomb network arrays of 500 μm diameter and 50 µm 
width was produced by micro pattern generator (μPG 101, Heidelberg Instruments) 
with 60% 40mW energy, followed with resist developing (AZ726MIF, 1 min) and 
45s chrome etching. After rinsing and removal of residual resist in acetone, a Cr 
mask with honeycomb pattern can be obtained. 
Positive resist AZ40XT was used to generate the master mold by UV 
lithography. First, 50 µm AZ40XT resist layer was spin-coated on the mask at 500 
rpm for 10s and then 1500 rpm for 20s. The resist was then prebaked following the 
sequence of 1 min at 65°C, 1 min at 95°C and 8 min at 126 °C. After cooled down to 
room temperature, the mask was backside exposed with UV light (365 nm 
wavelength and 9.1 mW/cm2) for 90 s, following with a post-bake process (30 s at 
65°C, 30 s at 95°C and 2 min at 105 °C). The mask was then developed in 
AZ319MIF for 2.5 min with mild agitation. After rinsing with DI water, the mask 
with patterned resist was dried with nitrogen gun, resulting in AZ40XT master mold. 
Next, AZ40XT resist master was evaporated by TMCS for anti-sticking surface 
treatment for 1-3 min. A PDMS solution was prepared using GE RTV 615 PDMS 
components A and B at a ratio of 10:1 and then poured on the top of the resist master. 
After curing at 80°C for 2 h, the PDMS mold can be peeled off (shown as Fig. 3.3). 
 
 
Fig. 3.3 Photograph of PDMS mold for honeycomb frame. 
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b) Aspiration-assisted PEGDA frame production 
 PEGDA honeycomb frame was fabricated with PDMS aspiration-assisted 
molding technique. In brief, the PDMS mold was first placed on a glass slide. Then, 
the PDMS-glass assembly was placed in a desiccator for degasing during 15 min. At 
the same time, a PEGDA pre-polymer solution mixed with 1 v/v% Irgacure 2959 as 
photo-initiator was prepared and used to fill the PDMS-glass cavity by degassing 
induced micro-aspiration. After the free space of PDMS-glass cavity was filled 
completely, it was exposed with UV light (365 nm wavelength) at 9.1 mW/cm2 for 
30s. Then the solidified PEGDA network was formed after peeling off PDMS mold. 
 
c) PEGDA ring mounting and Au deposition 
To increase the mechanical strength and convenience of handle, 100 µm thick 
PEGDA rings of 13 mm outer diameter and 9 mm inner diameter were prepared in a 
similar manner. Firstly, a Cr mask defining the ring geometry was generated with 
μPG 101 at 60 % 40 mW energy. After development and chrome etching, acetone 
was applied to remove the residual resist. Then a 100 µm thick SU8-3050 resist was 
spin-coated on a clean silicon wafer at 500 rpm 10 s and then 1000 rpm for 30s, and 
then soft-baked at 65 °C for 1 min and 95°C for 45 min. After cooling down to room 
temperature, the mask was exposed with UV light for 28s. The resist was then post 
baked at 65°C for 1 min and 95°C for 5 min. After development with SU8 developer 
and trimethylchlorosilane (TMCS) evaporation, the PDMS mold was produced by 
soft lithography and placed on a glass slide. Then, the PEGDA solution was injected 
into the mold and solidified by UV exposure for 30 s. Finally, the ring was mounted 
on PEGDA frame, using about 10 μl pre-cured PEGDA solution as binder for UV 
curing. Then the whole frame was immersed into isopropanol ultrasound bath for 10 
min and then DI water ultrasound bath for 10 min to remove the residual unreacted 
PEGDA and photo-initiator. Fig. 3.4 shows the photo of PEGDA honeycomb frame 
mounted with a ring. 
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Fig. 3.4 Photograph of PEGDA honeycomb frame mounted with a ring. 
 
Prior to electrospinning, the backside surface of PEGDA frame was deposited 
with 10 nm thick Au by sputter coater (K675X, EMITECH, Germany) at 25 mA 
current to obtain more uniform nanofiber layer and enhance the attachment of gelatin 
nanofiber and PEGDA frame . 
 
3.2.2 Gelatin nanofiber electrospinning 
 
Fig. 3.5 Schematic of electrospinning on PEGDA frame. 
The obtained PEGDA frame coated with Au was fixed on a silicon wafer for 
gelatin nanofiber electrospinning. First, the gelatin solution was prepared. 10 wt% 
gelatin powder (G2625, Sigma-Aldrich, France) was dissolved in the mixed solution 
of acetic acid, ethyl acetate and distilled water with a volume ratio of 21:14:10. Then 
a syringe with gelatin solution was mounted in a syringe pump (KD Scientific). The 
spinneret was connected to the anode of high potential power supply (TechDempaz, 
Japan) with bias voltage of 11 KV and the cathode was connected to the grounded 
silicon wafer. Then the PEGDA substrate with golden surface on top was fixed onto 
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the silicon wafer to collect nanofibers, shown as Fig. 3.5. The pump federate was 
fixed at 0.2 ml/h and the distance between spinneret tip and collected PEGDA 
substrate was 10 cm. 
  
Fig. 3.6 PEGDA frame supported gelatin nanofiber net with a tweezer holding. 
 
After electrospinning, gelatin nanofibers collected on PEGDA substrates were 
dried in vacuum overnight to evaporate the remaining solvent. Then crosslinking 
solution was prepared by dissolve 0.2M 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC) and 0.2 M N-hydroxysuccinimide (NHS) in 
ethanol completely. The electrospun gelatin scaffolds were cross-linked in the 
crosslinking solution for 4 h. After crosslinking, samples were rinsed with ethanol 
three times and then dried in vacuum overnight to remove the remaining chemicals. 
Fig. 3.6 shows the final PEGDA frame supported gelatin nanofiber net. 
  
Fig. 3.7 SEM photographs of gelatin nanofiber at different electrospinning time. 
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To optimize the porosity and pore size of gelatin nanofiber, different 
electrospinning time was tested based on the other constant parameters. The 
morphology of fibers observed by SEM was shown as Fig. 3.7. For both 7 min and 
15 min of spinning time, single layer nanofiber mat can be obtained. But when 
spinning time was 30 min or more, nanofiber mat becomes multilayers and there was 
almost no through hole among fibers. The size of pores and porosity of nanofiber 
mat were analyzed by imageJ from SEM photos, as shown in Fig. 3.8. The porosities 
for 7 min and 15 min of spinning time were 79.8±0.8% and 63.65±1.35%, 
respectively. Both of them are transparent enough for a final suspension culture 
system. But for 30 min of electrospinning, the porosity was difficult to measure by 
software since the multi-layer and the too small pores. The pores for 15 min spinning 
were mainly less than 5 μm2 and almost no more than 20 μm2, while for 7 min of 
spinning time, the area of most pores was from 0 to 20 μm2, and some of them were 
even more than 100 μm2, which was much larger than the size of cells.  
 
Fig. 3.8 Pore size distribution of gelatin nanofiber at different electrospinning time 
(7 min and 15 min). 
To confirming this effect, the same number (2×105) of hiPSCs was seeded on the 
substrates with different density of fibers. After 24 hours, the adhesion and coverage 
of cells on gelatin fibers was shown as Fig. 3.9. For the nanofiber layers by 
electrospinning for 15 min and 30 min, adhesive cells almost covered the entire 
fibrous area with very slight difference between each other. However there were 
obvious much fewer cells attached on the nanofibers with 7 min electrospinning. 
Therefore considering both high permeability and enough support for cells, 15 min 
was chosen as the optimum electrospinning time for the next studies. 
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Fig. 3.9 Human iPSCs cultured on gelatin nanofiber substrate with different 
electrospinning time. (a: 7min; b: 15min; c: 30min) 
 
3.3 Cell characterization methods 
3.3.1 SEM observation 
Cell samples were fixed in PBS containing 4% formaldehyde for 30 minutes. 
Then, they were rinsed twice with PBS buffer, and immersed in 30% ethanol (in DI 
water) for 30 min. Afterward, the samples were dehydrated in a graded series of 
ethanol solutions with concentrations of 50%, 70%, 80%, 90%, 95%, and 100%, 
respectively, and in each for 10 min then dried with a nitrogen gas flow. Before 
observation, a 2 nm thick gold layer was deposited on the samples by sputtering. The 
observation was performed with a SEM machine (Hitachi S-800) operated at 10 kV.  
 
3.3.2 Immunocytochemistry 
For the immunostaining of NIH-3T3 and Hela cells, after culture for 2 days, the 
cells on nanofiber patch were fixed with 4% paraformaldehyde (PFA) in PBS for 15 
min. Then cells were washed with PBS three times. Afterward, cells were 
permeabilized with 0.5% Triton-X-100 for 10min. After washing with PBS for three 
times, cells were then blocked in 1% BSA solution for 30 min, followed with PBS 
washing for three times. Then the cytoskeleton and nuclear of cells were stained with 
Atto 488 Phalloidin (Sigma) and DAPI (Life technology) for 20 min, respectively. 
After washed with PBS for three times again, cells can be observed under an 
inverted optical microscope (Zeiss, Axiovert 200) equipped with a digital CCD 
camera (Evolution QEI). 
For the immunostaining of iPSCs and differentiated cardiomyocytes and 
neurons, after rinsing with PBS to remove unattached cells, the cells were fixed with 
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4% paraformaldehyde (PFA) diluted in PBS for 15 min. Then cells were treated with 
0.5% Triton X-100 in PBS at 4°C overnight (for antigens inside nuclear) or 10min at 
room temperature (for antigens outside nuclear) for permeabilization and then 
incubated in a blocking solution containing 5% v/v normal goat serum, 5% v/v 
normal donkey serum, 3% v/v bovine serum albumin, and 0.1% v/v Tween 20 in 
D-PBS overnight at 4 °C to block out non-specific bindings. Cells were then 
incubated with primary antibodies, i.e., anti-OCT4 (1:100 diluted, Santa Cruz), 
anti-NANOG (1:100 diluted, Santa Cruz), anti-α-Actinin (Sarcomeric) (1:500 diluted, 
Sigma), anti-Troponin T-C (1:200 diluted, Santa Cruz), anti-connexin 43 (1:100 
diluted, Cell Signaling), anti-MYH6 (1:50 diluted, Santa Cruz), anti-Pax6 (1:100 
diluted, Abcam), anti-Sox1 (1:100 diluted, Abcam), anti-Nestin (1:200 diluted, 
Sigma), anti-Olig2 (1:100 diluted, Abcam), anti-β tubulin III (1:400 diluted, Sigma) 
and anti-HB9 (1:100 diluted, Abcam) in blocking solution at 4°C overnight. After  
incubation with the primary antibody overnight at 4 °C, cells were incubated with 
the appropriate secondary antibody, i.e., Alexa Fluor 488 Donkey anti-rabbit IgG 
(1:300 diluted, Jackson ImmnoResearch) and Alexa Fluor 594 Donkey anti-mouse 
IgG (1:300 diluted, Jackson ImmnoResearch) in blocking buffer at room temperature 
for 1 h. Then, cells were incubated with 300 ng/ml 4’-6-diamidino-2-phenylindole 
(DAPI) for 30 min for nuclear staining, and finally washed three times with PBS. 
Then stained cells were observed with an inverted optical microscope (Zeiss, 
Axiovert 200) equipped with a digital CCD camera (Evolution QEI). 
 
3.3.3 Live/dead assay 
Cell viability was studied with live/dead assay. Briefly, cells on substrate were 
incubated with 2 μM of Calcein AM and 2 μM EthD-1 for live and dead cell staining, 
respectively. After 30 min incubation at 37°C and 5% CO2, cells were analyzed with 
a fluorescence microscope, as described above.  
 
3.3.4 Total RNA purification 
Total RNAs from normal cultured hiPSCs, dome-like EBs, hiPSCs derived 
cardiomyocytes or derived neurons were harvested using the RNeasy Mini Kit 
(Qiagen, Valencia, CA) following the manufacturer’s instructions. mRNA 
concentrations were measured in a NanoDrop1000 spectrophotometer (Thermo 
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Fisher). 
 
3.3.5 Reverse transcription-polymerase chain reaction (RT-PCR) 
A reaction mixture (25 µL) containing 5 units of Taq DNA polymerase (Takara, 
Japan), 1 µl cDNA and 0.2 µM PCR primers (shown in Table 3.1) in PCR buffer 
was subjected to amplification in a DNA thermal cycler (Applied Biosystems 7300 
Real-Time PCR System). PCR was performed for 30~35 cycles (94 °C, 30 sec; 
58 °C, 30 sec; 72 °C, 60 sec) with an initial incubation at 94 °C for 5 min and a final 
extension at 68°C for 3 min. Amplified products (10 µL) were resolved by 1.2% w/v 
agarose gel electrophoresis and visualized by ethidium bromide staining. RT-PCR 
results of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used as 
control. 
Table 3.1 Forward and reverse primer sequences used for PCR detection 
Primers Sequence 
OCT4 forward 5′-GACAGGGGGAGGGGAGGAGCTAGG-3′ 
OCT4 reverse 5′-CTTCCCTCCAACCAGTTGCCCCAAAC-3′ 
NANOG forward 5′-CAGCCCCGATTCTTCCACCAGTCCC-3′ 
NANOG reverse 5′-CGGAAGATTCCCAGTCGGGTTCACC-3′ 
PAX6 forward 5′-ACCCATTATCCAGATGTGTTTGCCCGAG-3’ 
PAX6 reverse 5′- ATGGTGAAGCTGGGCATAGGCGGCAG-3′ 
BRACHYURY forward 5′-GCCCTCTCCCTCCCCTCCACGCACAG-3′ 
BRACHYURY reverse 5′-CGGCGCCGTTGCTCACAGACCACAGG-3′ 
AFP forward 5′-GAATGCTGCAAACTGACCACGCTGGAAC-3′ 
AFP reverse 5′-TGGCATTCAAGAGGGTTTTCAGTCTGGA-3′ 
Nestin forward 5’-ATCGCTCAGGTCCTGGAAGG-3’ 
Nestin reverse 5’-AAGCTGAGGGAAGTCTTGGAG-3’ 
Olig2 forward 5′-GGGCCACAAGTTAGTTGGAA-3′ 
Olig2 reverse 5′-GAGGAACGGCCACAGTTCTA-3′ 
GAPDH forward 5′-AACAGCCTCAAGATCATCAGC-3′ 
GAPDH reverse 5′-GGTCTCTCTCTTCCTCTTGTGC-3′ 
 
3.3.6 Quantitative RT-PCR (q-PCR) 
Total RNA was reverse transcribed using the RT First Strand Kit (Qiagen). 
cDNA was amplified and quantified with Power SYBR Green PCR MasterMix (Life 
Technologies) and relative primers. Briefly, “hot start” PCRs were carried out with 
an initial incubation at 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 
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then 60 °C for 3 min using an Applied Biosystems 7300 Real-Time PCR system 
(Life Technologies). Data analysis was carried out using Cluster 3.0 in combination 
with the TreeView 1.1.5 open-source software.  
Table 3.1 shows the forward and reverse primer sequences used for q-PCR. 
qBiomarker Validation PCR Array-Cardiomyocytes Differentiation Kit (Cat. No. 
337231 IPHS-102A) was used for cardiomyocytes q-PCR test and gene expression 
heat map generation.  
 
3.3.7 Flow cytometry 
iPSCs differentiated cardiomyocytes on PEGDA supported nanofiber substrates 
and on glass slide were harvested with TrypLE Express for 5 min at 37°C. Then cells 
were washed twice with D-PBS and cell numbers were counted. For staining with 
FITC labeled cTnT antibody, cells were diluted to a final concentration of 1 × 107 
cells mL-1 in PBS containing 2% fetal calf serum. Then cells were incubated in 
antibody solution at room temperature for 30 min. A specific isotype control was 
used as a negative control. After removing the antibodies by centrifugation at 1000 
rpm for 5 min, cells were washed with D-PBS containing 2% fetal calf serum. 
Finally, cell suspensions were applied to a FACS Canto II flow cytometer (BD 
Biosciences). 
 
3.4 Off-ground culture for enhanced cell proliferation 
To demonstrate the advantages of this nanofiber substrate for cell processing, 
firstly two types of cells, fibroblast NIH-3T3 and cancer cell Hela were cultured on 
the substrate: 
 
3.4.1 NIH-3T3 and Hela cells culture 
Both NIH-3T3 and Hela cells were cultured with a culture medium composed of 
89% Dulbecco’s Modified Eagle Medium (DMEM), 10% Fetal Bovine Serum (FBS) 
and 1% penicillin/streptomycin at 37 °C with 5% CO2 supplementation for 3~4 days 
until 80~90% confluence, respectively. Then they were dissociated with Trypsin at 
37 °C for 5 min. After centrifugation at 1200 rpm for 5 min, cells were re-suspended 
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in fresh medium at desired density for seeding. 
Before cell seeding, the gelatin nanofiber patch was sterilized under UV light for 
15 min for both top and bottom surface. Then 50 μl medium containing 2×103 cells 
was added on the top of the substrate and in the center of PEGDA ring. After 
incubation at 37 °C for 1 h for cell adhesion, 2 ml more fresh medium was added 
around the patch gently. It’s worth mentioning that the nanofiber patch can be 
suspended inside the medium, which results into an “off-ground” culture for the cells. 
And without any coating, both these two kind cells can attach on fiber within 2 h.  
After two days culture, the cytoskeleton and nuclear of cells were stained. Fig. 
3.10 shows the immunofluorescence images of NIH-3T3 and Hela cells cultured on 
PEGDA-nanofiber substrate, in which cytoskeleton and nuclear were stained with 
Phalloidin (green) and DAPI (blue), respectively. And since PEGDA cannot absorb 
proteins, there is almost no cell attached on PEGDA frame, which demonstrated that 
cells can be patterned variably by easily changing the shape of PEGDA, on the 
PEGDA-nanofiber substrate.  
 
Fig. 3.10 Bright field and immunostaining fluorescence images of NIH-3T3 cells 
(left) and Hela cells (right) on gelatin nanofiber patch. Green: Phalloidin for 
cytoskeleton; Blue: DAPI for nuclear. 
But comparing to the morphology of cells cultured in normal culture dish, cells 
on the nanofiber substrate can’t elongate as much as in culture dish. Normally, 
hydrophilic substrate with high surface energy benefits more for the adhesion and 
spreading of cells. The isoelectric point of cells is around 3~4, which charged 
negatively in culture medium. Therefore, the absorption of cells increases on 
positively charged material surface. However the isoelectric point of gelatin is ~4, 
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negatively charged in medium, while nanofiber’s ζ-potential changes little compared 
to the raw material [7], so gelatin nanofiber should be also negatively charged even 
if after crosslinking, which decreased the spreading of cells on our gelatin nanofiber 
substrate compared to positively charged culture dish. 
 
3.4.2 Cell proliferation  
Then we compared the population doubling time of NIH-3T3 on our substrate to 
on multi-well plate. 9 substrates were cultured with the same number of NIH-3T3 
cells (2×103 cells). Then cells were digested off from one substrate after 24 h, 48 h 
and 72 h respectively. The number of cells was counted with a hemocytometer. The 
final data was obtained from the average result of three times repeating experiments 
(Fig. 3.11). The cell number on multi-well plate was counted 24 h similarly. 
 
 
Fig. 3.11 NIH-3T3 cell number increase versus culture time on PEGDA-nanofiber 
substrate and normal multi-well plate, showing a significant cell proliferation rate 
difference between the two types of culture substrates. 
After calculation, the doubling time of cells on substrate was 15.01 h, shorter 
than 19.79 h of normal culture, and the growth rates were 0.0462 and 0.035 for cells 
on substrate and culture plate respectively. It indicates that the proliferation rate of 
cells can be improved with this kind of off-ground culture substrate, which provides 
a three dimensional nutrition supply environment for cells, rather than only up-side 
nutrition supply in normal culture dish. 
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3.5 Cardiac patch differentiated from hiPSCs for drug test 
It’s reported that cardiovascular diseases (CVDs) are the main causes of death 
worldwide (more than 17.3 million deaths every year) [8]. Taking example of Europe, 
CVD causes over 4 million deaths and over 1.9 million deaths in the European 
Union (EU), which amount 47% of all deaths in Europe and 40% in the EU [9]. In 
America, CVDs are reported to be responsible for 800,000 deaths in 2011, which is 
even less than 600,000 deaths due to all cancers [10]. CVDs are various including 
stroke, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, atrial 
fibrillation, congenital heart disease and so on [11]. And the principal reason for 
CVDs is that unlike other types of cells, cardiomyocytes have very little, or no 
proliferation ability, which making heart cannot heal itself when there is injury or 
disease. Thus, it makes the options for cardiac regeneration treatment very limited. 
Some drug therapies have been proposed to alleviate several factors related to the 
initial damages, however in fact none of them leads to cardiac repair. For heart 
transplant, extreme time consuming for waiting and pretty high cost make it not a 
possible therapy way for most patients.  
Tissue engineering attracts much attention currently which serves a promising 
method for cardiac repair as well as regenerative medicine development. As an 
outstanding source, human iPSCs can be easily generated with patient-specific cells 
by reprogramming and differentiate into any cell types of three somatic germ layers 
including cardiomyocytes, serve as promising tools in disease modeling, cell therapy 
and regenerative medicine for cardiac disease therapies [12, 13].  
A qualified cardiac patch should provide pure cardiac cells and also supply an 
extracellular matrix (ECM) with good biocompatibility and robust mechanical 
properties. Here the designed cell culture system with PEGDA as honeycomb frame 
and the gelatin nanofiber was used for cardiac differentiation from human iPSCs. 
Both PEGDA and gelatin nanofiber are biocompatible materials and the honeycomb 
structure of PEGDA has been proved to have a definite elasticity and has been 
applied to cardiomyocytes culture, which could supply not only strength support but 
also deformability along with cardiomyocytes contraction [20-22]. 
In this part, we present a method for generating cardiac patch on the designed 
gelatin nanofiber substrate. The process is including three steps, shown as Fig. 3.12. 
First, human iPSCs were cultured on the substrate and formed hemisphere 
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embryonic bodies (EBs) by changing ROCK inhibitor treatment time; Then 
cardiomyocytes were differentiated from hemisphere EBs directly on the substrate; 
Finally, by simply transferring the whole cell patch on MEA system, the effect of 
several cardiac drugs were tested. 
 
 
Fig. 3.12 Schematic of hiPSCs differentiation into cardiomyocytes. 
 
3.5.1 Human iPSCs culture and hemisphere EBs generation 
Human iPSCs (cell line 253G1 from Kyoto university and human episomal 
iPSC line from Life Technology) were cultured in complete E8 medium (Life 
Technology), on vitronectin (Life Technology, 1:100 diluted in DPBS) coated culture 
dish at 37°C with 5% CO2 supplementation. The medium was changed every day 
until cells grow to 70% ~ 80% confluences. For iPSCs harvest, cells were cultured 
with 0.5 mM EDTA DPBS solution for 5 min at 37 °C.  
PEGDA-gelatin substrate was coated with 1:500 vitronectin diluted in PBS 
solution at room temperature for 1h, then 2×105 iPSCs in 50 μl E8 medium with 10 
μM Y-27632 was seeded on the substrate and then transferred into incubator. After 1 
h incubation for cell adhesion, 2 ml fresh E8 medium with 10 μM Y-27632 were 
gently added in culture dish. Then cells can attach on nanofiber (coated with 1:500 
diluted vitronectin) only inside the PEGDA frame because PEGDA is not protein 
absorbable. After culturing in the E8 medium with Y-27632 for 1~4 hours, the 
medium was changed with normal E8 medium without Y-27632. After several hours, 
inside each honeycomb-like frame, attached monolayer hiPSCs formed a dome-like 
hemisphere EB gradually, almost in the center of frame, as shown in Fig. 3.13. 
 
Chapter 3 Culture and differentiation of pluripotent stem cells 
101 
 
Fig. 3.13 Bright field image of hemisphere EBs on PEGDA honeycomb frame 
supported gelatin nanofiber substrate. 
 
a) The effect of Y-27632 treatment time 
At different Y-27632 treatment time, the flatness of dome-like EBs is different 
(Fig. 3.14a). As the treatment time of Y-27632 increasing, the migration of cells 
became more difficult, resulted in flatter EBs. When Y-27632 worked for only one 
hours, as shown as SEM photos (Fig. 3.14b), the dome-like EBs were almost 
hemisphere and had the most highest thickness, which lead to a smaller diameter 
since the cells’ number was constant. There were two reasons for this phenomenon, 
one is the more diluted vitronection coating, which is an important component of the 
ECM for hESC or hiPSCs attachment through interactions with a variety of integrin, 
especially αVβ5 integrin [14]. Compared with 1:100 diluted vitronectin for normal 
iPSCs culture, 1:500 diluted vitronectin gave a weaker cell attachment on substrate; 
the other reason is the treatment time of Y-27632. Y-27632 is a selective inhibitor of 
the Rho-associated kinase p160ROCK and it is mainly used to prevent the 
dissociation induced apoptosis and promote the survival rate of embryonic stem cells 
and induced pluripotent stem cells [15]. So treated with Y-27632 is good for increase 
cells survival. However ROCK is a key regulator of cell migration and also can 
affect cell-cell adhesion [16], thus decrease of ROCK inhibitor working time will 
promote cell migration and cell-cell adhesion, which will lead iPSCs to be inclined 
to form spheroid morphology, while increase of Y-27632 time means increase the 
inhibition of cell migration and cell-cell interaction, which will make the migration 
of cells become more difficult, leading to a weaker cell-cell adhesion power and 
resulting a flat cluster morphology. As statistics, the average diameter of EBs for 1 or 
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2 hours Y-27632 treatment is similar and around 220 to 230 μm (shown as Fig. 
3.14c). Therefore, 2 hours of Y-27632 treatment time was applied for the following 
cardiomyocytes differentiation experiments. 
 
 
Fig. 3.14 Effect of Y-27632 treatment time on the flatness of iPSC clusters. (a) 
Bright field images of iPSC clusters at different Y-27632 treatment time; (b) SEM 
images of iPSC clusters at different Y-27632 treatment time; (c) Diameter 
distributions of iPSC clusters at different Y-27632 treatment time.  
 
b) Viability of hemisphere EBs  
A good beginning cell state is very important for the next differentiation. So we 
let the hemisphere EBs cultured for two more days, and stained them with Calcein 
AM and EthD-1 with live/dead assay. As shown in Fig. 3.15, almost all the cells of 
EBs part were live, and there were only few dead cells around EBs, which indicated 
that there was no obvious effect to the viability of cells when the Y-27632 treatment 
time was decreased to 2 hours. 
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Fig. 3.15 Immunofluorescence staining and bright field images of hemisphere EBs 
cultured for 48 h after Calcein AM/EthD-1staining for cell viability test. 
 
c) Pluripotency of hemisphere EBs 
To evaluate the stemness of hemisphere EBs generated on our PEGDA 
supported gelatin nanofiber substrate, pluripotent stem cell markers OCT3/4 and 
NANOG were used to stain the hemisphere EBs. The immunofluorescence results 
showed a typical hiPSC-like staining pattern, revealed that the expression of these 
markers was maintained (Fig. 3.16a). Reverse transcription-polymerase chain 
reaction (RT-PCR) analysis shown as Fig. 3.16b, demonstrated that the hemisphere 
EBs still kept to express pluripotency genes (Oct3/4 and NANOG), but not express 
three-germ differentiation genes (PAX6, BRACHYURY and AFP), which is similar 
to the undifferentiated hiPSCs cultured on traditional 2D culture dish, confirming 
that the formation of dome-like EBs on PEGDA supported gelatin nanofiber 
substrate does not affect the pluripotency of iPSCs. 
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Fig. 3.16 Pluripotency of hemisphere EBs on nanofiber substrate. (a) 
Immunocytochemistry analysis of Nanog and Oct 3/4 in hemisphere EBs; (b) 
RT-PCR results of hemisphere EBs and conventional cultured iPSCs. 
 
3.5.2 Cardiomyocytes differentiation from hemisphere EBs 
a) Cardiomyocytes differentiation protocol 
Once hemisphere EBs formed, cardiomyocytes differentiation was started since 
the next day, according to GiWi protocol developed by Lian et al [17], by 
modulating Wnt signaling with small molecules. As shown in Fig. 3.17a, 12 μM 
CHIR99021 in RPMI 1640/B27 without insulin medium was added in dish to change 
E8 medium, and after 24h of CHIR99021 treatment, the medium was changed with 
RPMI/B27 without insulin. 72 h after addition of CHIR99021, 5 μM IWP2 RPMI 
1640/B27 without insulin medium was added to exchange medium. On day 5 of 
differentiation, IWP2 was removed by changing new RPMI/B27 without insulin 
medium. Then every 3 days, change medium with RPMI/B27 medium. Cell 
morphology during differentiation was recorded by an inverted microscope. Since 
GSK3 inhibitor was added, many cells stated to migrate out from EBs. As 
differentiation processing, separated EBs begun to connect to each other to form a 
thick cell sheet (Fig. 3.17b).  
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Fig. 3.17 (a) Schematic of the protocol for the differentiation of cardiomyocytes 
from human iPSCs generated hemisphere EBs; (b) Bright-field images of the typical 
morphology at day -2, day 0, day 3, day 5 and day 12. 
With the same protocol, hiPSCs cultured on glass slide were differentiated into 
cardiomyocytes at the same time as a control. After treated by GSK3 inhibitor and 
Wnt inhibitor successively, cell contraction on PEGDA supported nanofiber 
substrate and glass slide can be observed around Day 7 and Day 8, respectively. 
 
b) Qualitative characterizations 
For qualitative analysis the distribution of cardiomyocytes related proteins 
expression, the differentiated cells on both nanofiber substrate and glass slide at day 
20 were stained with cardiomyocytes related antibodies. The immunofluorescence 
staining images were shown as Fig. 3.18. TnnT2, a highly cardiomyocytes-specific 
protein, was positive for the cells differentiated in both 2D (glass slide) and 3D 
(nanofiber substrate) environment, while on 3D nanofiber culture system, the 
expression of TnnT2 showed enhanced sarcomeric organization, which indicated a 
more mature cardiac cell state. α-MHC is a cardiac muscle-specific protein involved 
in active force generation. A decreasing expression of α-MHC on 3D substrate was 
found compared to the cells on 2D glass slide. It has been found that α-MHC 
expression was dropping along with cardiac maturation [25], which indicated that 
3D off-ground differentiation system may promote cardiac maturation. 
Immunostaining of α-actinin and connexin43 was shown as Fig. 3.18. Striated 
sarcomeres (α-actinin positive) can be observed for the differentiated cells on both 
3D substrate and 2D glass slide. Connexin43, for staining gap junction, plays a 
significant role in the coordination of cells contraction, which showed more positive 
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for the cells on nanofiber substrate compared to the control. 
   
Fig. 3.18 Immunofluorescence staining images of cardiomyocytes derived from 
hiPSCs on nanofiber substrate (3D) and glass slide (2D). (a) Blue: nuclear; green: 
α-actinin; red: connexin43; (b) Blue: nuclear; green: TnnT2; red: α-MHC. 
 
c) Quantitative characterizations 
Quantitative characterizations were used to further confirm the advantages of 
nanofiber substrate providing 3D off-ground environment for cardiomyocytes 
differentiation. As expect, there were 74.7% cTnT positive cardiomyocytes 
generated on nanofiber substrate compared to 34.5% on 2D glass slide at day 21 
according to flow cytometry results (Fig. 3.19). The genetic level difference for the 
cells differentiated in 3D and 2D environment was compared by analyzing the 
mRNA expression patterns of 22 cardiac differentiation related genes with q-PCR, 
shown as Fig. 3.20. Compared to the cells on day 0, almost all the genes related to 
differentiation and cardiac were higher expressed for the differentiated cells in both 
2D and 3D environments at 9 days. Compared to 2D differentiation, all the 
cardiac-specific genes, such as NKX2-5, TNNT2, TNNI3 were much higher 
expressed in 3D off-ground differentiation environment. And the expression of both 
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the genes related to cardiac structure, such as DES, ACTN2, and genes related to 
cardiac function, such as PLN, GATA4 was also improved for the cells on nanofiber 
in 3D differentiation environment. At the same time, the genes related to 
sodium/calcium/potassium channels which play significant roles during cardiac 
contraction, such as SLC8A1, RYR2 and KCNQ1 were also increasingly expressed 
in 3D off-ground differentiation system. Conversely, the expression of ADRB1 gene, 
which affects the resting heart rate and can be involved in heart failure, was 
decreased a little compared to 2D control differentiation. 
 
 
Fig. 3.19 Flow cytometer analysis with specific cardiomyocytes marker cTnT for the 
cells derived from hiPSCs on nanofiber substrate (3D) and glass slide (2D) at day 
21.  
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Fig. 3.20 Heat map of 22 cardiac related mRNAs expression of hiPSCs at day 0 and 
the cardiomyocytes derived from hiPSCs on nanofiber substrate (3D) and glass slide 
(2D) at day 9, as determined by q-PCR. 
 
3.5.3 Cardiac drug test on multi-electrode array 
Extracellular electrical signals recording for derived cardiac patch were 
performed by using a PC-based data acquisition system (Multi Channel System, 
Reutlingen, Germany), composed of multi-electrode array (MEA), preamplifiers, 
filter amplifiers and data acquisition boards (AD Instruments, Japan). The MEA is 
made of a 50×50 mm glass substrate with a 1.4×1.4 mm matrix of 60 silicon nitride 
insulated electrodes (30 µm diameter and 200 µm distance) imbedded in the center. 
Data were recorded at 20 kHz with 16-bit precision. 
The functional electrophysiological properties of derived cardiomyocytes on 
PEGDA supported nanofiber substrate was determined by MEA. At day 21, the 
substrate with cells can be easily transferred from culture medium to the testing 
chamber (filled with pre-warmed RPMI/B27 medium) of MEA data acquisition 
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system by tweezers handling (Fig. 3.21). This is clear advantageous due to the fact 
that the tissues formed on the monolayer nanofibers can serve as more robust 
barriers to drugs because of tight junctions between cells. The spontaneous field 
potentials (FPs) of iPSCs derived-cardiomyocytes were monitored by the 
extracellular recording of MEA system. The testing chamber was always kept at 
37 °C by a temperature control system during the whole testing process.  
 
 
Fig. 3.21 Electrophysiology test of cardiac patch on MEA. (a) Cardiac patch inside 
MEA testing chamber filled with medium. (b) Bright field image of cardiac patch on 
the micro electrodes of MEA. (c) Overall view of cardiac-representative field 
potential on 64 channels recorded from cardiac patch by MEA.  
 
After 15 min for system stability, the original signals of cardiomyocytes on day 
21 were obtained. The field potential of contracting cells was simultaneously 
recorded by an 8×8 electrode grid, and the overall recorded signals of 60 channels 
were shown as Fig. 3.21c. The signals from all channels showed typical cardiac field 
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potential waveforms with very close synchronism and frequency.  
Next, fresh RPMI/B27 medium with 50 nM E-4031 (Sigma, M5060) were 
added to change the old medium for studying the effect of E-4031 on 
cardiomyocytes. After 10 min, the reaction FP signal was recorded, following with 
10 min treatment of 100 nM E-4031 and signal recording. The introduction of 
E-4031 showed a prolonged QT interval dependent by the drug concentration (Fig. 
3.22a). 50 nM and 100 nM E-4031 increased 36% and 52% QR interval, 
respectively (Fig. 3.22b). This was mainly due to the blocking effect of E-4031 on 
the rapid component of the delayed rectifier potassium current.  
 
Fig. 3.22 Drug tests of cardiac patch. (a) Effect of 50 nM and 100nM E-4031 on the 
field potential wave (green lines represent QT interval). (b) QT interval prolonged 
with the increase of E-4031 concentration. (c) Effect of cardiac drug ISP and Pro 
concentrations on the field potential wave of cardiac patch. (d) Beating frequency 
changes with ISP and Pro treatment. 
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Then, the cell reaction for cardiac drugs, Isoproterenol (ISP) (Sigma, I6504) and 
Propranolol (Pro) (Sigma, P0884), were tested in the same way. Isoproterenol, a 
beta-agonist, was introduced to the cells with gradual increased concentrations, 
which lead to a dose-dependent increase of beating frequency (Fig. 3.22c). Then the 
application of different concentration propranolol, a beta-blocker, resulted in a 
dose-dependent decrease of beating frequency (Fig. 3.22d). The above results of  
cardiac drug tests indicated a good drug reaction and functional performance of the 
cardiomyocytes generated on PEGDA frame supported nanofiber substrate. 
 
3.5.4 Discussion 
We present a monolayer gelatin nanofiber substrate with PEGDA honeycomb 
frame supporting, which could provide an off-ground 3D cell culture environment. 
There have been numerous methods reported for EBs generation [18-21]. They could 
product uniform EBs by micro-wells or other techniques, and when they started to 
differentiate EBs to cardiac cells, there were two ways: either they let EBs to 
dispersed suspended in differentiation medium or reseed EBs in culture dish. The 
first way resulted in heterogeneous cardiac clusters with irregular shape due to the 
inevitable fusing of EBs, while these irregular cardiac clusters have different cardiac 
functional properties, such as beating frequency [18]. Besides, this kind of separated 
suspended cardiac cluster was also difficult to be applicate, which need to disperse 
the clusters to single cells for reseeding. And the way of plating the generated EBs 
on coated culture dish for differentiation changed the 3D state and environment of 
EBs, and could not control an even distribution of plated EBs. Here to our best 
knowledge, we generated for the first time homogeneous hemisphere EBs adhesive 
inside each PEGDA honeycomb frame which allowing efficient cardiomyocytes 
differentiation to form a relatively uniform functional cardiac sheet directly on the 
same substrate. Due to both the non-protein adhesion of PEGDA, seeded hiPSCs can 
be separated into several colonies by the regular PEGDA frame and form dome-like 
EBs by easily controlling the treatment time of ROCK inhibitor. Unlike traditional 
suspension EBs which are very easy to merge together and difficult to be 
manipulated, hemisphere EBs are attached on the nanofiber patch, which can be 
operated and controlled easily by handling the whole patch.   
It has been reported a lot about the advantages of 3D cell culture environment, 
which can mimic the in vivo microenvironments more accurately [22, 23]. Although 
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in our work the hemisphere EBs was adhesive to the nanofiber, it was not the same 
as traditional 2D adhesive culture because the nanofiber layer was almost monolayer 
with very high porosity and large enough pore size which could let the cells located 
in the bottom of EBs still contacted to the same nutrient and factors as the cells 
located on the top during culturing and differentiation. Therefore, the environment 
was similar to the 3D environment of traditional suspension EBs. Lee et al [29] 
reported a similar PEGDA micropatterned PS/PSMA nanofiber, but their nanofiber 
layer was very thick and compact, which cannot provide a 3D exposure environment 
for cells. Following with dome-like EBs generation, the similar pluripotency of cells 
in EBs, the higher cardiomyocytes differentiation efficiency, genetic and protein 
specific markers expression levels and better beating uniformity, compared with 
traditional 2D monolayer cell differentiation were demonstrated. The proliferation 
enhancement effect of our nanofiber patch for fibroblast was mainly due to the 
improved permeability of patch, which has been shown before (Part 3.3). Similarly, 
the remarkable better cardiac differentiation performance may also attribute to this 
kind of 3D exposure culture environment, which could let cells contact with much 
more differentiation factors and nutrient not only from the top of EBs but also from 
the bottom gaps among nanofiber.  
After cardiomyocytes differentiation, the contraction of cardiac sheet on 
nanofiber showed much better synchronism and homogeneity, compared to the 
control differentiation on glass slide. This is because on nanofiber, cells formed 
separated homogeneous EBs first before differentiation, and during differentiation, 
each EB was exposed to the differentiation factors equally all over the whole 
substrate. Then the cells migrated and connected to form one thick cell layer, leading 
to a homogeneous beating cardiac sheet. However, on glass, cells were a large flat 
clone before differentiation and cell migration occurred during differentiation 
leading to a annular apophysis close to the edge, which was the only beating region, 
while most areas in the center of the annular apophysis circle were clam with almost 
no contraction. 
For the spontaneous functional electrophysiological performance 
characterization, no matter 2D monolayer differentiation or conventional EBs 
differentiation, the dispersing and re-seeding were needed [24, 25]. However this 
step was troublesome and brought certain unavoidable injury to the cells, and could 
also destroy the organization structure of cells that has been established. But in our 
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case, we just need to transfer the device with derived cells on it from culture medium 
to MEA testing chamber, which made it very convenient to monitoring the function 
property of derived cardiomyocytes. Furthermore we have demonstrated that this 
PEGDA supported nanofiber substrate was also a platform, which could be used 
directly for cardiac drug tests. Our results using MEA mapping technique showed 
that hiPSC derived cardiomyocytes responded appropriately to three different 
cardiac drug compounds known to affect QT intervals and chronotropy, which 
confirmed that the differentiated cells were cardiac-functional and this device could 
be supplied as a promising human cardiac model platform for drug safety tests. 
 
3.6 Functional motor neuron differentiation from hiPSCs 
 
Fig. 3.23 Motor neuron structure, including dendrites, cell body with nucleus, axon, 
myelin sheath, nodes of Ranvier and motor end plates. The impulses are transmitted 
through the motor neuron in one direction [26].  
 
Motor neurons are the cells located in spinal cord, projecting their axons outside 
the spinal cord to control muscles directly or indirectly through neuromuscular 
junctions [27]. Similar to other type neurons, motor neuron is composed of a cell 
body (soma), dendrites, and an axon as shown as Fig. 3.23, in which dendrites 
collect signals and then axon passes the signals to the muscles to control the 
contraction and relaxation of muscle, resulted into the movement. So any problem of 
motor neuron will affect the movement directly and cause motor neuron diseases 
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(MNDs). MNDs are neurodegenerative in nature and cause increasing disability and 
eventually death, such as amyotrophic lateral sclerosis (ALS) and spinal muscular 
atrophy (SMA) [28]. Unfortunately there is no a cure or efficient treatments for 
MNDs in present.  
 
Fig. 3.24 Related factors for hESC or hiPSCs differentiation into neurons. From 
neural induction of pluripotent stem cells to the expansion and early specification of 
neural progenitors and the final differentiation into specific neuronal lineages [29]. 
 
Due to the of pluripotency and the ability to give rise to any cell type of the 
organism, ESCs and more recently iPSCs have emerged as powerful tools for the 
study of neurobiology, and also hold great promises for regenerating complex neural 
tissues and repairing neuron injury whether from direct damage or from the disease 
of neuron development and degeneration [30]. Hence, in recent years, the related 
mechanisms about neural induction, differentiation and specification have been 
studied widely [31-33]. In the meantime, different subtypes of neurons have been 
generated by differentiation from stem cells, such as dopaminergic neurons [34, 35], 
interneurons[36, 37], motor neurons[14, 38, 39] and pyramidal neurons [40]. Fig. 
3.24 outlines the various stages and the related factors of hESC or hiPSCs 
differentiation into neurons, from neural induction of pluripotent stem cells to the 
expansion and early specification of neural progenitors and the final differentiation 
to specific neuronal lineages. For MNDs, human iPSCs derived motor neurons could 
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be very promising not only for generating reliable MNDs model in regenerative 
medicine development and pharmaceutical applications, but also for further 
transplantation and injury repair.  
In the past decade, there were several protocols have been developed to 
differentiate motor neurons from hiPSCs. However, there are still some limitations 
hindered the application of these protocols, such as time consuming (up to 2 months), 
genetic manipulation requirement, low efficiency and introduction of unknown 
factors [38, 39, 41]. In this part, we developed a protocol for motor neuron 
differentiation on gelatin nanofiber patch. After generate monolayer or hemisphere 
EBs on the patch, motor neuron differentiation was proceeded following three steps: 
neuroectrodermal induction based on dual inhibition of SMAD signaling [42], motor 
neuron differentiation into motor neuron progenitors, and motor neuron maturation, 
as shown as Fig. 3.25.   
 
Fig. 3.25 Schematic of the protocol for hiPSCs (either monolayer iPSCs or 
hemisphere EBs) differentiation into motor neurons. 
 
3.6.1 Motor neuron differentiation protocol 
a) Neuroectrodermal induction 
The induction medium was prepared with Knockout Serum Replacement (KSR) 
medium and N2 medium at different ratio. KSR medium contains 20% KSR, 0.1 
mM β-mercaptoethanol, 2 mM Glutamax, 1% Non-Essential Amino Acid (NEAA) 
and 4 ng/ml basic fibroblast growth factor (bFGF) in DMEM/F12. N2 medium 
contains 1% N2 supplement, 2 mM Glutamx and 1% NEAA in DMEM/F12. The 
neuron induction of hiPSCs was done by using N2/KSR medium at ratio of 0/100% 
(day 1-3), 25%/75% (day 4), 50%/50% (day 5-6), 75%/25% (day 7) and100%/0 (day 
8), respectively, together with 10 μM SB431542 and 0.1 μM LDN193189 (for dual 
inhibition of SMAD signaling) for all days. 
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b) Motor neuron differentiation 
From day 9 to 16, cells were treated with N2 medium containing 0.1 μM retinoic 
acid (RA), 0.5 μM purmorphamine (Pur) and 20 ng/ml bFGF. The medium was 
changed every two days.  
 
c) Motor neuron maturation 
At day 17, motor neuron progenitors were digested with 1 mg/ml Dispase and 
re-suspended in a maturation medium which is composed of 1:1 mixture of N2 
medium and B27 medium with a number of maturation factors. The B27 medium 
contains neurobasal medium, 2% B27 supplement, and 2 mM Glutamax. The 
maturation factors include 10 ng/mL brain-derived neurotrophic factor (BDNF), 10 
ng/mL glial-derived neurotrophic factor (GDNF), 10 ng/mL insulin-like growth 
factor 1 (IGF-1), 1 µM cyclic adenosine monophosphate (cAMP), 0.2 µg/mL 
ascorbic acid (AA), 0.1 µM RA, and 1 µM Pur.  
Prior to cell seeding, the nanofiber patch was treated in a laminin solution (1:50 
iMatrix511 in PBS, Clontech) at 37℃  overnight while glass slides and 
multi-electrode array (MEA, Multichannel, Germany) samples were first treated in a 
solution of poly-ornithine (PO, Sigma P4957) at 37°C for 2h and then in the 
laminin solution at 37℃ overnight. After cell seeding, the medium was changed 
every two days. 
 
3.6.2 Effect of beginning cell states and substrates on differentiation 
No matter which type differentiation from hiPSCs, the initial cell density is one 
of the critical parameters deciding the final differentiation efficiency [43, 44]. Here 
we optimized the seeding density for motor neuron differentiation on vitronectin 
coated glass slide (Ф15mm，A=2.36 cm2). We seeded hiPSCs at initial cell number 
of 4×105, 6×105 and 8×105. After two days, cells were induced and differentiated 
as the protocol above. During differentiation, the morphology of cells can be divided 
into four regions from the center to the edge of glass (shown as Fig. 3.26). In the 
center, cells were much denser and it’s difficult to observe the morphology of each 
cell. More close to the edge of glass, lower density and more elongated neuron 
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morphology can be observed. Interestingly, at day 16, there were neuron spheres 
appeared in the center of glass slide, and the cells on the edge elongated as 
neuron-like morphology.  
The differentiated cells were stained with neuron specific protein β-tubulin III 
and motor neuron progenitor specific marker Olig2 at day 16, as shown as Fig. 3.27. 
There were more Olig2 positive motor neuron progenitors in the center than on the 
edge of glass. And cells differentiated from low seeding density expressed more 
Olig2, which indicated for our protocol, the optimum seeding density is 4×105 cells 
per 2.36 cm2. 
 
 
Fig. 3.26 Cell morphologies at different regions of glass slide on day 8 and day 16. 
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Fig. 3.27 Immunofluorescence staining for neurons derived from different densities 
of hiPSCs on glass slide. DAPI: nuclear (blue); β-tubulin III: neural microtubule 
(green); Olig2: motor neuron progenitor (red). 
 
Currently there are lots of protocols for hiPSCs differentiation into neurons, 
generally the protocols can be divided into two main groups according to the 
beginning cell state [45, 46]: EBs differentiation or monolayer iPSC colonies 
differentiation. So far there was no unified opinion yet which method is better. 
Therefore, in this part, we will compare the differences between EBs and monolayer 
differentiation into motor neurons on nanofiber patch in off-ground condition, with 
conventional 2D differentiation on glass slide as control. 
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Fig. 3.28 Bright field images of cells during motor neuron differentiation from 
different beginning cell states at different substrates. 
 
Fig. 3.28 shows the bright field images of differentiating cells at different stages. 
After the formation of hemisphere EBs or monolayer colonies for two days, the 
iPSCs were induced to neuroectrodermal cells by inhibition of dual Smad signaling 
pathway, using TGF-β inhibitor SB431542 and BMP4 inhibitor LDN193189. 
Typical cell morphology changes can be observed at day 8. Meanwhile, cells started 
from EB like colonies migrated to the outside of the EB area and then connected to 
the neighboring ones. The results of immunostaining show that at day 8 most cells 
became both Pax6 and nestin positive which are neuroectodermal specific 
transcription factor and common neural progenitor marker, respectively (Fig. 3.29). 
The results of q-PCR revealed a higher nestin expression level of the cells on 
nanofibers than on glass, suggesting that the off-ground culture with crosslinked 
monolayer nanofibers lead to a better neuron induction of hiPSCs than conventional 
culture (Fig. 3.30).  
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Fig. 3.29 Immunofluorescence staining images of hiPSCs-derived neurons at day 8 
and day 16 from different beginning cell status. DAPI: nuclear (blue); Pax6: 
neuroectrodermal cells (green); Nestin: neuron stem cells (red); β-tubulin III: neural 
microtubule (green); Olig2: motor neuron progenitor (red).  
 
After day 8, cells were exposed to soluble morphogens RA and Pur for motor 
neuron specification. At day 16, the immunofluorescence images show clearly 
neuron specific β-tubulin III stained microtubules and motor neuron progenitor 
specific transcription factor Olig2. However, the results of q-PCR (Fig. 3.30) show a 
much higher expression level of Olig2 for the cells started from monolayer colonies 
than that from EB-like ones and on glass (Fig. 3.29), suggesting that monolayer 
iPSCs colonies could be better directed to the motor neurons under off-ground 
culture conditions. 
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Fig. 3.30 Relative mRNA expression of Nestin at day 8 and Olig2 at day 16 for 
different beginning cell status of motor neuron differentiation.  
 
3.6.3 Effect of different substrates on motor neuron maturation  
After day 16, motor neuron progenitors derived from monolayer iPSCs on the 
culture patch were digested and reseeded for maturation on three types of substrates, 
i.e., pre-coated glass slide, MEA or culture patch. Fig. 3.31 shows the morphology 
changes of the cells at day 22, 26 and 30 on different culture supports. In the 
beginning, single neurons started to adhere on the substrate and showed extension of 
neurites extension. Due to cell proliferation, neuron clusters and even neuron spheres 
(especially on glass slide) were formed. Then, elongated axons (up to several 
hundred micrometers) appeared at day 30. However, significant differences in 
cell/cluster morphology can be observed with different types of culture supports. 
Apparently, neurons cannot attach on well on MEA, which lead to a poor 
proliferation. Neurons are also more likely to form large clusters on MEA and glass 
while they spread on the culture patch due to compartmentation and less stiff 
substrate. Indeed, neurons are found in the relatively soft tissue of the nervous 
system, they thrived similarly on softer materials in vitro [47, 48]. Compared to the 
environment of nervous system in vivo, glass and MEA are too rigid for neuron 
culture, while the culture patch formed by crosslinked monolayer gelatin nanofibers 
should provide a culture support quite similar to the in vivo extracellular matrix for 
both neuron proliferation and neurites extension. 
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Fig. 3.31 Bright field images of motor neuron morphology reseeded at different 
substrate and different day. 
 
Cells on glass slide were stained with motor neuron specific transcription factor 
marker HB9 and neuron specific protein β tubulin III at day 22 and day 30, as shown 
as Fig. 3.32. Most of neurons were HB9 positive motor neurons. We observed 
β-tubulin III positive neuron networks obviously. But there were also some β-tubulin 
III positive but HB9 negative neurons existed, especially at day 30.  
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Fig. 3.32 Immunostaining images of motor neurons on glass slide during maturation 
at day 22 and day 30. DAPI: nuclear (blue); HB9: motor neuron (red); β-tubulin III: 
neural microtubule (green). 
 
After day 30, neural electrical signals were monitored on real time every two 
days with MEA system. Similar to the electrophysiology test of cardiac patch, 
neuron patch can also be handled and transferred easily with a tweezer onto MEA 
platform (shown as Fig. 3.33).   
 
Fig. 3.33 Bright field images of neuron patch on MEA. 
 
Around day 38, there was spontaneous extracellular field potentials could be 
detected for neuron patch, as shown as Fig. 3.34, which proved the neurons became 
mature enough and formed functional neuron network. But the neuron signals were 
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not detected on every electrode. It was probably due to either the worse contact of 
patch and electrodes comparing to the case of neurons directly seeded on MEA, or 
the various maturity of neurons in different locations. Besides, we should however 
mention that the patch is not perfectly flat so that the distance between the patch is 
not in conformal contact with each of the electrodes of MEA, leading to electrode 
dependent signal intensity. Fig.3.34 (b-d) show 10 second recorded signals by 
electrode 78#, 51# and 46# respectively.  
 
Fig. 3.34 Spontaneous electrical signals of motor neurons on nanofiber patch 
recorded by MEA. (a) Overall view of spontaneous neuron activity detected on 64 
channels recorded. (b) Electrical signals detected by electrode 78# for 10 s. (c) 
Electrical signals detected by electrode 51# for 10 s. (d) Electrical signals detected 
on electrode 46# for 10 s. (e) Two typical groups of neuron spike detected by 
electrode 46#. (f) Spike sorting for the electrical signals detected by electrode 46#. 
Taking example of channel 46#, spikes could be detected with a signal-to-noise 
ratio ranged from 3:1 to 5:1. With spike sorting tool implemented in MC_Rack 
software, signals from channel 46# can be divided into two main groups of spikes 
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generated from the activity of 2 neurons according to waveform dissimilarity, shown 
as Fig. 3.34 (e-f). And the individual spikes typically displayed a negative 
component of 150~200 μV for the spike group 1, and a negative component of 
50~80 μV followed by a positive component of 50~130 μV for group 2. For most of 
electrodes with spike detected, the signals were attributed to 1~2 neurons per 
electrode. And the duration of each spike was around 1 ms, which matches the 
normal neuron signal characteristic.  
The electrical signals of cells reseeded on MEA were also monitored every two 
days, however until day 50, there was no electrical signal detected. It revealed that 
the off-ground neuron culture system with nanofiber patch can enhance motor 
neuron maturation, due probably to the more similar in vivo extra neural 
environment compared to the rigid 2D substrates. 
 
3.7 Conclusion 
In this chapter, we firstly described the fabrication of the culture patch made of 
crosslinked monolayer gelatin nanofibers and PEGDA frame. Next, we show the 
advantage of this culture patch for off-ground culture, which leads to a significant 
increase of the proliferation rate comparing to that cultured conventionally. We then 
used the culture patch for the shape control of hiPSCs colonies (varying from 
monolayer to hemisphere EB-like by changing the Rock inhibitor treatment time). 
Afterward, the EB-like colonies were used for cardiac differentiation on the culture 
patch, showing ~74.7% of differentiation efficiency compared to ~34.5% with the 
culture dish method. When the culture patch with derived cardiomyocytes was 
placed on a multi-electrode array, we obtained expected field potential signals as 
well as the drug type and dose dependent responses. Finally, we used the culture 
patch to control motor neuron differentiation of hiPSCs. Motor neuron progenitors 
were obtained on the patch, showing the expression of their characteristic proteins. 
After reseeding to different types of culture support, representative electrical signals 
could be recorded at day 30 with the patch, due to spontaneous firing of neurons, but 
no firing was detected with for the neurons reseeded on MEA device until day 50. 
Our results also show that the differentiation efficiency of hiPSCs to neurons is 
higher when started from flat iPSCs colonies comparing to that of EB-like ones.  
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Over-all, the culture patch we proposed in this work can be used for advanced 
studies of cardiac and neuronal differentiation and electrophysiological recordings. 
Comparing to the more conventional culture dish methods, the culture patch method 
could be a more efficient alternative for process optimization and thus a large variety 
of applications.  
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In this chapter, we present a study of isolation and culture of cancer cells. We 
first describe the development of a CTCs isolation technique by using conical shape 
holes and microfluidic device. The processing parameters such as flow rate and cell 
density are studied for different types of tumor cells. Cell culture is also performed 
after isolation to show the post-isolation capability of the proposed device. 
Afterward, clinical trials are performed and mechanical analysis is used to 
theoretically demonstrate the advantages of the conical shape holes of the filter and 
the microfluidic design. Finally, we describe a multi-well device for tumor spheroids 
formation. The performances of the culture with three different types of materials are 
compared, showing the suitability of agarose formed device. Then, we show the drug 
effects on the tumor spheroids formation. 
 
4.1 Introduction 
Cancer is one of the leading causes of mortality and every year it accounts for 
millions of deaths all over the world [1]. It has been proven that the early diagnosis 
of cancers is the key to against cancer diseases. Circulating tumor cells (CTCs) in the 
peripheral blood of cancer patients are promising biomarkers for cancer detection 
and diagnosis [2]. However, CTCs are extremely rare in the blood, which is about 
only 1~10 CTCs among 1 billion blood cells, leading to the main technical challenge 
to capture them [3]. To address this, efforts have been made by several research 
groups [4-8]. However, there are still problems influence the isolation process or the 
further analyze and have to be solved, such as write blood cells contamination, low 
cell viability after capture, low operation speed. After the CTCs isolation, the further 
culture of CTCs is significant for phenotypic and genotypic analyze of single CTC to 
understand in depth cancer metastasis. 
On the other hand, as we know that malignant cells in neoplastic tissue, like 
healthy cells in normal tissue, are organized in complex 3D networks displaying 
nutrient and signal gradients, cell–cell contact, as well as cell–extracellular matrix 
(ECM) interactions [9]. Therefore, generating an organotypic model mimicking in 
vivo solid tumor tissue, such as 3D tumor spheroids, benefit for drug delivery, 
toxicity, and metabolism, compared to conventional 2D cultures, due to their more 
physiological cell–cell contact geometry, mass transport, and mechanical properties 
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[10, 11]. However, the available systems are mostly appropriate for small size 
spheroid formation, which cannot efficiently recapture the spheroid complexity of 
solid tumours. And to facilitate the diffusion of nutrients, drugs and other factors into 
the spheroid area, it is also important to form the 3D assays with the materials of 
high permeability [10].  
 
4.2 CTCs capture 
4.2.1 Device fabrication 
Capture of CTCs from peripheral blood of cancer patients has major 
implications for metastatic detection and therapy analyses. Here we designed and 
fabricated a microfluidic device with the integration of a filter with conical-shaped 
microhole array and a micro-injector with cross-flow components for size dependent 
capture of tumor cells (shown as Fig. 4.1). During operation, A filter made of 
PEGDA with conical holes is sandwiched between two patterned PDMS layers and 
the sample was loaded from inlet 1 and collected from outlet 2, passing through the 
filter with a syringe pump for constant pulling speed. 
 
Fig. 4.1 Schematic of the experimental setup of microfluidic device with integrated 
conical-hole filter for capture of circulating tumor cells. 
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Both filter and microfluidic device were made of biocompatible materials 
(poly(ethylene glycol) diacrylate (PEGDA) and polydimethylsiloxane (PDMS), 
respectively) with rather standard fabrication processes. PDMS is now widely used 
for the fast prototyping of microfluidic devices whereas PEGDA can be easily 
functionalized to tune the protein or cell adhesion properties of the filter surfaces. 
Next we will give the details for the fabrication of PEGDA filter and the integration 
in microfluidic chips.  
 
a) Fabrication of conical-hole microfilters  
The fabrication procedure of PEGDA microfilter is shown in Fig. 4.2. It 
includes three main steps: PDMS mold generation, PEGDA micro-filter production 
and PEGDA ring mounting. 
 
 
Fig. 4.2 Fabrication procedure of conical-hole filters. (a) Fabrication of PDMS mold 
with conical pillars; (b) Replication of PDMA pattern into PEGDA thin membrane, 
the same replication process is used for the fabrication of PEGDA ring; (c) UV 
assisted bonding of PEGDA membrane and ring. 
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a) PDMS mold generation by lithography 
We designed a dots arrays of 5.5 or 6.5 or 8.0 μm diameter and 30 µm period by 
L-Edit software. Then a chromium mask of relevant holes arrays was produced by 
micro pattern generator (μPG 101, Heidelberg Instruments) with 40 mW and 60% 
energy followed with resist developing (AZ726MIF, 1 min) and 45 s chrome etching. 
50 µm AZ40XT resist layer was spin-coated on the mask and prebaked 
following the sequence of 1 min at 65°C, 1 min at 95°C and 10 min at 126°C. After 
cooled down to room temperature, the mask was backside exposed with UV light 
(9.1 mW/cm2) for 250 s at an incident angle of 20° (for a final of half conical angle 
of 13°) and a rotation speed of 3 rpm. Following with a post-bake (30 s at 65°C, 30 s 
at 95°C and 3 min at 105 °C), the mask was developed with AZ319MIF for 3 min. 
After development, conical holes of bottom and top diameters of 5.5, 6.5, 8.0 μm 
and 19.4, 20.4, 21.9 μm were obtained. After rinsing with DI water, the mask with 
patterned resist was dried with nitrogen gun. 
Then the resist surface on mask was evaporated with TMCS for surface 
anti-sticking. A PDMS solution was prepared using GE RTV 615 PDMS components 
A and B at a ratio of 10:1 and then poured on the top of the resist master, followed 
with a curing process at 80°C for 2 h. The SEM photos of PDMS mold with conical 
shape pillars are shown as Fig. 4.3. 
Fig. 4.3 SEM photos of PDMS mold with conical pillars. 
 
b) PDMS aspiration-assisted molding for PEGDA filter 
Then the solid PDMS mold layer with conical pillars was placed on a glass slide. 
The PDMS-glass assembly was placed in a desiccator for degassing for 15 min. 
Meanwhile, a PEGDA solution mixed with 1 v/v% 2-hydroxy-2 
Chapter 4 Isolation and culture of cancer cells 
137 
-methylpropiophenone (HOMPP) as photo-initiator was prepared protected from 
light and used to fill the PDMS-glass cavity by degassing induced micro-aspiration, 
followed by UV exposure at 9.1 mW/cm2 for 30s. Finally, the solidified PEGDA 
filter was peeled off, resulting in a microfilter with conical holes and a porosity of 
3.6%. Fig. 4.4 shows the SEM photos of PEGDA filter with conical holes. 
 
 
Fig. 4.4 SEM images of PEGDA filter with conical-hole array. (a) Cross section of a 
conical holes array; (b, c) Bottom and top view of SEM images of conical-hole array, 
respectively; (d) Top view SEM image of a single conical hole. Scale bar: (a) 40 µm 
(b, c) 100 µm (d) 5 µm. 
 
c) PEGDA ring mounting 
To increase the mechanical strength and handle the filter easily, 100 µm thick 
PEGDA rings of 13 mm outer diameter and 6 or 9 mm inner diameter were prepared 
in a similar manner. Briefly, a 100 µm thick SU8-3050 resist was exposed with a Cr 
mask defining the ring geometry. After development and trimethylchlorosilane 
(TMCS) evaporation, the PDMS mold was produced by soft lithography and placed 
on a glass slide. Then, the PEGDA solution was injected into the mold and solidified 
by UV exposure. Finally, the ring was mounted on the filter, using pre-cured PEGDA 
solution as binder for UV curing. For comparison, filters of cylindrical holes were 
obtained using UV lithography at normal incident angle without rotation. Fig. 4.5 
shows the photo of final PEGDA filter mounted with ring. 
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Fig. 4.5 Photograph of a 9 mm diameter PEGDA filter mounted with PEGDA ring 
aside a 1 cent euro coin. 
 
b) Microfluidic device integration  
The microfluidic chip for micro-filter integration was composed of two layers. 
The sample was loaded into the microfluidic device from the inlet of the top 
chamber (inlet 1) and collected from the outlet of the bottom chamber (outlet 2), 
passing through the microfilter sandwiched between the two structured PDMS layers. 
The layouts of the upper and bottom PDMS layers are shown in Fig. 4.6.  
 
 
Fig. 4.6 Layout for the fabrication of upper (a) and bottom (b) PDMS layers. 
Here the upper PDMS was produced by soft lithography with a mold fabricated 
by a CNC milling system. First, a two level pattern was produced on a PMMA plate. 
The first level is a cavity of 13 mm diameter and 130 µm in depth, designed for 
embedment of PEGDA filter. The second level includes a 6 mm or 9 mm chamber, 8 
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radial channels of 400 µm width, the inlet, the outlet and the ring channels of 1 mm 
width, all having a depth of 400 µm. After machining, the mold was ultrasonic 
washed with isopropanol. Then, the pattern was replicated twice into PDMS by soft 
lithography and both inlet and outlet holes were punched, resulting in the desired 
upper layer.  
The bottom layer was fabricated by standard soft lithography with a mold 
fabricated by UV lithography. First, a chromium mask was produced by µPG 101 
and then replicated into a 100 µm thick photoresist (SU8-3050, Micro resist). After 
development and evaporation of TMCS, PDMS was poured on the SU8 mold with a 
thickness of ~ 1 mm and cured at 80°C for 2 h. After peeling off, the main chamber 
of diameter of 6 mm or 9 mm was punched.  
The surfaces of upper and bottom PDMS layers were treated by oxygen plasma 
shortly and the PEGDA filter was sandwiched between the two PDMS layer, 
following by a thermal bonding at 80°C for 30 min. Finally, the inlet and outlet of 
the bottom layer were punched and the PDMS-PEGDA assembly was irreversibly 
bonded to a glass slide after plasma treatment of the PDMS layer. Fig. 4.7 shows a 
microfluidic device operating with blood sample.  
 
 
Fig. 4.7 Photograph of a microfluidic device operating with a test blood sample. 
 
4.2.2 Experimental 
a) CTC isolation process 
Three cell lines (MCF-7, HT-29 and U87) were prepared in 10% FBS and 1% 
penicillin/streptomycin with their respective media, McCoy's 5A Modified Medium 
and Dulbecco’s Modified Eagle Medium (DMEM) at 37°C with 5% CO2 
supplementation for 3-4 days. Prior to filtration tests, cells grown to confluence were 
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detached by Trypsin at 37°C for 3 min. After centrifugation at 1200 rpm for 5 min, 
cells were resuspended in PBS or PBS diluted healthy human blood (VPBS:Vblood＝
1:1) to the desired density. Human blood was collected from healthy donors in 
collection tube with EDTA to prevent coagulation and used within 24 h.  
Before isolation, a metallic needle was mounted on the bottom of an Eppendorf 
tube and then inserted in the inlet of the upper layer of the device to facilitate 
injection. Before sample introduction, the device was rinsed with PBS first. Then, 
the sample was introduced from the Eppendorf tube by negative pressure generated 
with a syringe pump connected the outlet of the bottom layer. By varying the speed 
of the syringe pump, the flow rate of the sample across the filter could be controlled. 
After filtration of blood samples, the device was rinsed with 300 µl PBS once from 
inlet 1 to outlet 2 and once from inlet 2 to outlet 2 for more clear observation. 
 
b) Immunostaining and microscopic imaging  
The captured cells were fixed and treated inside the device. 4% 
paraformaldehyde (PFA) diluted in PBS at 10 μl/min for 15min was injected from 
inlet 1 to outlet 2, followed by PBS rinsing at 50 μl/min for 6 min. Similarly, 0.2% 
Triton X-100 in PBS was injected into the device at 10 μl/min for 10 min for 
permeabilization and 300 μl 1% BSA in PBS was introduced at 10 μl/min for 30 min 
to block out non-specific bindings. Afterwards, cells were stained with dye solutions 
(passing from inlet 1 to outlet 1). First, 600 μl immunostaining solution, containing 5 
μg/ml Anti-Pan-cytokeratin (AE1/AE3) Alexa Fluor 488- (1:100 diluted in PBS; 
eBioscience SAS) and Anti-Human CD45 PE (1:20 diluted in PBS, eBioscience SAS, 
France), was injected at 10 μl/min for 1 h to stain tumor cells and WBCs, 
respectively. Then, the nucleus were stained by 4’,6-diamidino-2-phenylindole 
(DAPI,100 nM, Life Technologies) at 10 μl/min for 10 min. Finally, the device was 
rinsed by 300 µl PBS for 6 min and fluorescence images were obtained with an 
inverted optical microscope (Zeiss, Axiovert 200) equipped with a digital CCD 
camera (Evolution QEI). 
 
c) Cell culture after capture  
A filter of 6.5 µm hole-diameter treated with Maxgel ECM mixture (1:25 diluted 
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in complete McCoy's 5A medium, Sigma-Aldrich) at 37°C for 1 h was used for 
culture test. After filtration of HT-29 cells spiked in PBS at a flow rate of 0.2 ml/min, 
the upper PDMS layer could be peeled off and the filter was took out gently and 
placed into a petri dish. 70 μl culture medium was dropped on the filter in the center 
of the ring and then incubated for 1h for cell attachment. Then, 1.5 ml medium was 
added gently around the ring for culture at 37°C in a 5% CO2 incubator.  
 
d) Cell viability assay 
After 3 days culture of captured tumor cells on the filter, the viability of cells 
was studied by live/dead assay with LIVE/DEAD® viability/cytotoxicity kit (L-3224, 
Thermofisher Scientific). Briefly, 2 μM of Calcein AM and 2 μM EthD-1 in PBS 
was used to replace the culture medium for live and dead cell staining, respectively. 
After 30 min incubation at 37°C and 5% CO2, fresh PBS was used to replace the 
staining solution. Cells were then observed and analyzed with a fluorescence 
microscope, as described above. Live cells were Calcein AM positive with green 
color, while dead cells were EthD-1 positive with red color. Cell viability was 
calculated by live cells number divided by total cells number. 
 
e) Scanning electron microscopy observation  
Samples were fixed in PBS containing 4% formaldehyde for 30 minutes. Then, 
they were rinsed twice with PBS buffer, and immersed in 30% ethanol (in DI) for 30 
minutes. Afterward, the samples were dehydrated in a graded series of ethanol with 
concentrations of 50%, 70%, 80%, 90%, 95%, and 100%, respectively, each for 10 
min and dried with a nitrogen gas flow. Before observation, a 2 nm thick gold layer 
was deposited on the samples by sputtering. The observation was performed with a 
scanning electron microscope (Hitachi S-800) operated at 10 kV.  
 
f) Hydrodynamic simulation    
Numerical simulation has been performed with commercial software (COMSOL 
Multiphysics). For simplicity, cylindrical- and conical-holes were replaced by a 
linear array of rectangular or trapezoidal slits, respectively, keeping the other 
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geometrical parameters as the same of two-dimensional filters (6.5 µm entrance size, 
30 µm thickness, and 30 µm pitch size). The results were obtained with a transfilter 
pressure of 100 Pa and water viscosity of ~1 × 10−3𝑃𝑃. 𝑠 without cells.  
 
g) Definition of capture efficiency, purity and cell viability 
The capture efficiency of the device for the targeting tumor cells was defined as 
the ratio of tumor cells found on the filter, 𝑛𝑐 , to the initial tumor cells injected into 
the device, 𝑛𝑖 , 
𝑇𝑇𝑇𝑇 = 𝑛𝑐
𝑛𝑖
× 100%                   (1) 
The capture purity of the device for the targeting tumor cells was defined as the 
ratio of tumor cells found on the filter, 𝑛𝑐 , and the total number of cells found on 
the filter, 𝑛𝑐 + 𝑛𝑤𝑤𝑐 , 
𝑇𝑇𝑇𝑃 = 𝑛𝑐
𝑛𝑐 +𝑛𝑤𝑤𝑐 × 100%              (2) 
where 𝑛𝑤𝑤𝑐  is the number WBCs found on the filter.  
The cell viability of the tumor cells captured by the filter was defined as the 
ratio of live tumor cells, 𝑛𝑐𝑐 , and dead tumor cells 𝑛𝑐𝑐 , both being found on the 
filter 
𝑇𝑇𝑇𝑃 = 𝑛𝑐𝑐
𝑛𝑐𝑐 +𝑛𝑐𝑑 × 100%                 (3) 
 
4.2.3 Results  
a) Cancer cell capture  
We fabricated 30 µm thick PEGDA filter with 30 µm pitch conical holes at 
constant angle of 13°. For comparison, filters with conical holes of three different 
entrance diameters (5.5, 6.5 and 8.0 µm) were produced over an area of disk of two 
different diameters (6 and 9 mm). For demonstration, HT-29 cancer cells were 
spiked in a diluted blood sample of a healthy person at concentration of 103 cells/ml 
and the filtration experiments were performed with a filter of 6.5 µm conical holes at 
a constant flow rate, controlled with a syringe pump at a constant pulling speed. As 
results, we recovered the most of the spiked HT-29 cells on the filter with a limited 
number of normal blood cells (Fig. 4.8). Here, fluorescence images were recorded 
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after immunostaining (green for CK positive, red for CD45 positive, blue for nuclei 
of all cells). By counting the total cell number injected into the device and those of 
CK and CD45 positive for tumor cells and leukocytes respectively on the filter, we 
obtained a capture efficiency of ~95% and a capture purity of ~86%. 
 
 
Fig. 4.8 HT-29 cells on the surface of a filter. (a-c) Fluorescence images of HT-29 
cells and WBCs stained with anti-CK-AlexaFluor 488 (green) and anti-CD45-PE 
(red), respectively. Nuclei were stained in blue with DAPI. Here HT-29 cells were 
spiked in a blood sample and the filtration was done with a filter of 6.5 µm hole 
diameter. (d) Merged image of (a), (b) and (c). Scale bar: (a-d) 30 µm. 
 
b) Validation with clinical samples  
Blood samples donated by 14 cancer patients and 6 healthy donors were used to 
test the potential clinical relevance of the device. The volume of each blood sample 
was 2 ml. Without red blood cells lysing, we diluted all samples in PBS at a volume 
ratio of 1:2 before filtration. The filtration experiments were performed with a filter 
of 6.5 µm conical holes at a flow rate of 0.2 ml/min. After filtration and 
immunostaining, fluorescence images of the cells captured on the filters were 
recorded (green for CK positive, red for CD45 positive, blue for nuclei of all cells). 
Fig. 4.9 shows one example of the fluorescence images obtained with the blood 
sample of a lung cancer patient. Again, both cancer cells (DAPI+/CK+/CD45-) and 
white blood cells (WBCs, DAPI+/CK-/CD45+) were captured, validating the 
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feasibility of CTC capture by using our device.  
 
Fig. 4.9 CTCs of a cancer patient. (a) Fluorescence Nucleus staining with DAPI 
(blue). (c, b) Fluorescence of a CTC after staining with anti-CK-AlexaFluor 488 
(green) and anti-CD45-PE (red), respectively. (d) Merge image of (a-c). Scale bar: 
30 µm. 
Statistically, CTCs could be detected in the blood samples of a large portion of 
cancer patients but not in that of healthy donors (shown as Table 4.1). Among 14 
blood samples of the cancer patients, only 5 did not show up the CTC signature, 
due probably to the limited volume of our blood samples. Previously, it has 
been reported that even with 7.5 ml blood samples of cancer patients, no CTC 
could be detected in some samples [12]. Similar to the capture of cancer cells 
spiked in blood samples, only a limited number (a few of hundreds) of WBCs 
were found on the surface of the filter (Fig. 4.10), which made easy the 
fluorescence imaging and enumeration of CTCs. In addition to the cancer 
cells and WBCs, some other types of cells which are neither CK nor CD45 
positive may show up, but their presence did not affect the detection of CTCs. 
More systematic analyses will be conducted for a more detailed clinical 
validation of the device.  
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Table 4.1 Validation of the method with clinical samples. CTC enumeration 
after filtration with 2 ml blood samples diluted in PBS at a volume ratio of 
1:2. 
 
Blood sample CTC number 
Healthy donors 
1# 0 
2# 0 
3# 0 
4# 0 
5# 0 
6# 0 
Lung cancer 
7# 2 
8# 1 
9# 4 
10# 0 
11# 2 
12# 6 
13# 2 
14# 0 
Nasopharynx cancer 
15# 1 
16# 0 
Mediastinal tumor 
17# 1 
18# 2 
Cardia cancer 19# 1 
Cervical cancer 20# 0 
Breast cancer 21# 0 
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Fig. 4.10 Fluorescence images of WBCs of a healthy donor on the filter. (a) 
Fluorescence of nuclei staining with DAPI (blue). (c, b) Fluorescence of after 
staining with anti-CK-AlexaFluor 488 (green) and anti-CD45-PE (red), respectively. 
(d) Merge image of (a-c). Scale bar: (a-d) 30 µm. 
 
c) Flow rate and cell density dependencies  
To quantitatively evaluate the performance of the method, experiments were 
performed with HT-29 cells spiked in PBS at a concentration of 5×104 cells/ml. After 
filtration, cells were stained by DAPI and CK, showing a clear coincidence of these 
two types of fluorescence (shown as Fig. 4.11). 
 
Fig. 4.11 Fluorescence images of tumor cells on the filter. (a) HT-29 cell nuclei are 
stained with DAPI (blue). (b) HT-29 cells were stained with anti-CK-AlexaFluor 
488 (green). (c) Merged image of (a) and (b). The tumor cells were spiked in PBS at 
a 104 cells/ml concentration of. Scale bar: 100µm. 
 
The flow rate dependency of the cell capture efficiency was studied by using 
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HT-29 cells spiked into PBS at 100 cells/ml concentration. In the range of flow 
investigation (0.2~2.0 ml/min with filters of 6.5 µm holes diameter and 6 mm 
diameter filter area), we observed an increase of the capture efficiency with the 
decrease of the flow rate (Fig. 4.12). A further increase of the capture efficiency 
(>95%) was possible with a smaller flow rate. For the same capture efficiency (95%), 
the flow rate was increased by a factor of 2.25 when the 6 mm diameter filter was 
replaced by the 9 mm diameter filter, which corresponds to a decrease of the 
filtration time from 18 min to 8 min for a 6 ml sample.  
 
Fig. 4.12 Capture efficiency as a function of flow rate. The error bars represent the 
standard derivation (s.d.) of three measurements. 
Similarly, we evaluated the cell density dependency of the capture efficiency 
(Fig. 4.13) by enumerating cell on the 6 mm diameter filter after immunostaining. 
As expected, the capture efficiency of our device is almost the same for different cell 
densities due to the fact that the number of captured cell (10~100) is much less than 
the number of the holes of the filter (~104) and there should be no change of the 
pressure across the filter under given experimental conditions.  
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Fig. 4.13 Capture efficiency of 10, 20, 50, 100 HT-29 cells spiked in 1 ml PBS at a 
flow rate of 0.2 or 0.5 ml/min, respectively. The error bars represent the standard 
derivation (s.d.) of three measurements. 
 
d) Cell type and hole size dependencies  
To assess the reliability of our device for different tumor cell types, the capture 
efficiency has been evaluated for three cell lines (MCF-7, HT-29 and U87), each 
spiked in PBS at a 100 cells/ml concentration and injected into the device at a flow 
rate of 0.2 or 0.5 ml/min. Not surprisingly, remarkable differences of the capture 
efficiency could be observed due to the size differences of these tumor cells (Fig. 
4.14). Here, three types of filters of different hole diameters (5.5, 6.5, 8.0 μm) were 
used, which also allowed us to evaluate the hole size dependency of the capture 
efficiency. Clearly, the smaller the hole size, the higher the capture efficiency. Using 
the filters of 5.5 µm diameter holes, a capture efficiency of 98%, 96% and 85% 
could be achieved for MCF-7, HT-29 and U87, respectively. Increasing the hole size 
from 5.5 µm to 6.5 µm has negligible effect on the capture of MCF-7 but the filter of 
8.0 µm diameter holes resulted in a much decreased capture efficiency, suggesting an 
optimal size (~6.5 µm) of conical holes for MCF-7 capture. The filters of 6.5 µm 
diameter holes could also be accepted for HT-29 capture but filters of 5.5 µm in 
diameter or smaller is preferable for U87 capture.  
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Fig. 4.14 Cell-type dependency of capture with filter of different hole sizes at a flow 
rate of 0.5 ml/min. The error bars represent the standard derivation (s.d.) of three 
measurements. 
 
To understand the observed cell type dependencies of micro-hole capture, the 
size of each cell type and their nuclei were determined (Fig. 4.15) by analyzing the 
bright field images of suspended cells and the fluorescence of the cell nuclei stained 
with 0.5 µg/ml Hoechst 33342 in a suspension of cells in PBS. As expected, MCF-7 
has the largest size of cell body and nuclei, giving rise to the best capture efficiency 
for the given hole size of the filter (6.5 µm). U87 and HT-29 have comparable cell 
sizes, but U87 has much smaller nuclei, which led to capture efficiency significantly 
lower than that of HT-29 using the same filter of 6.5 µm hole diameters. Since the 
nuclei are much more difficult to deform than the cytoplasm, the entrance diameter 
of conical holes for filtration should be correlated to the size of corresponding 
nucleus rather than the size of the cell.  
 
Chapter 4 Isolation and culture of cancer cells 
150 
 
Fig. 4.15 Cell and nuclei sizes measured with a suspension of cells stained by 
Hoechest33342. The error bars represent the standard derivation (s.d.) of three 
measurements. 
 
e) Cell viability assessment  
We took SEM photos of tumor cells captured on filter after one hour (Fig. 4.16). 
From the photos, there were a lot of tentacle-like pseudopodia prolongation shown 
as the yellow arrows, which means cells started to adhere on the filter for 
proliferation and migration.  
 
 
Fig. 4.16 SEM photos of captured tumor cells after one hour (scale bar: 5 μm). 
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HT29 cells spiked in PBS were used to evaluate the cell viability after filtration 
with 6.5 µm conical-hole filters. In total, about 90% cells could be captured for 104 
injected cells. Calcein AM and EthD-1 were used to stain live and dead cells 
respectively, indicating that more than 95% of captured HT-29 cells were alive. Cell 
culture was tested with the same filter after filtration (Fig. 4.17a and b).  
 
Fig. 4.17 Cell culture and viability test. (a) Bright field image of cells on the PEGDA 
filter after capture and culture for 3 days. (b) Immunostaining fluorescence of HT-29 
cells after Calcein AM/EthD-1staining. (c) Statistic data of cell number per cluster at 
day 4. Scale bar: (a) and (b) 50 μm. The error bars represent the s.d. of three times of 
counting with a number of randomly selected areas. 
 
After 3 days, live cells localized on the surface of the filter formed cell clusters 
due to growth (Fig. 4.17c). As can be seen, most of the clusters have a cell number 
less than 6, due probably to the single cell proliferation initially captured on the filter 
at different places. Considering a doubling time of ~23 h, not all captured cells are 
capable to expand. Some of cells need time for adaptation or repairing, some others 
could be lost during culture medium exchange, etc. Among the larger clusters, half 
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have more than 8 cells per cluster, which is due probably to the capture of more than 
one cell in close proximity to each other.  
 
4.2.4 Discussion 
We put forward the novel design of the filter with high density conical holes to 
achieve the best compromise between the capture efficiency, purity and viability of 
CTCs. In general, the capture efficiency of CTCs increases with the decrease of the 
hole-size but a too much small hole size will lead to poor capture purity because of 
the accumulation of undesired blood cells on the filter. The optimal hole-size 
preventing the loss of precious cells should be comparable or smaller than the nuclei 
size of the CTCs, which can also be smaller or overlap with the size of erythrocytes. 
Considering however the fact that the shapes of erythrocytes can be extensively 
changed under the influence of mechanical forces in a flow or restraint area of 
circulation, erythrocytes may easily penetrate into the hole under influence of applied 
transfilter pressure. The question is how erythrocytes escape from the hole. The red 
blood cells (RBCs) are non-nucleated cells in form of disks of 6.2~8.2 µm diameters 
and 0.8~2.5 µm thickness. Although abundant, they can pass quickly through 
microholes of comparable sizes. WBCs have comparable or larger sizes. Once 
penetrated, their retention depends mainly on the transfilter pressure which cannot be 
large for high viability of captured CTCS, the interaction with hole wall and the shape 
of the hole. To illustrate the advantage of using conical holes, we consider a model of 
soft particles squeezed in two types of holes (cylindrical and conical) with the same 
size at the entrance. In simplified geometries shown in Fig. 4.18, one can relate the 
built-up pressure to the surface tension of the particle according to Laplace’s law, 
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where γ is the surface tension, R1 and R2 are respectively the radius of the curvature 
of the tailing and leading edges of the particle. Thus, ∆P = 0 for cylindrical holes and 
∆P> 0 for conical holes because of the difference between the two curvatures. With 
a surface tension47of ~3.0×10-5 N/m and a radius of curvature of tailing and leading 
edge R1=3.25 µm and R2=2R1, respectively, ∆P ~ 9.2 Pa. Although this built-up 
pressure is rather small, it may efficient stimulate WBCs to escape the conical holes, 
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suggesting a better clearance of the conical-hole filter than that of the cylindrical 
ones.  
 
Fig. 4.18 Schematic of cell retention in a cylindrical (a) and conical hole (b): Cells 
squeezed in two filter types can have different built up pressure due to the difference 
in surface tension of their leading and tailing edges. 
 
For comparison, our model was tested by performing capture of tumor cells 
under the same experimental conditions but using the two types of filtration holes. 
HT-29 cells were spiked into blood samples and then loaded into the devices at a 
flow rate of 0.2 ml/min. After capture and immunostaining, we deduced a capture 
efficiency of 96% (98%) and a capture purity of 86% (39%) with a conical 
(cylindrical) hole filter (Fig.  4.19). As expected, the capture efficiencies of both 
filters were pretty high but much more WBCs were found on the filter of cylindrical 
holes (Fig. 4.20). The retention of WBCs and other blood cells may have other side 
effects such aggregation due to the release of clogging factors from the deformed or 
lysed cells, making the cylindrical-hole clearance more difficult and thus increasing 
the transfilter pressure which is undesirable for a constant-flow filtration.  
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Fig. 4.19 Comparison of cylindrical- and conical-hole filters on the capture 
efficiency and purity of tumor cells at a flow rate of 0.2 ml/min. The error bars 
represent the S.D. of three measurements. 
 
 
Fig. 4.20 Fluorescence images of WBCs on the filter. Blood samples of a healthy 
person were diluted in PBS at 1:1 (v/v%). After filtration and anti-CD45 staining, 
fluorescence images were taken, showing a much reduced WBC retention by conical 
holes (a) than cylindrical ones (b). Scale bar: 100 μm. 
 
The cell viability is one of the most critical issues in current research of CTC 
capture since living cells can be expanded and needed for downstream phenotypic 
and genotypic analyses. In principle, a low transfilter pressure should be applied 
during filtration to avoid the stress induced cellular damage. In our experiments, the 
transfilter pressure was controlled by the flow rate with a syringe pump. Consider a 
non-Newtonian fluid through a cylindrical hole at a constant flow rate, the trans filter 
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pressure can be calculated by [13] 
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where a is the hole radius and L is the thickness of the hole,η the viscosity and Q the 
flow rate of the liquid. For given a, η and Q, ∆P increases with L. 
 In the case of conical holes, the calculation is more complex. In the limit of very 
large aperture angles, the thickness of the hole can be considered as infinitely small so 
that a minimal transfilter pressure is obtained. For the filter composed by an array of 
holes, the transfilter pressure should be inversely proportional to the number of holes. 
In our case, the number of holes in a 6 (9) mm diameter filter is 3.6×104 (8.2×104), 
which is huge comparing to the number of tumor cells that can be captured. With a 
flow rate of 0.2 ml/min and a blood sample of viscosity of 3~4×10-3 Pa·s, we 
obtained a transfilter pressure of 213~284 (95~126) Pa for a 30 µm thick 
cylindrical-hole filter of 6 (9) mm diameter. In the case of conical holes with very 
large angles, the thickness of the filter can be considered to be very small (L~0). 
Accordingly, we obtained a transfilter pressure of 24~32 (10~14) Pa, which is one 
order of magnitude lower than that obtained with the 30 µm thick cylindrical-hole 
filter. Such a decrease of transfilter pressure can lead to a significant increase of the 
cell viability [5, 14-16], proving again the advantage of conical-hole filters. Moreover, 
such a small transfilter pressure will remain the same during filtration if the clearance 
of the filter is efficient. Note also that the small transfilter pressure resulting from the 
flow rate we applied should be significantly smaller than the stiffness of the most of 
tumor cells, which guarantees high cell viability during and after filtration. As 
expected, the most of captured tumor cells were immobilized in the hole area but on 
the surface of the filter due to the small size of the hole and the low transfilter pressure 
(Fig. 4.21).  
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Fig. 4.21 SEM image of tumor cells on the filter. HT-29 cells were spiked in PBS at 
a 104 cells/ml concentration. After filtration, cells were fixed by dehydration and 
coated by 2nm thick gold. Scale bar: 100µm. 
 
Finally, numeric simulation has been performed to compare the flow dynamics 
with the two types of filters using simplified geometry and boundary conditions (Fig. 
4.22). The results show that for the same transfilter pressure the flow rate across the 
conical holes is significantly larger than that across the cylindrical ones. In other 
words, under conditions of constant flow rate, the transfilter pressure of the conical 
holes should be significantly smaller than that of cylindrical ones, in agreement with 
the above analyses. Streamlines are also shown, illustrating a flow focusing effect, i.e., 
no flow goes to the areas at equidistance of neighboring holes. These results also show 
a clearly flow focusing effect, suggesting the necessity of introducing a cross-flow 
component to flush gently away the cells accidently deposed on the surface of dead 
areas at equidistance of neighboring holes to void clogging of blood cells. In our 
devices, this has been done by designing a number of radial channels connected 
between the inlet channel and the upper chamber. Effectively, this design which is 
different from the previous ones allowed us to gain in capture purity of tumor cells. 
Nevertheless, this cross flow component should also be small enough to avoid 
additional flow stress. For a flow rate of 0.2 ml/min and a filter of 6.5 µm holes and 9 
µm diameter, the maximum value of induced shear stress is ~ 8 Pa for a cell size of 15 
µm diameter, which is reasonably small to avoid the cell damage but sufficient to flush 
away the non-adherent cells. Note also that once a tumor cell is captured by a hole the 
flow can bypass this cell, reducing further the pressure and/or shear stress induced cell 
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damage.  
 
Fig. 4.22 Hydrodynamic simulation of flow focusing. The same transfilter pressure 
(100 Pa) were applied, showing both flow focusing but a higher flow rate through 
trapezoidal slits than through rectangular ones. 
 
4.3 Tumor spheroids formation 
4.3.1 Device fabrication 
Fig. 4.23 shows the schematic process flow of multi-well array fabrication. A 
flat PDMS film of 2 mm thickness was prepared by casting a mixture of PDMS 
pre-polymer and cross-linker (GE RTV 615) at ratio of 10:1 on a silicon wafer. After 
curing at 80°C for 1 h, the PDMS layer was peeled-off and an array of holes was 
created on the PDMS layer using a computer numeric controlled (CNC) milling 
machine and a biopsy punch of 2 mm diameter. Afterward, the PDMS layer was 
exposed in trimethylchlorosilane (TMCS) vapour for 1 min. This PDMS layer with 
holes was then used as master to cast a second layer of PDMS with posts. After 
curing at 80℃ for 2 h, the second PDMS layer was peeled off.   
The agarose multi-well arrays were produced by using the second layer PDMS 
as mold. A solution of 5% agarose in DI water was dissolved at 120°C for 5 min and 
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then immediately casted on the PDMS mold. After cooling down to room 
temperature and waiting for 10 min, a solid agarose layer was obtained by 
gelatinization. Then, the agarose layer was gently removed from the PDMS mold, 
resulting in a multi-well device for spheroid culture.   
For comparison, PDMS multi-well arrays were prepared similarly, while 
PEGDA multi-well arrays was produced by UV assisted casting with a PEGDA 
(average Mn=250) solution mixed with 1 v/v% Irgacure 2959 as photo-initiator.  
Prior to cell seeding, all multi-well devices were sterilized by UV irradiation and 
then equilibrated with culture medium for at least 15 min. 
 
Fig. 4.23 Schematic fabrication process flow of agarose multi-well arrays and tumor 
spheroid formation. 
 
4.3.2 Experimental 
a) Cell seeding and tumor spheroid formation 
Here we chose human glioblastoma cell line U-87 for tumor spheroid studies. 
U-87 cells were prepared in Dulbecco’s Modified Eagle Medium (DMEM) 
completed with 10% FBS and 1% penicillin/streptomycin at 37°C with 5% CO2 
supplementation for 3~4 days. After proliferated to confluence, cells were detached 
by Trypsin at 37 °C for 3 min and centrifuged before re-suspended in a culture 
medium at a density of 5×106 or 107 cells/ml. The multi-well devices were placed in 
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a culture dish and each well of the device was then filled with 50 μl cell containing 
medium. After 15 min incubation for cells settling inside the wells, 2 ml more 
medium was added gently around the device. Finally, the culture dish with the 
multi-well device was transferred into incubator. After 24 h incubation, tumor 
spheroids can be observed in each well.  
 
b) Drug test and live/dead assay 
At day 2 or day 4, the old culture medium was changed with new culture 
medium contained with 10-7 M anti-cancer drug Combretastatin A4 (CA4). After 
another 2 days, apoptotic cells can be observed around cancer spheroids.  
Cell viability was studied by live/dead assay. Briefly, PBS solution with 2 μM of 
Calcein AM and 2 μM EthD-1 was used to change the medium for live and dead cell 
staining, respectively. After 30 min incubation at 37°C and 5% CO2, fresh PBS was 
used to wash out the residual dyes for 2 times. Stained cell spheroids were 
transferred on a glass slide for fluorescence observation with an inverted optical 
microscope (Zeiss, Axiovert 200) equipped with a digital CCD camera (Evolution 
QEI).  
 
4.3.3 Results and discussions 
a) Materials comparisons of multi-wells 
Fig. 4.24 shows the microphotographs of tumor spheroids formed in multi-wells 
made of PDMS, PEGDA and agarose. After 2 days, spheroid shaped cell aggregates 
could be found in all three types of wells. As can be observed, no cell attached on the 
agarose well but a large number of cells attached on PDMS both inside and outside 
the well (indicated by red arrows), due to the different surface properties. More 
interestingly, the spheroid in PDMS well is likely composed by three smaller 
aggregates, suggesting strong attachment to the surface of each of them during the 
growth phase. In PEGDA well, a flatten spheroid was observed, together with some 
spread cells on the board of the well. And due to the worse optical transparency of 
PEGDA, it’s difficult to observe the tumor spheroids clearly by microscope. Agarose, 
a typical hydrogel, is low-cost, transparent and not toxic to cells [17]. The quite 
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smooth and hydrophilic surface, as well as the highly soft nature of agarose makes 
the well not adhesive to cells, which results a much easier cell aggregation than other 
two types of wells. More interestingly, agarose is permeable to gas and small 
biomolecules, which facilitate diffusion of nutrients, drug and other cell factors. 
Therefore, agarose was chosen as an ideal material of multi-wells for tumor spheroid 
generation and spheroid culture under physiological conditions.  
 
 
Fig. 4.24 Microphotographs of tumor spheroids in multi-wells made of PDMS, 
PEGDA and agarose, respectively. Scale bar: 0.5 mm. 
 
b) Generation and growth of tumor spheroids in agarose wells 
Fig. 4.25 shows the growth of tumor spheroid in agarose wells. As expected, 
tumor cells aggregated first in the well and then formed compact spheroids. 
Afterwards, the spheroid grew until day 10 due to cell proliferation. After 10 days, 
the size of the spheroid remained almost the same (about 1.4 mm). Interestingly, the 
size of the spheroid decreases during the first 4 days. This decrease can probably be 
attributed to the sharp change from hemisphere-like aggregation to spheroid and the 
compact of cells due to strong cell-cell interaction.  It is also interesting to note that 
increasing the cell seeding density has no effect on the final size of the spheroid 
which was always about 1.4 mm, due probably to the limitation of diffusion length. 
In fact, when the size of the spheroid becomes too large, there will be no sufficient 
nutrient diffused to the center area. The spheroid can be considered as a 
self-organized entity in which the proliferation of cells should be strongly affected or 
regulated by cell-cell interaction in the whole entity. More details analyses have to 
be developed for further studies.    
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Fig. 4.25 (a) Tumor spheroid formation in an agarose well at different time; scale bar: 
0.5 mm; (b) Size variation of the spheroid as a function of time. 
 
c) Combretastatin A-4 effects on tumor spheroids growth 
To study the anticancer drug effect, CA4 was added in the medium at day 4, 
which is a stilbene inhibits tubulin polymerization at the colchicine-binding site of 
tubulin and high cytotoxic against a variety of human cancer cells including some 
multidrug resistant cancer cell lines [18, 19]. As expected, the spheroid stopped to 
grow and some of the cells were detached from the spheroid (Fig. 4.26). The 
live/dead cell staining images showed that in the culture medium with the drug, 
many cells were dead after three days drug treatment, whereas no matter at day 4 or 
day 7, almost all cells were alive in the medium without CA4. But for the different 
time of addition drug, there was difference on drug effect. From the live/dead 
staining results, for drug adding at day 2, there were dead cells on both the area next 
to the edge and the central area of the spheroid after three days, but for drug adding 
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at day 4, there were fewer dead cells compared to earlier drug adding, which were 
mainly distributed only on the edge area of the spheroid at day 7. In the process of 
the tumor spheroid growth, beginning from single separated cells, cells keep 
aggregation until day 4, shown as Fig. 4.26. It means that when the drug was added 
at day 2, the tumor spheroid was not organization enough, which will let drug 
penetrate into the center of spheroid to effect on the cells, whereas for drug added at 
day 4, the tumor sphere was compact and became a self-organized entity, it will be 
more difficult for drug to effect in the center of spheroid. It has also been reported 
that these cell–cell contacts and ensuing communication in closely packed 3D cell 
structures can influence the response of cells to drugs [20, 21]. 
 
Fig. 4.26 Effect of anticancer drug CA4 on the morphology of tumor spheroids and 
cell viability. (a) Morphology change of the tumor spheroid with or without CA4 
adding for drug added at day 2 and day 4 respectively. Scale bar: 0.5 mm. (b) Bright 
field and live/dead cell staining microphotographs of the spheroid after 3 days with 
or without CA4 treatment added at day 2 and day4 respectively. Scale bar: 0.5 mm. 
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4.5 Conclusion 
In conclusion, we developed a microfluidic device with a conical-shaped 
microhole array and a micro-injector with cross-flow components for CTCs isolation. 
This device was first validated by filtration of tumor cells spiked in blood and then 
used for detection of CTCs in blood samples of cancer patients. Furthermore, three 
tumor cell lines were tested with microhole arrays of different hole-sizes, showing a 
clear cell-type dependency of the capture efficiency and suggesting a (cell) nuclei 
size dependent design of microholes. As results, we achieved a capture efficiency of 
~95% and a capture purity of ~86%, respectively. Finally, tumor cells after filtration 
were cultured on the same filter for several days, showing a cell viability of ~95%, 
thereby providing a solid base for downstream phenotypic and genotypic analyses. 
Together with the simplicity of the method and the possibility to integrate other 
microfluidic functions into the same device, more systematic studies are warranted 
to elucidate the underlying cellular and molecular mechanism of CTCs and to 
promote the clinical relevance of current efforts on microfluidics.  
On the other hand, we also developed a simple but reliable technique for tumour 
spheroids formation by using agarose multi-wells. In 2 mm diameter agarose wells, 
1.4 mm diameter U87 tumour spheroids can be formed and cultured for many days. 
Interestingly, the size of the tumour spheroids does not change with the further 
increase of seeding cell density. Anti-cancer drug CA4 added at different stages of 
tumour spheroid formation have different drug effect. More systematic studies are 
expected for more clear and mechanistic understanding of spheroid formation and 
anti-cancer drug effect on tumors. 
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This thesis work aimed at development of new devices and new methods for 
biomedical research, drug testing, regenerative medicine and disease diagnosis. 
Induced pluripotent stem cells and cancer cells have been chosen for demonstration 
of the high potential of our microengineering approaches.    
Firstly, we demonstrated a patch form made of monolayer gelatin nanofiber on 
biodegradable PEGDA micro-frame, to provide off-ground culture conditions and 
tools for easy handling that can be used for various downstream analyses and 
implantation. As expected, we found a significant improvement of the proliferation 
rate of normal mammalian cells, comparing to that cultured conventionally. When 
used for human induced pluripotent stem cells (hiPSCs) culture, we could be able to 
tune precisely the shape of hiPSC colonies (from monolayer to hemisphere EBs), 
which is desired for the proliferation of hiPSCs. The hemisphere EBs had 
comparable pluripotency to the traditional cultured iPSCs. The generated hemisphere 
EBs on patch were then differentiated into cardiomyocytes by modulating Wnt 
signaling with small molecules. ~74.7% of differentiation efficiency was obtained on 
the nanofiber patch compared to ~34.5% of traditional 2D differentiation. RT-PCR 
results indicated that cardiomyocytes cells derived on PEGDA supported nanofiber 
substrate showed also higher cardiac related gene expression. This cardiac patch can 
be easily handled and transferred into multi-electrode array (MEA) system for 
cardiac drug test by field potential monitoring. The derived cardiac sheet showed 
corresponding reaction to different drugs and different drug dose, which indicated 
the cardiomyocytes derived on nanofiber patch, had a good functional performance. 
Similarly, we did also motor neuron differentiation of hiPSCs on this patch, which 
performed an enhanced differentiation efficiency compared to on glass slides. And 
after comparison of motor neuron differentiation from monolayer iPSC colony and 
hemisphere EBs on nanofiber patch, we found a much better differentiation 
efficiency of monolayer differentiation. After achieving motor neuron progenitors at 
day 16, the progenitor cells were digested off from patch and reseeded on different 
substrates for maturation. At day 38, neuron representative electrical signals and 
firing were detected for neuron patch; however no signal detected for the motor 
neurons reseeded on MEA until day 50, which revealed that the off-ground neuron 
culture system with nanofiber net can enhance motor neuron maturation. 
Secondly, our work for cancer cell study is composed of two parts: cancer 
diagnosis and in vitro tumor model building. On one hand, for cancer diagnosis, we 
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demonstrated a microfluidic device for high efficiency and high purity capture of 
circulating tumor cells (CTCs). The key novelty of this approach lies on the 
integration of a filter with conical-shaped microhole array and a micro-injector with 
cross-flow components for size dependent capture of tumor cells without significant 
retention of non-tumor cells. First, this device was validated by filtration of tumor 
cells spiked in blood and then used for detection of CTCs in blood samples of cancer 
patients. Additionally, three tumor cell lines were tested with microhole arrays of 
different hole-sizes, showing a clear cell-type dependence of the capture efficiency 
and suggesting a (cell) nuclei size dependent design of microholes. As results, we 
achieved a capture efficiency of ~95% and a capture purity of ~86%, respectively. 
Then, tumor cells after filtration were cultured on the same filter for several days, 
showing a cell viability of ~95%, thereby providing a solid base for downstream 
phenotypic and genotypic analyses. Then more systematic studies are warranted to 
elucidate the underlying cellular and molecular mechanism of CTCs. Together with 
the advantage of easy operation, low-cost and high potential of functional integration, 
this approach offers unprecedented opportunities for metastatic detection and cancer 
treatment monitoring. On the other hand, for in vitro tumor model building, 
multicellular tumor spheroid has been proved to be a promising method. In this work, 
we developed a simple but reliable technique for the fabrication of multi-well array 
for tumor spheroids formation. After comparison of different materials for the 
multi-wells, agarose was found to be the best material. In 2 mm diameter agarose 
wells, 1.4 mm diameter U87 tumor spheroids can be formed and cultured for many 
days. Interestingly, the size of the tumor spheroids does not change with the further 
increase of seeding cell density. Anti-cancer drug CA4 added at different stages of 
tumor spheroid formation have different drug effect. More systematic studies are 
expected for more clear and mechanistic understanding of spheroid formation and 
anti-cancer drug effect on tumors.  
To conclude this thesis work, we have successfully demonstrated several 
microdevices for advanced study in cell biology and biomedical research. 
Accordingly, the microengineering techniques developed in this work should allow 
gaining new knowledges in this interdisciplinary and emerging field. We believe that 
the results we obtained in this work could contribute to the progress of 
micro-engineered devices and that much more can be done along this promising 
research direction. 
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Though this thesis work is limited to proof-of-concept, we believe in the high 
application potential of our approaches, as discussed below.  
Nanofiber patch for iPSCs studies: 
Our findings suggest that this new type of monolayer nanofiber culture substrate 
can be used not only for off-ground culture but also for a variety of cell-based assays 
and in vivo evaluation, due to the versatility and the flexibility offered by the patch 
form of the stadium. It can also be used for drug assays which minimize the animal 
models since the tissue formed on monolayer nanofibers can more accurately 
simulate normal cell morphology, proliferation, differentiation and migrations, as 
compared to the conventional cell culture. To this regard, it is important to note that 
although different animal models, including murine and non-human primates could 
be used to evaluate the effect of hiPSCs but in many cases it is not relevant to 
translate animal data into clinical assays due to their clear differences (ex. the 
beating rate and timing of maturation). Thus, the proposed patch can also be used to 
study personal disease models since hiPSCs have also high potential to model 
different disease states by using hiPSCs issued from patients.  
Besides, this patch is very easy to be integrated into microfluidic device (such as 
the similar device for CTCs capture), meanwhile, the pluripotency of iPSCs provides 
diversity of cell types. Both of these advantages make the further organ-on-chip 
study possible, for more flexible and accurate studying the physiological and 
pathophysiological processes in living organs, and operating drug screening and 
assessment. 
Due to the flexibility of this patch, it will be also a promising tool for tissue 
engineering and regeneration medicines. It can be very simple to replace PEGDA to 
other biodegradable materials, such as poly(lactic-co-glycolic acid) (PLGA). 
Although gelatin is already a natural biomaterial, which can be biodegraded in vivo, 
it’s also very simple to change it to other materials case by case, such as collagen. 
After in vitro specific differentiation of iPSCs, the whole cell patch will be very 
flexible for in vivo transplantations and therapy. 
The iPSCs proliferation and differentiation are both sophisticated and complex.  
For example, the manipulator has to change medium every day during the iPSC 
proliferation and various mediums have to be prepared every one or two days during 
Chapter 5 Conclusion and perspective 
172 
the iPSC differentiation. In addition, the processes of iPSCs proliferation and 
differentiation are often non-producible due to lot-to-lot variation as well as 
uncertainly of human factors. Thus, it is highly desirable to develop automatic 
culture and differentiation systems, together with the nanofiber patches or other 
advanced stem cell devices. Most recently, a prototype system has been proposed 
along this direction, as shown in Fig. 5.1. Fig. 5.1a is a medium storage container 
with temperature controlling system. There is also a UV sterilization system inside 
the container (Fig.5.1b). The six-well plate can be settled on the culture platform 
(Fig.5.1c) and then transferred into incubator during culture. For the medium 
changing during the culture and differentiation, the program can be pre-set on the 
control panel. The next step will be a systematic evaluation of the proposed 
apparatus and then push it for large scale applications by creating a dedicated startup 
company. 
 
Fig. 5.1 Automatic culture and differentiation system. (a) Medium container; (b) 
Inside chamber of container during UV sterilization; (c) Culture platform with two 
positions for 6-well plate. 
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CTCs isolation related studies: 
For more careful and systematic studies of CTC isolation as well as post-CTC 
isolation and/or clinic applications, automatic systems and standard protocols have 
to be proposed. In collaboration with other partners, the ENS Laboratory for 
Microfluidics has also been worked along this direction. A prototype of automatic 
isolation and staining has been proposed, shown as in Fig. 5.2. Here, two plastic 
layers with cross-flow microfluidic channels (Fig. 5.2a) can be fixed separately in 
the top and bottom part of a steel holder or clamp (Fig. 5.2b). The conical filter for 
CTCs isolation can then be inserted between the two plastic layers by nut screw 
fixation. The sealing of the filter is achieved with two elastomer layers pre-mounted 
on the two plastic layers. Then, the filtration (and immunostaining process) can be 
performed in an automatic way with the prototype apparatus (Fig. 5.2c). After 
processing, the filter with cells can be moved away from the device for microscopic 
observation and/or down-stream analyses. 
 
Fig. 5.2 Commercial CTCs detection products and equipment. (a) mass produced 
microfluidic chip; (b) Steel holder for chip; (c) CTCs detection equipment. 
CTCs enumeration is significant for cancer diagnosis, in practice, numbers alone 
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correlate with outcomes, as in the case of breast cancer, where greater than 5 CTCs 
in 7.5 ml of blood is indicative of clinical progression [1]. However besides CTCs 
detection, we expect to get beyond simple enumeration, thus there are a lot of further 
downstream studies we can do with the captured CTCs.  
Unlike other antibody affinity-based capture methods, the CTCs captured by our 
device are capable for further molecular biological analyze. First, the isolated CTCs 
provide researchers another route for biomarker discovery. In oncology, such work 
usually relies on archival tumor tissue, but often samples aren’t available, as in the 
case of inoperable cancers, or where biopsies are difficult to obtain [2]. CTCs offer a 
noninvasive way for samples collection. Besides, CTCs can provide to researchers 
an update of what mutations are driving the cancer. Researcher can study the genetic 
mutation and molecular cytogenetic profile and understand in depth epithelial 
mesenchymal transition (EMT) during metastasis by immunological and molecular 
studies, such as fluorescence in situ hybridization (FISH) analysis.  
On the other hand, the CTCs captured with our device show good viability and 
which were also cultured successfully after isolation, making it possible for 
monitoring the biological response of a tumor or treatment, and evaluation of its 
resistance to therapies. Since the most present therapy and drugs can kill the primary 
tumor to some extent, while the main problem sabotaged conquering cancer is to 
prevent metastasis efficiently. On this point, CTC is also useful tool for the 
development of novel drugs specialized metastasis, while efficient control of 
metastasis will largely prolong the survival time of patient and decrease cancer death, 
which is promising for cancer curing. 
Tumor spheroids formation related studies: 
We have demonstrated an agarose multi-well array for tumor spheroids 
formation and also preliminarily tested the effect of anti-cancer drug CA4. Many 
interesting studies can be done by using such as device. For example, one can 
observe the inner structure of the tumor organoids and then compare it with the 
layered structure of the in vivo spheroids [3]. Accordingly, one can also follow the 
spheroids formation under drug treatment. In general, the tumor growth is restricted 
by nutrient and oxygen supplying [4]. In order to mimic the in vivo tumor 
organization, it is essential to introduce vascular-like structures to improve the 
exchange of nutrient and gas inside spheroids. In this respect, microfluidic should be 
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an efficient tool for performing tumor-on-chip studies as well as more efficient 
anti-cancer drugs assessment.  
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1. Introduction  
Graphene and graphene oxide (GO) have drawn much attention in the field of 
tissue engineering due to their outstanding chemical, electrical and mechanical 
properties [1-3]. In particular, GO is a novel one-atom-thick two-dimensional carbon 
material, with many unique physicochemical properties, such as large surface area, 
sp2 carbon domains, and hydrophilic functional groups [4]. 
GO functionalized substrates serve as a structural reinforcement with high 
elasticity and flexibility, and has been demonstrated to enhance the proliferation and 
differentiation of various stem cell lines, including iPSCs, mesenchymal stem cells 
and neuron stem cells[1, 5-7].  
In this thesis, we have developed a PEGDA frame supported gelatin nanofiber 
net in Chapter 2, which has been demonstrated to supply an off-ground culture 
environment for cells to improve cell proliferation and iPSCs differentiation in 
Chapter 4. Considering the above advantages of GO, we will try to develop a method 
to deposit GO on the nanofiber substrate, which should further enhance cell growth 
and differentiation.   
 
2. Experimental 
PEGDA frame and gelatin nanofiber net was fabricated as shown as chapter 2. 
After crosslinking, nanofibers were rinsed with ethanol for three times to remove 
residual EDC and NHS, then washed with DI water for three times to remove 
ethanol. GO solution (1 mg/ml) was supplied by Institute of Nanotechnology and 
biotechnology. Then GO solution was diluted into desired concentration and 
dispersed by ultrasound machine for 10 min.  
We tried two methods for GO deposition: 
1) Drop 100 μl 0.3 mg/ml GO solution on the top of substrate and then 
dried under vacuum over night to remove all the solvent. 
2) Immerse substrate inside 0.5 mg/ml GO solution for 15 min, and then 
dried under vacuum overnight to remove all the solvent. 
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3. Results 
After drying, there was GO deposited on the substrates by both methods. But 
GO distributed much more even on the substrate treated with the second method. Fig. 
1 shows the Ramen spectrum result of GO modified substrate by the second method. 
There are two peaks for GO incorporated nanofiber compared to normal nanofiber 
substrate, which are conformed to the characteristic peaks of GO. D band located at 
1350 cm−1 and G band at 1600 cm−1 indicate the presence of GO on nanofiber 
substrate. 
 
Fig. 1 Raman spectra of gelatin nanofibrous substrate (black) and GO 
incorporated gelatin nanofibrous substrate (red).  
4. Perspective 
We are looking forward to use this GO incorporated gelatin nanofiber substrate 
for cell culture and iPSCs differentiation. 
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1. Introductions 
La recherche biomédicale a connu un essor phénoménal au cours des dernières 
décennies, grâce au développement des nouvelles méthodes et technologies telles 
que l'imagerie à haute résolution, les puces à ADN et les séquenceurs ADN, la PCR, 
le criblage à haut début, les cellules souches pluripotentes induites, etc. Parmi des 
approches diverses-et-variées, un bon nombre de progrès ont été faits avec 
l’accompagnement des structures et dispositifs micro-fabriqués. Par exemples, des 
biomatériaux de plus en plus sophistiqués ont été réalisés par la micro- et 
nanofabrication pour la culture cellulaire et l’ingénierie tissulaire. De même, les 
dispositifs microfluidiques ont été réalisés pour manipuler les échantillons de très 
faible quantité biologique. 
Nous nous intéressons particulièrement au contrôle du microenvironnement 
cellulaire d’un tissu, ce qui implique l’organisation des matrices extracellulaires 
(ECM), la gestion de facteurs solubles, l’ordonnance des contacts cellulaires, etc. A 
priori, le comportement d’une cellule est déterminé non seulement par l’ensemble de 
gènes, de protéines et d’autres espèces sous-cellulaires mais aussi par 
l'environnement immédiat de la cellule. L’ECM, par exemple, fournit un support 
structurel et biochimique de la cellule qui est déterminant pour l'adhérence, la 
prolifération, la migration et la différenciation des cellules. En raison de la 
complexité de l’ECM et la variation dynamique des facteurs solubles et de 
l'interaction cellule-ECM, une compréhension approfondie du rôle du 
microenvironnement cellulaire est important dans la culture de tissus fonctionnels. 
Traditionnellement, les cellules isolées d'un tissu corporel et mises en culture ne 
sont plus dans un milieu naturel (in vivo) mais plutôt dans un milieu artificiel (in 
vitro) sur une plateforme de culture telle que des boîtes de culture, des flacons, des 
plaques multi-puits, etc. Même si les processus cellulaires peuvent être maintenus ou 
modifiés, les marges de manipulation ou de contrôle sont très limitées. D’une part, 
les surfaces dans de ces plateformes sont généralement plates ou bi-dimensionnelles. 
Quels que soient les traitements (revêtement ou microstructuration), ces supports de 
culture est toujours très différents de ceux réellement présents in vivo. D’une part, la 
configuration dynamique des facteurs solubles autours d’une cellule mise en culture 
est loin d’être comparable à la configuration in vivo. En effet, la plupart des cellules 
dans un tissu sont au voisinage des capillaires pour échanger les facteurs solubles, 
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les nutriments et les produits métaboliques par diffusion autour de ces capillaires 
mais le milieu de culture in vitro est souvent statique ou perfusé. Ces grandes 
différences ont laissé à penser que les approches conventionnelles pour la culture in 
vitro ne sont pas idéales. Faute de mieux, on ajoute les actifs pour augmenter le taux 
de réussite et corriger le comportement des cellules. En effet, cela est le cas pour la 
plupart des cellules différentiées et maturées.  
La culture et la manipulation in vitro des cellules souches pluripotentes telles 
que les cellules embryonnaires et les cellules pluripotentes induites est beaucoup 
plus critique en raison de leur plus grande sensibilité aux microenvironnements 
cellulaires. Ces cellules souches peuvent devenir d’autres types de cellules de façon 
spontanée ou dériver en cellules cancéreuses, ce qui s'accompagne de problèmes de 
survie, d'instabilité des gènes, d'hétérogénéité, etc. Des approches diverses et variées 
ont été proposées telles que la co-culture avec les cellules nourricières (feeder cells), 
les substrats recouverts d’une couche de gel de protéines ou de polymères, les 
substrats micro- et nano-structurées etc. Une question cruciale reste en suspens: 
quelle est l’approche la plus adéquate ? Pour mieux répondre à cette question, nous 
devons travailler sur le grand principe de mimétisme qui consiste à imiter le 
microenvironnement cellulaire d’un tissu et reconstruire ce tissu en considérant son 
organisation. Comme « la nature ne fait rien de vain, rien d'inutile » (Aristote), nous 
pensons que la meilleure approche découle de ce grand principe pour réaliser un 
nouveau support ou une nouvelle plateforme de culture cellulaire intégrant 
l'ensemble des paramètres mentionnés plutôt que d’améliorer les approches 
existantes.     
Toutefois, il est normalement difficile d'imiter exactement la composition et le 
fonctionnement complexe d’ECM dans un tissu natif. Nous devons retenir quelques 
principes de base à partir de nos expériences précédentes : i) minimiser les contacts 
exogènes des cellules avec les matériaux ‘artificiels’ (verre, plastique, etc.), ii) 
maximaliser la perméabilité ou les échanges des cellules avec le milieu, iii) 
construire le support avec des protéines de matrixe extracellulaire naturelle.  
Par ailleurs, nous sommes également intéressés par le diagnostic biomédical et 
en particulier le diagnostic du cancer. L’idée est d’apporter une nouvelle solution 
pour isoler les cellules tumorales circulantes en utilisant un filtre micro-fabriqué et 
un dispositif microfluidique conçus à partir des analyses de micro-écoulement 
hydrodynamiques et de migration des cellules à travers un trou conique.     
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Ce travail de thèse vise à développer de nouveaux supports/dispositifs pour des 
applications biomédicales, y compris l'ingénierie tissulaire, la médecine régénérative, 
le diagnostic, etc. Les supports/dispositifs sont utilisés pour contrôler la culture et la 
différentiation des cellules souches pluripotentes induites et l’isolation et l’analyse 
de cellules tumorales circulantes. Nous allons d’abord proposer un patch de culture 
en forme monocouche de nanofibres réticulées, permettant de cultiver et de 
différentier les cellules souches pluripotentes induites humaines (hiPSCs) “hors sol”. 
Puis, nous démontrerons la possibilité de former des tissus cardiaques et neuronaux 
sur patch à partir de hiPSCs. Ensuite, nous développerons un dispositif 
microfluidique avec une membrane composée de trous de forme conique pour isoler 
les cellules tumorales circulantes et cultiver les cellules ainsi isolées. Enfin, nous 
évaluerons l’effet de drogues anticancéreuses sur la formation des sphéroïdes 
tumoraux en utilisant des multi-puits d’agarose micro-fabriqués. Finalement, nous 
espérons contribuer au progrès des techniques de la micro-ingénierie vers les 
applications à grande échelle et cliniques.  
2. Étude de cellules souches 
2.1 Introductions 
Les cellules souches et les cellules souches pluripotentes en particulier sont 
essentielles pour développer de nouvelles méthodes et outils de l'ingénierie tissulaire 
et la médecine régénérative. Par définition, les cellules souches embryonnaires 
(ESCs) sont pluripotentes, puisqu’elles sont à l’origine de tous les types de cellules 
maturées ou différentiées de nos corps. En 2006, un nouveau type de cellules 
souches pluripotentes a été réalisé par le Prof. Yamanaka de l’Université de Kyoto 
(prix Nobel de 2012 de médecine), à partir d’une cellule de peau en utilisant quatre 
facteurs de gènes bien choisis. Ce type de cellules ressemble à des cellules souches 
embryonnaires, appelées par conséquent "cellules souches pluripotentes induites" 
(iPSCs). Cette mise au point a ouvert une grande porte au progrès de l'ingénierie 
tissulaire et à la thérapie de transplantation, puisque les problèmes d’éthiques, de 
ressources cellulaires et du rejet immunologique sont désormais relégués au second 
plan.   
Comme les ESCs, les iPSCs sont capables de se proliférer infiniment et de se 
différencier en cellules ectodermique, mésodermiques et endodermiques. En plus, les 
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ESCs et les iPSCs ont presque les mêmes caractéristiques au niveau de l'expression 
de gènes et la production de protéines, du temps de doublement, des profils de 
méthylation de la chromatine, de la formation du corps embryonnaire, de la 
formation de chimère viable, et de la capacité de différentiation (leur différence est 
en cours d'évaluation). Cependant, l’utilisation des ESCs provenant de l'embryon 
humain est strictement interdite dans de nombreux pays, de sorte que le nombre de 
lignées de cellules souches embryonnaires approuvées pour la recherche est très 
limité. Cette interdiction entrave la possibilité de répondre à certains besoins des 
plus urgents, notamment ceux relatifs à la modélisation et à la thérapie de maladies. 
Les iPSCs peuvent probablement supplémenter les ESCs dans le cadre de la 
médicine régénérative. Les iPSCs de patients fournissent une plate-forme spécifique 
à partir de laquelle il est possible d'obtenir des informations mécanistiques de 
diverses maladies, de mener à bien le criblage de médicaments, d'évaluer leurs 
potentiels thérapeutiques et d'explorer la réparation des gènes couplée à la thérapie 
cellulaire.  
Toutefois, aucune méthode générique n’est encore disponible pour la production 
de masse des iPSCs humaine de haute qualité, sans risque d'instabilité génétique et 
de tumorigénicité. De nombreuses études ont été faites sur l’effet du  milieu de 
culture et/ou des facteurs solubles, mais relative peu ont été consacrés sur l’influence 
de substrat de culture. On ne sait même pas quelles sont les meilleures rigidités du 
matériau et quelles sont les meilleures morphologies de surface du substrat pour la 
culture et la différentiation des iPSCs. 
La première préoccupation est la prolifération des iPSCs, à savoir, ces iPSCs 
devraient se propager sur de nombreuses générations sans perdre leur pluripotence, 
leur pureté et leur qualité. Dans des conditions de culture classiques, les hiPSCs sont 
impures et présentent souvent des anomalies chromosomiques importantes et à haut 
risque de tumorigénicité. En ajoutant des cellules nourricières ou en utilisant un 
substrat couvert de Matrigel, la qualité de hiPSCs pourrait être largement améliorée, 
malheureusement ces deux solutions ne sont pas pertinentes pour les applications 
cliniques en raison de la présence de facteurs d'origine animale. Ce problème a été 
surmonté en utilisant des substrats revêtus de protéines recombinantes telles que la 
laminine, la vitronectine, l’E-cadhérine ou des polymères synthétiques. Ces études, 
ainsi que des essais supplémentaires en utilisant des substrats non plans, soulignent 
l'importance de l'utilisation des protéines / molécules des ECMs et surfaces texturées 
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qui prennent en compte une partie de la spécificité de microenvironnement cellulaire 
in vivo.  
La deuxième préoccupation est la différenciation contrôlée des iPSCs. 
Précédemment, les iPSCs ont été différenciées en plusieurs types de tissus 
somatiques, y compris les cardiomyocytes, les neurones, des ilots d'hépatocytes, etc., 
mais les méthodes et les protocoles proposés sont encore en pleine évolution. A 
priori, les cellules différentiées telles que les cellules cardiaques et les neurones ont 
des différences morphologies et ont des réponses variables aux propriétés 
mécaniques et physicochimiques des substrats, ce qui impose l’utilisation de 
différents types de substrats. Par ailleurs, il est préférable que les cellules souches 
différenciées soient organisées en forme de tissus pour les applications cliniques 
envisagées, ce qui souligne l’importance de l'interaction cellule-cellule par rapport à 
l'interaction cellule-substrat.  
Dans cette étude, nous proposons une nouvelle plateforme de culture, le patch de 
culture, pour cultiver et différentier les iPSCs en cellules cardiaques et neuronales.   
2.2 Fabrications de patch de culture 
 
 
 
 
        
 
 
 
 
 
Figure 1. Schéma du patch de culture en filet de gélatine sur un réseau de PEGDA en 
forme de nid d’abeille.   
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Le patch de culture que nous développons est sous forme de filet ou 
monocouche de nanofibres de gélatine réticulées avec des tailles de pores inférieures 
à celles des cellules déposés sur un réseau de PEGDA en forme de nid d’abeille 
(Figure 1). 
Fabrication du support en PEGDA : Un masque optique de chrome est 
fabriqué par un faisceau laser focalisé. Puis, une couche de résine (AZ40XT, 
Microresist) est déposée sur le masque, suivi par un recuit de 10 min à 125°C. Après 
avoir été irradiée par une lumière UV à travers le masque, la couche de résine est 
développée, résultant en un moule de résine.  
Après avoir été exposé au triméthylchlorosilane (TMCS) comme traitement 
antiadhésif,  un mélange des composants A et B de PDMS (GE RTV 615) dans un 
rapport de 10: 1 est appliqué au moule. Cette étape est suivie d'un recuit à 80°C 
pendant 2 h. Puis la couche de PDMS est décollée et posée, côté structuré en contact 
avec une lame de verre. L'ensemble PDMS-verre est placé dans un dessiccateur pour 
dégazage pendant 15 min. Puis, la cavité PDMS-verre est remplie par effet de 
microaspiration avec un mélange de PEGDA avec 1% (en volume) d'Irgacure 2959 
(photo-amorceur), suivi d'une exposition aux UV à 12mW / cm2 pendant 30 sec. 
Enfin, la couche de PDMS est retirée, résultant en un réseau de PEGDA solidifié en 
forme de nid d’abeille.  
Pour augmenter la résistance mécanique de ce réseau, un anneau de PEGDA est 
ajouté au-dessus du nid d’abeille. Cet anneau a été préparé selon le protocole décrit 
ci-dessus et collé sous UV sur le réseau de nid d’abeille en utilisant la solution de 
PEGDA comme adhésif. 
Dépôt des nanofibres de gélatine: Les nanofibres de gélatine sont directement 
fabriquées sur le nid d’abeille de PEGDA par électrofilature. Une solution de 
gélatine de 10% en poids est préparée par dissolution des poudres de gélatine 
(G2625, Sigma-Aldrich, France) dans une solution mixte d'acide acétique, d'acétate 
d'éthyle et d'eau distillée selon un rapport volumique de 21:14:10. L’électrofilature 
est faite en utilisant une pompe à seringue, une source d'alimentation de haut 
potentiel et une plaquette de silicium comme support de dispositif PEGDA et de 
collecteur de nanofibres. Les nanofibres de gélatine sont obtenues sur l’échantillon 
de PEGDA en plaçant la plaquette de silicium à une distance de 10 cm de l’aiguille 
de la seringue chargée de la solution de gélatine et en appliquant une tension de 
polarisation de 11KV entre l’aiguille (anode) et la plaquette (cathode),. Le flux 
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d’injection de la solution de gélatine est fixé à 0,2 ml / h. Après récupération, les 
nanofibres de gélatine sont séchées sous vide pendant une nuit afin d'évaporer le 
résidu de solvant. Les nanofibres sont ensuite réticulées dans une solution d'éthanol 
avec 0,2 M d'EDC (1-éthyl-3-(3-diméthylaminopropyl) carbodiimide) et 0,2 M de 
NHS (N-hydroxysuccinimide, référence) pendant 4 h. Après réticulation, 
l’échantillon est rincé trois fois à l'éthanol avant d'être séché pendant une nuit sous 
vide pour éliminer les produits chimiques restants. 
La figure 2 montre un patch de culture qui formé de nanofibers de gélatine de 
diamètre 100-500 nm et une structure de PEGDA de hauteur et largeur 50 µm,  
 
Figure 2. Images de microscope électronique à balayage d’un filet de gélatine déposé 
sur un réseau en forme de nid d’abeille.    
 
2.3 Culture des cellules de référence sur patch  
Pour démontrer l'avantage du filet, deux types de cellules, des fibroblastes 
NIH-3T3 et des cellules cancéreuses Hela, ont été cultivées en même temps sur les 
patchs de culture et les boîtes de culture. 
Ces cellules sont d’abord préparées séparément pendant 3-4 jours dans un milieu 
Eagle modifié par Dulbecco (DMEM) avec 10% de FBS et 1% de pénicilline / 
streptomycine à 37°C avec 5% de CO2. Puis les cellules cultivées à confluence ont 
été détachées avec de la trypsine. Cinquante µl de milieu contenant 
approximativement 2 × 104 de cellules sont déposés à l'intérieur de l'anneau d’un 
patch placé dans une boîte de culture. Les cellules sont incubées pendant 1 h pour 
l’adhésion puis 2 ml de milieu de culture sont ajoutés. La culture est réalisée à 37 °C 
dans un incubateur à 5% de CO2. 
Les résultats montrent que les deux types de cellules peuvent se fixer sur les 
filets en moins de 2 h et que le nombre de cellules augmente plus vite sur le filet que 
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sur la boîte de Pétri. La figure 3 montre les images d'immunofluorescence de deux 
types de cellules cultivées sur patchs, dans lesquelles les cytosquelettes et les noyaux 
ont été colorés à la phalloïdine-FITC (vert) et au DAPI (bleu), respectivement. Du 
fait que les protéines ne peuvent pas être déposées sur le PEGDA, aucune cellule 
n'adhère sur le réseau de PEGDA. Enfin, nous avons observé que le nombre de 
cellules augmente presque deux fois plus vite sur le filet que sur boîte de Pétri 
(figure 4). 
 
Figure 3. Images en fond clair et de fluorescence des cellules NIH-3T3 (à gauche) et 
les cellules HeLa (à droite) sur filets de gélatine. Vert: Phalloïdine pour cytosquelette; 
Bleu: DAPI pour noyau. 
 
Figure 4. Augmentation du nombre de cellules NIH 3T3 sur deux types de supports 
en fonction du temps de culture. 
 
2.3 Contrôle de l’agrégation des iPSCs sur patch  
Préparation des iPSCs : Les iPSCs sont d’abord mises dans une boîte de 
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culture revêtue de vitronectine et remplie d’un milieu de culture « E8 complet » 
(Life technologies). Les cellules sont incubées à 37 °C avec 5% CO2. Le milieu est 
alors changé une fois par jours jusqu'à 70% ~ 80% de confluence. Les cellules sont 
enfin détachées avec une solution de 0,5 mM EDTA dans du DPBS. 
Contrôle de l’agrégation des iPSCs : Le patch est d’abord traité dans une 
solution de vitronectine diluée 500 fois dans du PBS à température ambiante pendant 
1 h. 50 µl de milieu de culture E8 contenant 2 × 105 des iPSCs et 10 µM d’Y-27632 
(inhibiteur de ROCK) sont alors déposés à l'intérieur de l'anneau du patch placé dans 
une boîte de culture. Après avoir incubé 1 h pour l’adhésion cellulaire, 2 ml de 
milieu E8 frais avec 10 µM d’Y-27632 est ajouté dans la boîte de culture. Le milieu 
de culture est ensuite remplacé 1 à 4 h après par du E8 sans Y-27632, suivi d'une 
nouvelle incubation de 24 h. On observe alors la formation des colonies d'iPSCs au 
centre de chaque compartiment du réseau de nid d'abeille en forme d’hémisphère si 
le traitement d’Y-27632 dure 1 h à 2 h ou d’hémisphère aplati si le traitement dure 4 
h. Une fois les colonies formées, les facteurs de différentiation peuvent être ajoutés 
directement dans le milieu de culture pour produire, par exemple, des cellules 
cardiaques et des progéniteurs de neurones, sur les filets (Figure 5).   
Figure 5. Schéma de la formation de colonies et la différenciation des iPSCs dans un 
compartiment de nid d’abeille d’un patch de culture. 
La figure 6 montre des colonies d’iPSCs de différentes formes, obtenues avec 
presque le même nombre de cellules mais avec temps de traitement d’Y-27632 
différents (1, 2 et 4 h). Les colonies à gauche et au milieu ont une forme 
d’hémisphère, tantdis que celles à droite ont plutôt une forme très aplatie (barre 
d’échelle 250 µm). 
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Figure 6. Microphotographie des colonies d’iPSCs de différentes formes, contrôlée 
par le temps de traitement au Y-27632 à 1 h, 2 h et 4 h, respectivement. 
Les colonies formées dans les compartiments du patch sont similaires en taille et 
en forme. En plus, elles démontrent toutes une bonne viabilité et les expressions 
caractéristiques de la pluripotence des iPSCs (Figure 7).  
 
Figure 7. Colonies hémisphériques des iPSCs dans les compartiments d’un patch de 
culture, montrant une bonne homogénéité, une bonne viabilité et une bonne 
pluripotence cellulaire. 
2.4 Production de patch cardiaque  
Une fois que les colonies hémisphériques sont formées, la différentiation des 
iPSCs sur patch de culture peut se faire de la manière suivante (Figure 8) : Le milieu 
de culture E8 est d’abord remplacé par RPMI 1640/B27 sans insuline avec 12 µM de 
CHIR99021. Après 24 h d’incubation, le milieu est remplacé par RPMI 1640/B27 
sans insuline (jour 1). Après 48 h d’incubation, le milieu est remplacé par RPMI 
1640/B27 sans insuline avec 5µM d’IWP2 (jour 3). Après 48 h d’incubation, le 
milieu est remplacé par RPMI 1640/B27 sans insuline (jour 5). Puis, le milieu est 
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changé tous les 3 jours par RPMI / B27. Normalement, la contraction des cellules 
peut être observée pendant la période de jour 8 à jour 12. 
 
Figure 8 (a) Protocole de différentiation des hiPSCs pour réaliser un patch cardiaque. 
(b) Image de microphotographie des colonies des iPSCs vers cardiomyocytes à jour 
-2, 0, 3, 5 et 12. 
 
On observe que ces cellules sont en contraction avec une fréquence de battement 
de ~1 Hz, indiquant une maturation après différentiation de 4 semaines en utilisant le 
protocole (Lian et al, Nature Protocole 8, 162, 2013) (barre d’échelle : 20µm). 
La figure 9 montre les images de fluorescences des protéines liées aux 
expressions des cardiomyocytes dérivés des iPSCs au jour 20 sur un patch de culture 
et sur une lame de verre pour comparaison (bleu : DAPI, vert : a-Actinin ; rouge : 
TnnT2). Ces images montrent clairement la formation de sarcomères, suggérant que 
le patch favorise la maturation cardiaque. La figure 9 montre aussi les résultats de la 
cytométrie en flux, montrant que 74,7 % de cellules sont positives en TnnT2 sur 
patch mains que seulement 34,5% de cellules sont positives en TnnT2 sur verre au 
jour 21. Enfin, les résultats de q-PCR montrent une plus forte expression des gènes 
liés aux fonctions cardiaques sur patch par rapport au contrôle. 
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Figure 9 Comparaison des images d’immunofluorescence, de la cytométrie en flux, 
et de la q-PCR des cardiomyocytes différenciés sur patch et sur lame de verre.  
Une fois que le patch cardiaque est obtenu, il peut être placé sur une surface des 
multi-électrodes (MEA) pour évaluer l’effet de drogues, par exemple, par mesures 
électrophysiologiques (Figure 10). Nous avons observé un effet des drogues très 
similaire, la variation de l’intervalle des ondes T et Q et la variation de fréquence de 
battement étant dépendant du type et de la dose de drogue utilisés. Ainsi, le patch 
cardiaque que nous proposons est prêt à être utilisé comme une nouvelle plateforme 
pour évaluer la toxicité des drogues. 
 
Figure 10. Caractérisation électrophysiologie d’un patch cardiaque pour évaluer les 
effets de drogues. (a,b) Le patch est placé sur un réseau de multi-électrodes. (c) 
Variation de l’intervalle QT en fonction de la dose d’E-4031 (0, 50 et 100 nM) (d) 
Variation de fréquence de battement en fonction de la dose d’ISP et de Pro.  
2.5 Production de patch neuronal  
De la même manière, les iPSCs sont différenciées en neurones moteurs sur patch 
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de culture. Le protocole présenté dans la figure 11 suggère trois étapes de production 
de patch neuronal, i.e ., production des cellules neuroectrodermales par l'inhibition 
de la signalisation SMAD, production des progéniteurs des neurones moteurs et 
maturation des neurones moteurs.   
 
 Figure 11. Schéma du protocole de différentiation des iPSCs vers des neurones 
moteurs. 
La figure 12 montre les images de fluorescences des progéniteurs de neurones 
dérivées des iPSCs sur patch (bleu : DAPI, vert : Nestin ; rouge : β-Tubulin III), 
indiquant un taux de différentiation relativement élevé après 2 semaines de culture 
dans un milieu de culture contenant 10 µM d'acide rétinoïque).  
Après 16 jours de différentiation, les progéniteurs des neurones moteurs sur 
patch sont réensemencés sur lame de verre, réseau de multi-électrodes et patch de 
culture pour maturation. Les figures 13a et 13b montrent les images de 
microphotographie et d’immunofluorescence des cellules sur lame de verre au cours 
de la maturation. La figure 13c montre une image d’un patch neuronal sur un réseau 
de multi-électrodes (MEA) et les signaux électriques représentatifs des neurones au 
jour 38, ce qui prouve que le patch de culture est tout à fait apte à la production des 
neurones moteurs et adéquat dans le cadre d'une caractérisation par mesures 
électrophysiologiques. 
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Figure 12. Immunofluorescence des iPSCs différentiées aux jours 8 et 16. DAPI : 
Nucléaire (bleu); Pax6 : Cellules de neuro-ectoderme (vert); Nestine : Cellules 
souches neuronales (rouge); β-tubuline III: Microtubules neuronaux (vert); Olig2: 
Progéniteurs de neurones moteurs (rouge). Expression relative de l'ARNm de 
Nestine au jour 8 et d’Olig2 au jour 16. 
 
3. Étude des cellules cancéreuses 
3.1 Introduction 
Le cancer est l'une des principales causes de mortalité avec plusieurs millions de 
morts dans le monde chaque année. Parmi toutes les mortalités liées au cancer, le 
cancer métastasé représente 90% des décès. La métastase est la propagation d'une 
tumeur d’un organe à un autre qui n’est pas directement connecté au premier. La 
métastase du cancer est un processus complexe, son mécanisme n’est pas encore 
complètement compris. Typiquement, une métastase comprend les étapes suivantes : 
la transition épithéliales mésenchymateuses (EMT) et l'invasion, la propagation 
hématogène et l'extravasation, la transition mésenchymateuses épithéliales (MET) et 
la colonisation métastatique. Il a été prouvé que dans la métastase, des cellules 
tumorales circulantes (CTC) jouent un rôle essentiel. 
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Figure 13. Patch neuronal. (a) Images de microphotographie de neurones moteurs 
réensemencés au cours de la maturation sur un lame de verre; (b) Image 
d’immunofluorescence des neurones moteurs sur lame de verre aux jours 18 et 30. 
DAPI: Nucléaire (bleu); HB9: Neurone motrice (rouge); Olig2: Progéniteurs des 
neurones moteurs (rouge); β-tubulin III: Microtubules neuronaux (vert) ; (c) Image 
d’un patch neuronal sur un réseau de multi-électrodes (MEA) et signaux électriques 
représentatifs des neurones au jour 38. 
Le diagnostic précoce de la tumeur primaire, permettant de réduire au mieuxla 
métastase, est considéré comme l'arme clé pour gagner la guerre contre le cancer. 
Actuellement, trois techniques principales, i.e. l'imagerie, la biopsie et l'analyse de 
sang, sont utilisées pour le diagnostic du cancer. Parmi ces trois techniques, l'analyse 
du sang, i.e. des molécules ou des CTCs présentes dans le sang périphérique d’un 
patient, est maintenant en développement rapide. La détection des CTCs est 
particulièrement intéressante pour la détermination caractéristique du cancer. Le 
problème est que les CTCs sont rares et très rares dans le sang d’un patient, environ 
1 ~ 10 CTC sur 1 milliard de cellules de sang. Par conséquent, le principale défi 
technique est de les isoler ou de les capturer. Pour ce faire, de nombre essais ont été 
menés. La capture par affinité est basée sur l'interaction immunochimique entre les 
billes magnétiques ou les surfaces structurées et les  cellules tumorales qui 
expriment des marqueurs de surface spéciaux tels que l'EpCAM, une molécule 
d'adhésion des cellules épithéliales surexprimée par la majorité des cellules 
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tumorales. Ces méthodes sont efficaces pour capturer les CTCs de phénotypes 
épithéliaux mais inapplicable à celles qui n’ont pas ces marqueurs épithéliaux. On 
sait maintenant que lorsqu’une cellule tumorale entre dans le sang, elle pourra perdre 
son identité à cause de la transition épithéliale-mésenchymateuse, ce qui signifie que 
cette approche est intrinsèquement problématique. En revanche, les méthodes 
physiques telles que la centrifugation, la diélectrophorétique et la filtration sont 
capables d'isoler les deux types de phénotypes, (épithélial et mésenchymateux). A 
priori, ces méthodes sont plus appropriées pour les analyses de l'hétérogénéité de 
tumeurs, de la résistance aux médicaments des tumeurs, etc. Cependant, ces 
approches sont technologiquement biaisées et il est souvent difficile de parvenir à un 
compromis entre l'efficacité de la capture, la pureté et la viabilité des cellules. Par 
exemple, la méthode de filtration a été développée depuis quelques décennies en 
utilisant presque le même genre de dispositif (filtre de polycarbonate par gravure 
pré-irradié par des ions très énergiques). Le problème de cette approche est la 
contamination : on bloque les cellules du sang en même temps des cellules tumorales 
si la taille de trous du filtre est suffisamment petite pour efficacement isoler les 
CTCs. En outre, les trous dans ce filtre sont répartis de façon aléatoire et il se peut 
que deux ou plusieurs trous soient joints; dans ce cas, des CTCs peuvent passer à 
travers le filtre. Afin de surmonter ce problème, les techniques de microfabrication 
ont été utilisées pour la fabrication de filtres avec des trous beaucoup mieux définis. 
Aucune d'entre elles ne sont jusqu'à présent en mesure de répondre aux exigences de 
l'application clinique. 
Non seulement il manque des méthodes efficaces pour capturer les CTCs mais 
très peu d’études ont été menées sur les CTCs capturés. A ce propos, il sera 
intéressant d’avoir des modèles in vitro en réalisant, par exemple, des sphénoïdes 
tumoraux à partir des CTCs capturés pour voir les processus de formation sous l'effet 
de drogues. Les cellules malignes dans les tissus néoplasiques, comme les cellules 
saines dans les tissus normaux, sont organisées en 3D in vivo. Ainsi, la génération 
des sphéroïdes tumoraux en 3D est nécessaire afin de se rapprocher des formes et 
propriétés physiques du contexte in vivo. Actuellement, les études in vitro sont 
effectuées sur des sphéroïdes de petites tailles, ce qui ne peut reprendre efficacement 
la complexité sphéroïde de tumeurs solides. Pour imiter les tumeurs in vivo, il faut 
aussi considérer les conditions physiologiques du site telles que les caractéristiques 
et les distributions de nutriments et des facteurs des cellules dans la zone sphéroïde.  
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La culture en suspension est fréquemment utilisée pour réaliser des sphéroïdes 
mais il est difficile de contrôler leur uniformité et de les manipuler pour des études 
systématiques. L’utilisation d’un ballon rotatif ou de bioréacteurs peut améliorer 
l'uniformité de sphéroïdes mais aussi introduit des contraintes de cisaillement 
indésirables. L’utilisation des gouttes suspendues peut aussi améliorer l'uniformité de 
sphéroïdes. Le problème est que la manipulation de gouttes suspendues pour les 
essais de drogues nécessite beaucoup de temps pendant la progression sphéroïde. 
Plus récemment, des substrats à motifs 2D et 3D ont été proposés pour soutenir la 
formation de sphéroïdes. Afin de faciliter la diffusion des nutriments, des 
médicaments et d'autres facteurs dans la zone sphéroïde, nous avons choisi de 
travailler sur un modèle à multiples puits microfabriqués  en utilisant agarose, un 
matériau poreux et hydrophobique, permettant d’avoir une meilleure croissance de 
sphéroïdes ainsi que le criblage à haut débit. 
3.2 Capture de CTCs 
Nous avons conçu et fabriqué un dispositif microfluidique intégrant un filtre 
avec un réseau de micro-trous de forme conique et un micro-injecteur avec des 
composants à courant transversal (Figure 14). 
 
Figure 14 Dispositif microfluidique avec un filtre de trous coniques pour la capture 
des cellules tumorales circulantes. (a) Schéma du dispositif de filtration des CTCs. (b) 
Photographie d'un dispositif fonctionnant avec un échantillon de sang. (c) 
Photographie d'un filtre de diamètre de 9 mm. (d) Image de microscopie électronique 
à balayage d'un filtre avec des trous coniques. Barre d'échelle: 40µm. 
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Pour étudier les performances de ce dispositif, des cellules HT-29 ont été 
dispersées dans un échantillon de sang d'une personne en bonne santé. Les 
expériences de filtration ont été contrôlées par un pousse-seringue à une vitesse de 
traction constante. Comme résultat, nous avons récupéré la plupart des cellules 
HT-29 sur le filtre avec un nombre limité de cellules sanguines normales (Figure 15), 
montrant une efficacité de capture de ~ 95% et une pureté de capture de ~ 86%. Des 
échantillons de sang donnés par 14 patients atteints de cancer et 6 donneurs sains ont 
été utilisés pour tester la pertinence clinique de la méthode. Statistiquement, aucun 
CTCs n'a pu être détecté dans les échantillons de sang de donneurs sains mais une à 
plusieurs CTCs ont été capturées pour la plus part des patients atteints de cancer. 
 
Figure 15. Image d’immunofluorescence des cellules HT-29 sur la surface d'un filtre 
après avoir été dispersées dans le sang puis filtrées. HT-29 : anti-CK-AlexaFluor 488 
(vert) et globine blanc : anti-CD45-PE (rouge) ; Noyaux : DAPI (bleu). Barre 
d'échelle : 30 µm. 
Pour évaluer quantitativement la performance de cette méthode, une étude 
systématique a été effectuée avec des cellules HT-29 dispersées dans du PBS. Nous 
avons observé une augmentation de l'efficacité de capture avec la diminution de la 
vitesse d'écoulement (Figure 16a). Nous avons aussi constaté que l'efficacité de 
capture est pratiquement la même pour les échantillons de différentes densités 
cellulaires du fait que le nombre de cellules dispersées (10~100) est bien inférieur au 
nombre des trous du filtre (~104) (Figure 16b). Puis, nous avons remarqué que 
l'efficacité de capture dépend fortement du type de cellule et que la taille de trous du 
filtre doit être corrélée à la taille de noyaux des cellules (Figure 16c-d). Une fois 
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capturées, les cellules ont été cultivées sur le même filtre pendant trois jours. La 
plupart des cellules sont viables et le nombre de cellule a augmenté de façon 
remarquable à cause de la prolifération (Figure 16e-f). 
 
Figure 16: Performances des filtres avec des trous coniques. (a) Efficacité de capture 
en fonction de la vitesse d'écoulement. (b) Efficacité de capture pour 10, 20, 50, 100 
cellules HT-29 dispersées dans 1 ml de PBS, mesurée avec un écoulement de 0,2 ou 
0,5 ml/min, respectivement. (c) Dépendance de la capture au diamètre de trous pour  
un débit de 0,5 ml/min. (d) Taille des noyaux et taille des cellules mesurées avec une 
suspension de cellules. (e) Immunofluorescence des cellules HT-29 après coloration 
à la calcine AM / EthD-1. (f) Nombre de cellules par grappe au jour 4. Barre 
d'échelle: 50 µm. Les barres d'erreurs représentent l'écart type (SD) de trois mesures.  
Nous avons également développé une analyse théorique pour expliquer les 
avantages de ce dispositif (Figure 17). D'une part, un filtre avec des trous coniques 
permet d’égarer plus facilement les globines blanches par rapport à celui avec des 
trous cylindrique. Conformément à la loi de Laplace, lorsqu'une vésicule (WBC) 
entre dans un trou cylindrique, elle ne peut pas s’échapper sans pression à cause de 
la symétrie de courbure aux deux extrémités. Par contre, lorsque cette vésicule entre 
dans un trou conique, elle peut s’échapper rapidement sans pression puisque les 
courbures aux deux extrémités ne sont plus les mêmes (Figure 17a). Il en résulte 
théoriquement une meilleure sélectivité ou pureté de capture, ce que nous avons 
prouvé par l'expérience (Figure 17b). D'autre part, un filtre avec des trous coniques 
permet d’avoir une différence de pression des deux côtés de la membrane 
relativement faible par rapport au filtre de trous cylindriques, ce qui garantie une 
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meilleure stabilité des CTCs capturés ainsi qu'une meilleure viabilité cellulaire. 
Enfin, si le flux entre directement dans les trous sans composant tangentiel, il y aura 
des zones mortes entre les tous puisque, d’après nos simulations numériques, les 
lignes d’écoulement ne passent presque pas par ces zones, . Ceci explique l’intérêt 
d’utiliser un flux avec composants tangentiels grâce au canal circulaire avec 
multi-entrées radicales (Figure 17c). Là encore, nous améliorerons la sélectivité ou la 
pureté de capture (Figure 17d).  
 
Figure 17. Modèle et comparaison entre les filtres de trous cylindriques et coniques 
(a) Schéma de la rétention des cellules dans un trou cylindrique et conique; (b) 
Efficacité de capture et pureté des cellules tumorales pour une filtration au débit de 
0.2 ml/min; (c) Simulation de l'écoulement hydrodynamique de focalisation; (d) 
Canaux microfluidiques de la partie haute et la partie basse du dispositif. 
3.3 Formation de sphéroïdes tumoraux  
Nous avons développé une technique simple mais fiable pour la formation des 
sphéroïdes tumoraux (Figure 1). Un réseau de puits a été réalisé par les techniques de 
moulage en utilisant trois types de matériaux, PDMS, PEGDA et agarose. 
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Figure 18. Schéma de procédé de fabrication d’un réseau de multi-puits d'agarose et 
de formation de sphéroïde tumoral. 
Nous avons d’abord comparé les performances de formation de sphéroïdes dans 
les puits de ces trois types de matériaux (Figure 19a).  Clairement, l’utilisation des 
puits d’agarose est avantageuse en raison de la surface hydrophobe et la perméabilité 
élevée de ce matériau. Nous avons remarqué que même dans les puits d’agarose les 
sphéroïdes tumoraux ont cessé de croitre après cette taille quelle que soit la densité 
cellulaire initiale (Figure 19b). Dans des puits de 2 mm de diamètre d'agarose, des 
sphéroïdes tumoraux U87 de diamètre de 1,4 mm peuvent être formés après culture 
pendant 10 jours. Pour étudier l'effet du médicament anti-cancer, la Combretastatine 
A-4 (CA4) a été ajoutée au jour 2 ou jour 4, montrant des effets clairs sur la 
formation de sphéroïdes et la viabilité des cellules tumorales (Figure 19c). Plus 
important encore, nos résultats suggèrent qu'un traitement précoce de médicament 
était plus efficace pour interdire la croissance du sphéroïde tumoral. 
4. Conclusion et perspectives 
Ce travail a pour but de mettre au point des nouvelles techniques et outils pour la 
recherche avancée sur les cellules souches et les cellules cancéreuses. Nous avons 
d’abord proposé un patch de monocouche de nanofibres réticulées, permettant de 
cultiver et de différentier les cellules souches pluripotentes induites humaines 
(hiPSCs) “hors sol”. Puis, nous avons démontré la formation des tissus cardiaques et 
neuronaux sur patch à partir d'hiPSCs. Ensuite, nous avons développé un dispositif 
microfluidique avec une membrane composée de trous de forme conique pour 
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d'abord isoler les cellules tumorales circulantes (CTCs) puis les cultiver. Enfin, nous 
avons évalué l’effet de drogues anticancéreuses sur la formation des sphéroïdes 
tumoraux en utilisant des multi-puits d’agarose micro-fabriqués. En conclusion, nous 
avons progressé sur les techniques de la micro-ingénierie dédiées aus applications à 
grandes échelles et cliniques.  
 
Figure 19. (a) Formation des sphéroïdes tumorales dans multi-puits de PDMS, 
PEGDA et agarose, respectivement; (b) Formation de sphéroïde tumorale dans un 
puits d’agarose et variation de taille du sphéroïde en fonction du temps; (c) Effet du 
médicament anticancéreux CA4 sur la morphologie des sphéroïdes tumorale et 
viabilité des cellules. Barre d'échelle: 0.5 mm. 
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List of Abbreviations
2D Two-dimensional 
3D Three-dimensional 
AA Ascorbic acid 
ALS Amyotrophic lateral sclerosis 
BDNF Brain-derived neurotrophic factor 
BF Bright field 
bFGF Basic fibroblast growth factor 
CA4 Combretastatin A4 
CAM Cellular adhesion molecules 
cAMP Cyclic adenosine monophosphate 
CNC Computer numeric controlled 
CTCs Circulating tumor cells 
CVD Cardiovascular diseases 
DAPI 4’-6-diamidino-2-phenylindole 
DMEM Dulbecco’s Modified Eagle Medium 
EB (EBs) Embryonic body (Embryonic bodies) 
ECF Extracellular fluid 
ECM Extracellular matrix 
EGF Epithelial growth factor 
EMT Epithelial to mesenchymal transition 
ESCs Embryonic stem cells 
FACs Fluorescence-activated cell sorting 
FBS Fetal Bovine Serum 
FGF Fibroblast growth factor 
FISH Fluorescence in situ hybridization 
FPs Field potentials 
GDNF Glial-derived neurotrophic factor 
HA Hydroxyapatite 
HOMPP 2-hydroxy-2-methylpropiophenone 
HSCs Hematopoietic stem cells 
IGF-1 Insulin-like growth factor 1 
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iPSCs Induced pluripotent stem cells 
KSR Knockout Serum Replacement 
MEA Multi-electrode array 
MEA Multi-electrode array 
MEMS Micro-electromechanical systems 
MET Mesenchymal to epithelial transition 
MND Motor neuron disease 
MRI Magnetic resonance imaging 
MSCs Mesenchymal stem cells 
NEAA Non-Essential Amino Acid 
PCL Poly(ε-caprolactone) 
PCR Polymerase chain reaction 
PDMS Polydimethylsiloxane 
PEG Poly(ethylene glycol) 
PEGDA Poly(ethylene glycol) diacrylate 
PEGDMA Poly(ethylene glycol) dimethacrylates 
PET Positron emission tomography 
PFA Paraformaldehyde 
PGA Polyglycolic acid 
PLA Poly(lactic acid) 
PLGA Poly-dl-lactic-co-glycolic acid 
PLLA Poly-l-lactic acid 
PO Polyornithine 
Pur Purmorphamine 
RA Retinoic acid 
RBCs Red blood cells 
RT-PCR Reverse transcription-polymerase chain reaction 
SMA Spinal muscular atrophy 
TCP Tri-calcium phosphate 
TMCS Trichloromethylesilane 
VEGF Vascular endothelial growth factor 
WBCs White blood cells 
μTAS Miniaturized total chemical analysis system 
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Abstract: 
This work aimed to provide new tools and methods that can be used for advanced 
studies of stem cells and cancer cells. We first developed a patch method for 
off-ground culture and differentiation of human induced pluripotent stem cells 
(hiPSCs). The culture patch we proposed consists of crosslinked monolayer gelatin 
nanofibers on a honeycomb frame to ensure minimal exogenous material contact and 
maximum permeability. Then, we demonstrated the formation of cardiac tissue 
constructs and motor neurons on the patch, started from embryoid-body like and 
monolayer hiPSC colonies, respectively. We also developed a microfluidic device 
with integrated filter for isolation of circulating tumor cells (CTCs), showing high 
capture performances in terms of efficiency, selectivity and cell viability. Finally, we 
evaluated the anti-cancer drug effect on the formation of tumor spheroids by using 
microfabricated agarose multi-wells. All together, we progressed in micro-engineering 
toward large scale applications.  
  
Keywords: Stem cell; Cancer cell; Nanofibers; Microfluidics  
 
Résumé: 
Ce travail a pour but de mettre au point des nouvelles méthodes pour la recherche 
avancée sur les cellules souches et les cellules cancéreuses. Nous avons d’abord 
développé une méthode de patch pour la culture et la différentiation des cellules 
souches pluripotentes induites humain (hiPSCs) “hors sol”. Ce patch de culture est 
constitué des monocouches de nanofibres réticulées de gélatine sur un support en nid 
d'abeilles pour assurer un minimum de contact de matériel exogène et un maximum 
de perméabilité. Puis, nous avons démontré la formation des tissues cardiaques et des 
neurones moteurs sur le patch, partis de colonies des hiPSCs en forme d’embryoïdes 
et de monocouches respectivement. Nous avons également développé un dispositif 
microfluidique avec filtre intégré pour isoler les cellules tumorales circulantes (CTCs), 
montrant une haute performance de capture en termes d’efficacité, de sélectivité et de 
viabilité cellulaire. Enfin, nous avons évalué l’effet de drogue anticancéreuse à la 
formation des sphéroïdes tumoraux en utilisant des multi-puits d’agarose 
micro-fabriqués. Tous ensembles, nous avons progressé dans la micro-ingénierie vers 
des applications à grande échelle.  
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